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ABSTRACT

PART I
The chemistry of propargyliumdicobalt cations, known as the Nicholas reaction,
has witnessed widespread use in organic synthesis mainly owing to the high stabilization
of the carbocations, accompanied by their compatibility with numerous nucleophiles.
However, there is a considerable shortage of studies regarding the factors affecting the
stability and reactivity of the involved cations.
In this project, we investigated the chemistry of a novel Nicholas carbocation,
namely the benzo-homologue of the dehydrotropylium cation, known as a
benzodehydrotropyliumCo2(CO)6 cation. To obtain the desired cation, preparation of the
requisite alcohol precursor involved the key ring-closure of the cycloheptyne via an
intramolecular

Sakurai

reaction.

Additionally,

heterocyclic-based

cycloheptadienynolCo2(CO)6 complexes were also prepared. A Lewis acid mediated
ionization of the parent alcohol complex led to the in situ generation of the
benzodehydrotropyliumCo2(CO)6 ion, which was trapped with several nucleophiles,
where the preferred site of substitution was the site remote to the dicobalt alkyne unit.
Computational studies using NICS (1) values estimated the ion's aromaticity to be one
third

of

that

of

tropylium

ion,

which

is

comparable

dehydrotropyliumCo2(CO)6 ion previously studied in our group.

v

to

that

of

the

PART II

Allocolchicinoids are a well-recognized family of compounds (including both
natural and synthetic derivatives) which possess a 6-7-6 tricyclic core. Many of them are
known to have antitumor activity where they act by the same mode of action as the
natural alkaloid colchicine, that is to say by inhibiting the cellular tubulin assembly
process.
Particular attention has been devoted by our group to a series of allocolchicinoids
bearing a modified A-ring substitution pattern, which is different from the one seen in the
naturally-derived allocolchicine. Biological studies have shown their potency in targeting
cancer cells. Considering the dibenzocycloheptanone as the core of the allocolchicine, we
present herein our results on getting to allocolchicinoids based on an approach that
constructs the B-ring via catalytic conjugate addition reaction chemistry, ultimately
leading to the synthesis of allocolchicinoids of interest. The viability of this strategy is
demonstrated by the preparation of differently substituted C-ring substrates. This work
also reports the formal synthesis of allocolchicine iso-NSC 51046, and the first total
syntheses of two novel allocolchicines.
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PART I
CHAPTER 1: INTRODUCTION

1.1

Nicholas Reaction
For many years, the use of propargylic cations as electrophilic synthons has been

limited owing to the relatively low ability of the alkynyl function to impart stabilization to
the generated positive charge. This severe limitation has been overcome by the discovery
of Nicholas and Pettit1 in 1971 when they initially reported the use of dicobalt
hexacarbonyl (Co2(CO)6) unit as a protecting group for the CC triple bond. During their
development of this chemistry, the authors noted the facile acid-promoted
hydration/dehydration equilibrium between the dicobalt hexacarbonyl-complexed
propargyl alcohols (1) and their corresponding 1,3enynes (2) (Scheme 1.1).2,3

Scheme 1.1 Equilibrium of hydration/dehydration process of Co2(CO)6complexed
propargylic alcohols with their enyne complex.
1

This observation led to the postulation that the dicobalt hexacarbonyl group is
capable of stabilizing propargyl carbocation. Stemming from this pioneering finding,
Nicholas et al.2 developed the first substitution reaction involving a dicobalt
hexacarbonyl-complexed propargylic alcohol (3) in the presence of strong protic acid and
electron-rich benzene compounds. The generation of a cation (3a), propargylic to an
alkyneCo2(CO)6 group, usually by ionization of an oxygen-based function by a protic or
Lewis acid, followed by the trapping of that cation by nucleophiles, is commonly known
as the Nicholas reaction (Scheme 1.2).

Scheme 1.2 The Nicholas Reaction.

Generation of the propargyliumdicobalt cation is not restricted to the acidpromoted ionization of a propargylic alcohol complex. Alternatively, Smit and Caple4
reported that the carbocation could be generated from different precursors, namely 1,3enyneCo2(CO)6 complexes (4) and an electrophile (Scheme 1.3). Subsequently, a mild

2

oxidative demetalation can regenerate the alkyne functionality of the resulting substituted
products (5).

Scheme 1.3 Generation of propargyliumdicobalt cation from enyneCo2(CO)6 complex.

Cation Stability
The

remarkable

thermodynamic

and

kinetic

stability

of

[propargyliumCo2(CO)6]+ cations is evidenced by their convenient isolation and longterm storability as salts. Owing to their exceptional stability, the salts of such cations have
been isolated by Connor and Nicholas5 as stable, dark red solids upon treatment of the
Co2(CO)6complexed propargylic alcohols with excess HF-SbF5 or tetrafluoroboric acid
etherate. The authors also studied the thermodynamic stability of a group of cobaltcoordinated propargylium cations by determining the pK's for ionization of their
corresponding alcohol complexes. It was reported that the cations' measured pKR+ value
ranges from 6.8 to 7.4 (5.5 as reported in another reference6), which in fact is
comparable to that of the well-known stable cation, triphenylmethyl (trityl, Ph3C+) cation,
whose pKR+ is 6.6. It was also noted that the pKR+ values of the studied propargylic
carbocations were essentially identical, regardless of the substituents at the cation center.5
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Furthermore, the stability of the cations have been also confirmed through
spectroscopic studies. By comparing the IR spectra of the cationic species and the parent
alcohol complex, a noticeable increase in the IR absorption frequencies of the CO ligands
of the cationic complex was evident (~ 40-60 cm-1) when compared to those of the
alcohol complex. This shift denotes a significant charge delocalization onto the cobalt
carbonyl unit, a feature that can be rationalized by the increased CO bonding resulting
directly from reduced d (Co)*(CO) donation in the electron-poor cation.5

Reactivity and Regioselectivity of Propargyliumdicobalt Cations
The

alkyneCo2(CO)6

complexes

are

readily

prepared

by

stirring

octacarbonyldicobalt(0), which is commercially available, and the alkyne-containing
substrates, to form 2-hexacarbonylalkynedicobalt complexes. The reaction normally
proceeds at room temperature in many different types of organic solvents such as: diethyl
ether, tetrahydrofuran, and dichloromethane. A wide scope of alkynes can undergo this
complexation process, including terminal alkynes, symmetrical and unsymmetrical
disubstituted alkynes, diynes, triynes, and cyclic alkynes.7 The resultant complexes are
purified by chromatography on alumina or silica gel, to afford the products as dark
brown, or maroon-red colour oils or solids; they have remarkable stability if stored at low
temperatures.
The versatility of the Nicholas reaction largely arises from the compatibility of the
generated propargylic electrophilic synthon with a wide range of nucleophilic partners,
including both inter- and intramolecular processes.8 Our group and several others have
expanded the scope of this reaction by exploring a range of nucleophilic partners such as
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electron-rich arenes,9 alkenes,10 ketones,11 hydrides,12 allylmetaloids,13 and enol
derivatives including carbon and heteroatom-based ones.14,15 In addition, heteroatomic
nucleophiles like ROH, RNH2, RSH, PR3 are also compatible.16-18
When the generated cation, propargylic to an alkyneCo2(CO)6 group, is in an
acyclic system, the nucleophilic substitution tends to occur exclusively at the propargylic
site,19 unless the cation is also allylic (6), in which case the substitution has been found to
occur predominantly at the terminus remote to the alkyne–Co2(CO)6 unit, i.e. -site
(7, Scheme 1.4). This bias towards (E)-1,3enynes was first addressed by Padmanabhan
and Nicholas19a in 1982, where it has been attributed to the considerable steric hindrance
of the Co2(CO)6 moiety and not to any hypothetical stabilizing conjugative interaction
between the C=C double bond and the alkyne complex. Some exceptions have been
encountered in literature, such as cases where the nucleophilic attack reactions are
entropically driven towards the -site.20 Some oxygen-based nucleophiles proceed
through -site attack pathway to give the corresponding propargylic substitution
products.19a, 21

Scheme 1.4 Reactivity of acyclic propargylic/allylic cations with nucleophiles.
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The site selectivity studies were expanded further when our group targeted allylic
cations derived from cyclic precursor, namely cycloheptynes based ring systems (Scheme
1.5).22 To gain access to the cation of interest, the requisite precursor (i.e. the cyclic
allylic acetate alkynedicobalt complex (9)) was obtained readily by ring closing
metathesis.

Scheme 1.5 Reactivity of cyclic propargylic/allylic cations with nucleophiles.

The results of Nicholas reactions on the cation derived from the cyclic precursor
(9) showed preferential reaction at the terminus remote (i.e. γ-) to the alkynedicobalt
function (10), with increasing amounts of -product (11) for reaction partners with
greater nucleophilicity. Heteroatom-based nucleophiles, which react reversibly, gave products (10) exclusively. The thermodynamic preference for the -product has been
ascribed to the conjugative enyne stabilization in -product. Also, kinetically, this product
is believed to be favoured since it exhibits less steric hindrance at the -position.22
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1.2

Angle Strained Alkynes

A recurring theme in organic synthesis is the development of efficient ways to
synthesize medium-sized cycloalkynes.23 Since the triple bond prefers a linear geometry,
cycloalkynes often have limited stability.24 An eight-membered ring alkyne (13), (Figure
1.1), is the smallest ring size that can tolerate this deformed geometry and still be isolated
as a stable molecule.25 It has been generally accepted that the CC C bond angle in
cyclooctyne deviates 17 from the idealized 180 angle of a triple carbon-carbon bond.

Figure 1.1 Categories of various cycloalkynes based on their occurrence.26

In contrast to the isolable medium-sized cycloalkynes, their smaller homologues
(i.e. five-, six-, and seven-membered cycloalkynes, 14-16) are non-isolable; they are
however capable of existing as transient and highly reactive reaction intermediates that
oligomerize rapidly.28 The occurrence of these unstable cycloalkynes has been confirmed
experimentally by careful generation in solution and in a matrix. For example, irradiation
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of cyclopropenone compound (19) in an argon matrix at 17 K provided (14) readily and
allowed the measurement of the vibrational spectrum of cycloheptyne (Scheme 1.6).29

Scheme 1.6 Preparation of cycloheptyne by argon-matrix irradiation.

To gain access to the aforementioned cycloalkynes "in-solution", these highly
reactive intermediates were generated in situ in a fast reaction at very low temperatures
and in the absence of any reactive reagents that might interfere with the triple bond of the
alkyne. Once formed, these transient species could be trapped with specific reagents,
hence enabling the measurement of the kinetic stability of the cycloalkynes of interest.
For instance, in dilute dichloromethane solution at 25 C, cycloheptyne possess a halflife of less than a minute, but it can be increased to one hour at 78 C.30 Under analogous
conditions, the lifespan of cyclohexyne at 110 C is only a few seconds. Finally, no
experimental data supports the existence of cyclic alkynes with lower ring sizes (i.e. five-,
four-, and three-membered ones).
In the vast majority of cycloheptynes and smaller cycloalkynes, the strain of
bending the formally sp-hybridized carbon atoms substantially away from 180° would be
accompanied with a great energetic cost. This situation may be alleviated by resorting to
transition metal complexes of these cycloheptynes, particularly the dicobalt hexacarbonyl
complexes.31 Upon complexation of a carbon-carbon triple bond to a Co2(CO)6 unit, there
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are two critical features of the newly formed organometallic complex that are worth
highlighting: 1) a significant added stabilization to the cation generated at the propargylic
site, and 2) the normally linear digonally hybridized triple bond bends to ca. 140. These
specific features have made it possible for chemists to derive reactive intermediates and
cyclic alkynes which would otherwise not accessible in their metal‐free counterparts.

1.3 Preparation of Cycloheptynes and Benzocycloheptynes by Nicholas
Reaction Chemistry
Since its

discovery just

over

four decades

ago,2

the chemistry of

cycloheptyneCo2(CO)6 complexes (i.e., the Nicholas reaction) has proven to be
especially intriguing and widely used in organic transformations owing to the reliable site
of reactivity of the cations, their ready generation and significant stability, coupled with
their ability to engage in reaction with a broad spectrum of nucleophiles. The
intermediacy of these complexes has proven to be particularly reliable in the construction
of cycloheptynedicobalt complexes.32
Additionally, Nicholas reaction chemistry has proven its efficiency in preparation
of benzo-fused seven-membered ring compounds, in spite of the scarcity of methods
developed for quick access for those ring systems. Benzocycloheptanes and
benzocycloheptanones are of remarkable importance since they are commonly
encountered in a variety of natural and pharmacologically relevant products including
icetexanes,33 ()-colchicine and its analogue ()-allocolchicine,34 and purpurogalline,35 to
name a few (Figure 1.2).
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Figure 1.2 Selected examples of organic compounds with benzocycloheptane-based
skeleton.

1.3.1 Cycloheptynedicobalt Complexes
In 1986, the early efforts by Schreiber et al.36 paved the way for the synthesis of
this class of compounds. Their reported methodology employed a Lewis acid mediated
reaction of propargyl ether dicobalt hexacarbonyl complexes bearing a remote allylsilane
(23), to afford a cycloalkyne complex with an exocyclic vinyl group (24). By varying the
length of the carbon tether in the substrate, eight and even six-membered rings were
formed analogously. Another related preparation of this class of compounds was
developed by our group,37 where our initial efforts were primarily driven by the
developed knowledge about the γ-carbonyl cationCo2(CO)6 complexes and their
potential use as successful precursors for cycloheptyne formation. With that in mind, and
following experimentation with different substrate designs, a series of allylsilane
containing propargylic acetates (25) were deemed to be suitable precursors. In the
presence of BF3-OEt2, they readily underwent facile intramolecular cyclization via
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Nicholas reaction to give cycloheptenynes (26), bearing an endocyclic alkene function, in
respectable yields (84-89 %), (Scheme 1.7).

Scheme 1.7 Synthesis of cycloheptyneCo2(CO)6 complexes via intramolecular Nicholas
reaction.
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1.3.2 Benzocycloheptynedicobalt Complexes
The use of acyclic alkynedicobalt complexes and Nicholas reaction chemistry
have been established as powerful means for rapid preparation of cycloheptyneCo2(CO)6
complexes. Only a limited number of ring fused versions of these cycloheptyne
complexes are known; of these, our group has a special academic interest in gaining
access to benzocycloheptyne complexes. Ding and Green38 reported an effective
utilization of Nicholas reaction in the synthesis of a series of benzocycloheptynedicobalt
complexes in addition to other heterocyclic analogues. In their synthetic approach, the
design of the precursor was based on exploiting the ability of propargyldicobalt cations to
react with electron rich arenes via intramolecular Nicholas reaction to afford the benzofused cycloheptyne complexes. By subjecting the precursor (27) to BF3-OEt2, the
intended benzocycloheptyne-dicobalt complex was successfully formed (28, Scheme
1.8). Substrates with electron rich benzene rings underwent the cyclization reaction more
rapidly (compared to the unsubstituted counterparts). In addition, the reaction scope also
included successful preparation of hetero-fused cycloheptyne complexes, including
thienyl, furyl and indole systems.

Scheme 1.8 Preparation of benzocycloheptynedicobalt complexes via intramolecular
Nicholas reaction.
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1.4 Preparation of Cycloheptynes and Benzocycloheptynes by Other
Methods

1.4.1 Cycloheptynedicobalt Complexes
By Ring Closing Metathesis

Nicholas reaction chemistry is not the sole method to access cycloheptynedicobalt
complexes. Rapid access to cycloheptenyneCo2(CO)6 complexes is available via ring
closing metathesis (RCM) chemistry. Green39 reported the first RCM reactions on alkynecobalt complexes, where hexacarbonyldicobalt complexes of cycloheptenynes (30a) were
cleanly obtained by the ring closing metathesis of the corresponding acyclic dienes (29a),
using Grubbs' catalyst, (Cy3P)2Cl2Ru=CHPh in good to excellent yields (Scheme 1.9).

Scheme 1.9 Synthesis of cycloheptynedicobalt complexes via ring closing metathesis by
Green.39
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Two years later, Young's group40 reported the use of analogous chemistry to
obtain cycloheptyneCo2(CO)6 complexes (among other medium-sized rings). The
construction of the seven-membered ring of cycloheptyne was achieved by the metathesis
of dienes (29b) that were linked by a Co2(CO)6complexed alkyne, in the presence of
Grubbs I pre-catalyst (Cy3P)2Cl2Ru=CHPh (Scheme 1.10).

Scheme 1.10 Synthesis of cycloheptynedicobalt complexes via ring closing metathesis
by Young et al.40

The first attempted reaction was carried out with dienene substrate (29b), where
R1= H and R2= OH, but it failed to metathesize under the given conditions. This result
prompted a structural modification by incorporating a protecting group for the alcohol,
namely OTBDS, which in fact resulted in successful RCM, and the cyclic product was
obtained in 80 % yield. A variety of cycloheptynedicobalt complexes (30b) were
synthesized with variable propargylic substituents to furnish the RCM product in yields
ranging from moderate to excellent.
14

By Cycloaddition Reactions

Cycloheptynedicobalt complexes have also been prepared by means of
cycloaddition reactions. Tanino and co-workers41 used propargylic cationic species to
develop a [5+2] cycloaddition protocol to generate cyclic (34) and bicyclic (34a)
cycloheptyne–Co2(CO)6 adducts (Scheme 1.11). Under the influence of EtAlCl2,
hexacarbonyldicobalt propargyl cation (32), i.e. the five-carbon entity or pentadienyl
cation surrogate, reacted with enol triisopropylsilyl ethers (31 and 31a) via Nicholas
reaction to initially construct silyloxonium ion intermediates (33), which in turn
underwent intramolecular cyclization to furnish the cycloheptyneCo2(CO)6 complexes in
good yields (34 and 34a).

Scheme 1.11 [5+2] Cycloaddition reactions in the synthesis of cyclic and bicyclic
cycloheptyneCo2(CO)6 complexes.
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By Diels-Alder Reaction
Iwasawa group42 has demonstrated that cycloheptynedicobalt complexes can also
be generated by silica gel mediated Diels-Alder reactions (Scheme 1.12). When placed on
silica gel column under inert atmosphere, furan-enynone complex (35) underwent an
intramolecular Diels–Alder reaction providing a mixture of the starting alkyneCo2(CO)6
complex and the desired cyclized alkyneCo2(CO)6 complex (36) in equilibrium. The
alkene in the furan ring of the Diels-Alder adduct was then rapidly subjected to
hydrogenation with H2 and Pd/C to furnish reduced (37) as a stable complex in 62 %
yield (over two steps).

Scheme 1.12 Diels-Alder reaction in cycloheptynedicobalt synthesis.

By Michael Reaction
Iwasawa43 also reported another strategy that's suited for the stereoselective
synthesis of medium-sized cyclic compounds, including seven-membered ring ones.
Through the intermediacy of alkynedicobalt hexacarbonyl complex precursors (38)
containing silyl enol ether and electron-deficient alkene moieties on opposite ends of the
molecule, an intramolecular Michael-type reaction was promoted with a Lewis acid in the
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presence of 2,6-di-(tert-butyl) pyridine (DTBP) to afford a mixture of cyclized silyl enol
ether (39) and its hydrolyzed ketone (40) in a combined yield of 73 % (Scheme 1.13).

Scheme 1.13 Synthesis of cycloheptynedicobalt complexes using intramolecular
Michael-type reaction.

1.4.2 Benzocycloheptynedicobalt Complexes

By Carbonylative Heck Reaction
A novel approach was reported by Iwasawa and Satoh44 which involved the
unique usage of the carbonylative Heck-type coupling reaction in the synthesis of a
benzocycloheptynedicobalt complex (43), (Scheme 1.14). In order to carry out the
palladium catalyzed Heck-type coupling step, hexacarbonylalkynedicobalt complex (41)
was subjected to ligand exchange with 1,1-bis(diphenylphosphino)methane (dppm) to
produce the more thermally stable alkyneCo2(CO)4-dppm complex (42). In addition, the
optimal carbonyl source was found to be diphenylacetyleneCo2(CO)6.
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Scheme 1.14 Carbonylative Heck reaction.

By Rhodium(I)-Catalyzed [3 + 2] Annulation Reaction
An elegant approach has been reported by Murakami45 involving the development
of rhodium(I) catalyzed [3 + 2] annulation reactions to form benzotropones. In the main
proposal, reacting 2-cyanophenylboronic acid (45), as a three-carbon component, with an
internal alkyne or strained alkene afforded the five-membered ring indenone derivative
(41 to 93 % yield) in the presence of 5 mol % of [Rh(OH)(cod)]2 catalyst. However, in
one case, when ethyl 2-hexynoate (44) was used as the alkyne substrate, its reaction with
2-cyanophenylboronic acid (45) under similar reaction conditions resulted in the
unexpected formation of benzotropone (46) as the major product (64 %) instead of the
five-membered ring indenone derivative (Scheme 1.15).
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Scheme 1.15 Benzotropone skeleton formation via rhodium(I)-catalyzed [3+2]
annulation reaction.

Cyclization of bis-silyl enol ethers with 1,2-dialdehydes
A series of 4,5-benzotropones have been prepared by Langer and co-workers46
through two related pathways (Scheme 1.16). The first one involved a TiCl4-mediated
cyclization of 1,3-bis-silyl enol ethers (47) with phthalic dialdehyde (48). Alternatively,
the same 1,2-dialdehyde compound (48) could react with (2,4-dioxobutylidene)
triphenylphosphoranes (49) via a Knoevenagel/Wittig reaction to afford similar
benzotropones (50).
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Scheme 1.16 Formation of 4,5-benzotropones.

1.5 Origin of Current Project and Proposed Research
1.5.1

Dehydrotropylium–Co2(CO)6 Ion
Tropylium ion (also known as cycloheptatrienyl cation), is a well-recognized

seven-membered ring cyclic cation which depicts a classical example of a Hückel-type
aromatic compound with 6-electrons (51), (Figure 1.3).47 Given the significance of this
cationic species, our group has studied and reported the generation and reactivity of the
dehydrotropyliumCo2(CO)6 cation (52).48

Figure 1.3 Tropylium cation (51) and dehydrotropyliumCo2(CO)6 cation (52).
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The primary objective of the study was to provide a better understanding of the
stabilization of propargyldicobalt cations by investigating whether (25) demonstrates
greater stability than un-functionalized propargyldicobalt cations, and whether its nominal
6-electron system shows evidence of aromaticity.48 The dehydrotropyliumCo2(CO)6
cation was accessed from the corresponding cycloheptadienynol–Co2(CO)6 complex
precursor (54), which was in turn derived from [(diacetoxy)cycloheptenyne] dicobalt
complex (53), a compound previously prepared in our group via ring-closing metathesis
chemistry.39 The RCM adduct underwent a series of transformations, as shown in
(Scheme 1.17), including acid-induced alkene isomerization, MnO2 oxidation, and
DIBAL-H reduction, to give the target alcohol (54) with the desired -conjugated system.

Scheme 1.17 Synthesis of cycloheptadienynol–Co2(CO)6 complex (cation precursor).
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Reaction of alcohol (54) with HBF4 (in CH2Cl2 at -78 C) followed by the
addition of Et2O (or alternatively subjecting a solution of (54) in Et2O to HBF4 at -78 C)
afforded the dehydrotropylium ionCo2(CO)6 complex (52) as a dark solid precipitate.
The resultant precipitate was sufficiently stable to be analyzed by 1H NMR spectroscopy.
In addition to the detection of the desired cation, NMR analysis also revealed the
presence of two regioisomers of radical dimers (55a and 55b) whose structures are given
below (Scheme 1.18).48

Scheme 1.18 Generation and precipitation of dehydrotropyliumCo2(CO)6 complex
ion (52): 1H NMR resonances assignment and dimerization by-products.

Chemical shifts assignments of the cation's protons are depicted in (Scheme 1.18).
Perhaps the most noteworthy aspect of the spectrum is that all three chemically distinct
protons have resonances that appear upfield from those of the classical tropylium ion as
measured by Cox et al.49 ( 9.16 ppm in CH2Cl2). In regards to the protons in the two
22

propargylic sites of the complex, they are more downfield (in comparison to the rest of
the ring), which is indicative of slightly reduced positive charge possession. In view of
the brief stability of cation (52) as evidenced by its gradual decomposition in solution
even at temperatures as low as 20 C, this made
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C NMR analysis for the cation

unattainable.48
Reactivity studies of cation (52) showed that in the presence of reactive
nucleophiles (N > 1 on the Mayr50 scale), nucleophilic addition reactions took place
predominantly at the propargylic site (-site) of the cobalt-complexed alkynyl unit in the
cationic species. In the presence of less reactive nucleophiles (N < 1) however, cation (52)
underwent a different reaction pathway where dimerization products were formed instead
(Scheme 1.19).

Scheme 1.19 Generation and reactivity of dehydrotropyliumCo2(CO)6 complex ion.
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To assess the aromaticity (or the lack thereof) of the generated cation, three
different computational methods were evaluated: the harmonic oscillator model of
aromaticity (HOMA), by evaluation of homodesmotic reactions involving cation (52),
and by the nucleus-independent chemical shift, NICS (1) method. Upon examining the
results gained from each of the three methods, it was concluded that values obtained from
homodesmotic reactions and NICS(1) calculations presented a more accurate depiction of
the aromaticity measure, where both suggested that cation (52) possess ca. 25 % the
aromaticity of tropylium ion (51). On the other hand, the value obtained by HOMA
method was considered to be less reliable and hence was disregarded in the aromaticity
assessment.48

1.5.2

Tropylium Ion and Annulation Effect
Several decades ago, Pettit and co-workers51 disclosed interesting observations

when they reported that the annulation of benzo- or heterocyclic derived -systems
significantly affect the properties of the parent ionic species. Tropylium ion (51), which is
a representative of the nonbenzenoid aromatic 6-electron system, has a good
thermodynamic stability,47 where its pKR+ is 4.7. A significant destabilization of
tropylium ion is brought about by benzo-annulation as demonstrated by benzotropylium
ion (56), (Figure 1.4) (pKR+ = 1.7)52 and dibenzotropylium ion (57) (pKR+ = 3.7)53. This
suggests that the benzotropylium cation is about 103 times less stable than a tropylium
cation.54
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Figure 1.4 Tropylium cation (51) and examples of annulated tropylium ions (56-62).

Conversely, an appreciable stabilization is evident when a tropylium ion was
annulated with azulene; cyclohepta[a]-azulenylium ion (58), has been synthesized and its
enhanced stabilization was measured to be (pKR+ = 7.3)55. A similar trend has been
observed when tropylium ion was annulated to a furan (59) or thiophene ring (60) where
an increase in stability was obtained (pKR+ = 6.7 and 6.0, respectively).56 Two novel
tropylium ions were studied by Pedaja and Gronowitz57, which involved annulating a
benzo-fused tropylium ion to a thienyl ring in one case, and a selenolo-ring in another.
Using potentiometric titration methods, the authors measured the corresponding pKR+
values of these ions and were found to be 3.8 for benzo[4,5]thieno[2,1-b]tropylium ion
(61) and 3.4 for benzo[4,5]selenolo[2,1-b]tropylium ion (62).57 These values signified
that the stabilities of these "hybrid" ions were lower than the thienotropylium ion, but
higher than that of the benzotropylium ion. All these experimental data provide strong
evidence that combining more than one -system could endow new properties to the
original -system.54
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1.5.3 BenzodehydrotropyliumCo2(CO)6 Cation

In view of our group's long-standing and sustained interest in developing
preparation methods of benzocycloheptyneCo2(CO)6 complexes to enable formation of
various synthetic targets, it seemed to us of primary interest to further expand the utility
of benzocycloheptyne complexes by investigating the formation and underlying reactivity
of

the

benzo-homologue

of

the

dehydrotropylium

cation,

also

known

as

benzodehydrotropyliumCo2(CO)6 cation (Figure 1.5). Encouraged by the fruitful results
obtained by Amiralaei and Green48 in their previous work on preparation of Co2(CO)6
complex of dehydrotropylium ion, we chose to extend the cation-related studies to
include

the

benzo-fused

analogue

ion

as

well.

It

was

envisioned

that

benzodehydrotropyliumCo2(CO)6 cation would have a crucial role in acquiring better
understanding of this novel class of ions, including their preparative methods, generation,
associated reactivity towards nucleophiles, and finally the aromatic character.

Figure 1.5 Structure of benzodehydrotropyliumCo2(CO)6 cation.
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CHAPTER 2: RESULTS AND DISCUSSION

2.1

Towards the Synthesis of Target Benzodehydrotropylium
Co2(CO)6 ion

2.1.1 Retrosynthetic Analysis
In literature, there are a limited number of methodologies that provide access to
benzo-annulated

cycloheptyne

compounds.

To

prepare

the

desired

benzo-

dehydrotropyliumCo2(CO)6 ion, a synthesis plan was developed which involved two
main parts. The first one aimed to provide a reasonable synthetic route to the cation
precursor compound; this in turn would lead to initiating the second part which entailed
generating the corresponding cationic species and examining the possibility of trapping it
with nucleophiles of choice. The retrosynthetic strategy followed to prepare the
benzodehydrotropyliumCo2(CO)6 ion is envisaged in (Scheme 2.1). The central step
involves forming the cycloheptadienynol complex, which is perceived as the direct
precursor to the intended cation (63).
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Scheme 2.1 Proposed retrosynthetic approach to the formation of the benzodehydrotropyliumCo2(CO)6 ion.

2.1.2 Preparation of CycloheptadienynolCo2(CO)6 Complex: Cation
Precursor

The starting point of the synthetic plan was the assembly of 2-bromobenzaldehyde
(64) and (trimethylsilyl)acetylene (65) under appropriate Sonogashira-type reaction
conditions, i.e. palladium(0) as a catalyst and copper(I) as co-catalyst, to give the
trimethylsilyl-protected alkyne (66) in 85 % yield (Scheme 2.2). Subsequently, the
obtained alkyne (66) underwent desilylation by potassium carbonate in methanol to give
the terminal alkyne species (67) quantitatively.
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Scheme 2.2 Subjecting 2-bromobenzaldehyde to a Sonogashira reaction followed by
desilylation to install the intended terminal alkyne group.

The latter compound was in turn submitted to another Sonogashira-type cross
coupling reaction with 2-bromo-3-(trimethylsilyl)-1-propene (68) to afford the requisite
enyne substrate (69) in 71 % yield. The next step proceeded smoothly, where the prepared
alkyne was subjected to complexation with dicobalt octacarbonyl, and the corresponding
dicobalt hexacarbonyl-alkyne complex (70) was obtained in a very good yield (80 %).
Having the intended substrate in hand, the stage was set for attempting the cyclization,
which is the key step to obtain the benzocycloheptyne precursor.

Scheme 2.3 Formation of the enyne followed by complexation to form the dicobaltalkyne moiety.
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To promote the ring-closing process, it was necessary to utilize an appropriate
Lewis acid to mediate the reaction. Stemming from the fact that most of our previous
group's work has relied on using boron trifluoride as the preferred Lewis acid, and due to
its minimized tendency to induce decomposition in related cobalt complexes, it was
envisioned that it would be a logical starting point for this current work as well. To our
delight, the cyclization reaction proceeded smoothly in the presence of 1 equiv. of
BF3-OEt2 and the desired cyclic product (71) was obtained in 75 % yield.

Scheme 2.4 Proposed mechanism of formation of cycloheptadienynolCo2(CO)6
complex via BF3-mediated Sakurai reaction.

The ring closing step, which qualifies as a 7-exo-trig process, could be best
described as an intramolecular Hosomi-Sakurai reaction.59 Upon the initial complexation
of the Lewis acid to the oxygen, the carbonyl's carbon is activated by enhancing its
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electrophilicity. The allylic silane serves as a nucleophile (through its terminal carbon)
where it attacks the electron poor carbonyl resulting in the formation of the sevenmembered ring of the cycloheptadienynolCo2(CO)6 complex (71).
After successfully achieving the key cyclization reaction, the next objective was to
further derivatize the cycloheptadienynolCo2(CO)6 complex in hand, with the intent to
construct the 6-electron system in the cycloheptyne ring of the complex. This was a
crucial requirement for the benzodehydrotropylium complex ion to be generated from its
relevant precursor. Having stated this, a series of transformations were designed for this
purpose (Scheme 2.5).

Scheme 2.5 A series of transformations to obtain the benzodehydrotropyliumCo2(CO)6
ion precursor.

The first step involved converting the benzylic alcohol to the corresponding
ketone using a mild oxidant, MnO2, to give the intended oxidized product (72) in sub31

optimal yields (43% brsm). Although the desired product was obtained, it cannot be
denied that some drawbacks ascribed to this particular oxidation conditions rendered the
reaction slow and not highly efficient. The main drawback was the incomplete conversion
of the reactant even when adding a large excess of MnO2 and increasing the reaction time.
In addition, some inevitable decomposition was observed (even though it could be
minimized by keeping the temperature close to 0 C) which again contributed to low
yields. Due to the presence of cobalt moiety in the substrate, the choices of oxidants were
rather limited. The use of conventional oxidants such as Swern conditions was avoided
due to the potential risk of removal of the organometallic unit. Despite the low yields, a
reasonable amount of the ketone could be generated.
The isolated ketone (72) was then subjected to acid-catalyzed alkene
isomerization which indeed proved to be effective in furnishing the rearranged enone with
the endocyclic alkene (73) in 88 % yield. Now that the alkene and ketone were
conjugated in the cycloheptadienynoneCo2(CO)6 complex (73), this constituted the system skeleton needed for the cation's precursor.
The last transformation involved reducing the ketone to the corresponding
secondary alcohol (74) using hydride-based reducing agent, DIBAL-H. After isolating the
crude benzo-fused cycloheptadienynolCo2(CO)6 complex, it was purified using silica
gel-based column chromatography. The proton NMR spectrum of the purified alcohol
revealed the occurrence of an alkene isomerization, converting (74)  (75), where the
latter isomer bore a double bond that was in conjugation with the 6-electron system of
the annulated arene. This acid-induced isomerization indicated that the obtained isomer
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possessed higher stability than the previous compound, which in fact seems to be a
logical rationale, given the significant contribution of conjugation in enhancing stability.
On a side note, by examining the final structure of the alcohol precursor (75), it
could be noted that there is a methyl group on the carbon bearing the hydroxyl which
does not truly contribute to the aromaticity considerations of the cation. The justification
for the presence of this "extra" methyl group is that the original design of the synthesis
presented the need for a synthetic handle which was necessary for the cyclization process.

2.2

Hetero-Fused CycloheptadienynolCo2(CO)6 Complexes
Considering that the established preparative method worked well for the formation

of benzene annulated cycloheptyne complex, we sought to prove the viability of this
method in preparing other bicyclic ring systems, namely heteroaryl-based compounds. To
demonstrate the flexibility of our methodology, three different -excessive heterocyclic
ring systems were investigated which were: thiophene, furan, and indole; in addition, the
electron rich methoxy-aryl substrate was also included in the reaction scope study.
To obtain the relevant precursors for hetero-fused and methoxy-aryl
cycloheptadienynolCo2(CO)6 complexes, a synthetic protocol analogous to the one
reported earlier (when preparing the precursor for benzo-fused cycloheptyne complex
ion) was attempted.
The synthesis of the intended substrates was initiated by installing an alkyne
moiety through subjecting the corresponding bromo-arylaldehydes (76a-d) and TMSacetylene to Sonogashira reaction (Table 2.1).
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Table 2.1 Appending the alkyne group for various substrates via Sonogashira
reaction.

Entry

Substrate

Product

Yield (%)

79
1

2

82

3

85

4

98
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The reactions proceeded with great success and the resultant compounds (77a-d)
underwent desilylation under the appropriate reaction conditions (K2CO3 in methanol, or
TBAF) to furnish the terminal alkynes needed for the next coupling reaction. A summary
of the results is shown in Table 2.2.
Table 2.2 Products of desilylation reactions using potassium carbonate in methanol.

a

Entry

Substrate

Product

Yield (%)

1

77a

89

2

77b

65

3

77c

72

4a

77d

95

Desilylation was achieved using TBAF (1.0 M in THF).
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In the presence of 2-bromo-3-(trimethylsilyl)-1-propene and (78a-d), the
Sonogashira reaction was employed again to obtain the acyclic enynes (79a-d), which in
turn were subjected to complexation with Co2(CO)8 (Table 2.3). Indeed, the desired
alkyneCo2(CO)6 complexes (80a-d) were readily obtained in excellent yields, and this
set the stage for running the cyclization reaction, namely, the seven-membered ring
closure.

Table 2.3 Formation of acyclic enynes of various heterocyclic substrates and their
subsequent complexation with Co2(CO)8.

Entry

Substrate

1

78a

2

78b

Product/ (Yield)

Product/ (Yield)

36

3

78c

4

78d

With the prepared precursors complexes in hand, the next transformation involved
formation of the cycloheptynes via the Sakurai reaction. Once again, BF3 was the first
Lewis acid to be selected as a suitable mediator for the 7-exo-trig process. The success of
the cyclization process was variable from one substrate to another. Substrate (80a),
bearing an electron-donating methoxy group on its benzene ring underwent a rapid
cyclization and the intended product, (81a), was isolated in 72 % yield. In addition, the
C3-substituted thienyl-based substrate (80b) was also readily converted to the thiophenefused cycloheptyne complex (81b) in 90 % yield. Cyclization was also successfully
accomplished when C3-substitued furan substrate (80c) was subjected to analogous
conditions. Despite the fact that the starting material was fully consumed during the
reaction progress (clearly shown by TLC analysis), some decomposition was apparent
which led to relatively reduced overall yield of (81c, 60 %). The final heteroaryl substrate
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that we examined was the C3-subsitiuted indole (80d) which also resulted in the
formation of the intended cyclic product (81d). However, the percentage yield was
significantly reduced (54 % yield) due to occurrence of some decomposition of the
isolated product.
The ring closing step in all the given substrates was generally rapid, and the
reaction time ranged from 5 minutes to 1 hour. The cyclized products (81a-d) were
conveniently isolated following aqueous work-up with saturated sodium bicarbonate
solution, solvent removal, and silica gel flash chromatography. The results are presented
in (Table 2.4).
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Table 2.4 Cyclization reactions of various substrates via BF3mediated Sakurai reaction.

Entry

Substrate

Product

Yield (%)

1

80a

2

80b

91

3

80c

60

4

80d

54

72
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Having established that the proposed ring formation method was indeed widely
applicable to heteroryl-fused systems as well, it is worth noting that in principle, each of
the formed bicyclic alcohol compounds (81a-d) could likely be readily converted to the
corresponding ring-fused dehydrotropyliumCo2(CO)6 complex ion. This could
potentially generate a reasonable library of novel Nicholas cations that could be further
evaluated through reactivity studies with nucleophiles of choice.

2.3

Generation of BenzodehydrotropyliumCo2(CO)6 Ion and its
Reactivity

Accessing the benzodehydrotropylium ion now became feasible in light of the
availability of its requisite alcohol precursor. It was our belief that upon treatment of the
alcohol (75) with a Lewis acid, the cationic species (63) could be readily generated in
situ, which could then be trapped with nucleophiles of choice via an intermolecular
Nicholas reaction. Once again, boron trifluoride was our choice of Lewis acid reagent,
mainly due to the successful results achieved in generating the dehydrotropylium cation
in previous work in our lab.48 Based on previous reports, it has been shown that the
reaction of the Nicholas cation with different nucleophiles roughly obeyed Mayr's linear
free enthalpy equation:50 log k (20 °C) = s (E + N); where E is an electrophilicity
parameter, N is a nucleophilicity parameter, and s is a nucleophile-specific slope
parameter. On the basis of this model, nucleophile/electrophile combinations with (E + N
 5) are expected to proceed with a reasonable rate at room temperature. As such,
[propargyliumCo2(CO)6]+ cations which have E values ranging between 1.2 and 2.2
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are expected to undergo a reaction with nucleophiles with (N > 3).8 Therefore, several
nucleophiles possessing a range of strengths were studied, particularly as reflected by
Mayr’s N values of nucleophilicity scale, in an attempt to obtain an experimental measure
of the cation's electrophilicity and reactivity pattern.
Once the ion is generated, two different reactivity pathways were potentially
possible: substitution and elimination. To start with the substitution pathway, ionization
of the hydroxyl group leads to formation of a cation in the propargylic site (C-7) i.e. - to
the alkyne-cobalt unit. By resonance, this positive charge can be delocalized to C-9 i.e.
site with respect to the cobalt-alkyne unit. This creates two potential cationic sites for
nucleophiles, which would ultimately lead to two possible substitution products (82a and
82b) as shown in (Scheme 2.6).

Scheme 2.6 Formation of the substitution products upon nucleophilic attack on either
- or -sites of the in situ generated cation.
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The general synthetic protocol of the intermolecular Nicholas reaction employed
the addition of BF3-OEt2 (3 equiv.) to a dichloromethane solution of parent alcohol
(75, 1 equiv.) and nucleophile of interest (5 equiv.) at 0 C. Under these reaction
conditions, cation (63) readily reacted with allyltrimethylsilane (Mayr N value = 1.79) to
give primarily the corresponding C-9 (i.e. site) substitution product (84a) in addition to
a minor amount of C-7 (site) substitution product (84b) (combined yield 83 %;
84a:84b (: = 6:1). Moreover, the reactivity pattern of the more nucleophilic 2methallyltrimethylsilane (N = 4.41) was analogous to that of allyltrimethylsilane
(combined yield 68 %; 85a:85b (: = 6:1). Among the nucleophiles investigated was
the trimethylsilyl enol ether of acetophenone (N = 6.22), which underwent a reaction with
the cation to afford a mixture of C-9 (site) substitution product (86a, major) alongside a
smaller proportion of C-7 (-site) product (86b) (combined yield 55 %; 86a:86b (: =
4:1). On the other hand, N-methylpyrrole (N = 5.85) gave exclusively the C-9 (site)
product (87) in 81 % yield with no observable -site product.
Intermolecular trapping of the generated cation with the desired nucleophile was
not the only anticipated outcome of the reaction. In some cases, the cation underwent
elimination as shown in (Scheme 2.7), forming the exo-alkene compound (83). With
nucleophiles such as thiophene (N = 1.01), 1,3,5-trimethoxybenzene (N = 3.40), and 2methoxypropene (N = 5.41), the elimination product (83) was the only one obtained.
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Scheme 2.7 Formation of the elimination by-product.

A reversed reactivity pattern was obtained when an oxygen-based nucleophile was
tested. Methanol was the nucleophile of choice, and it predominantly reacted at the -site
of the carbocation to give a propargylic substituted product as the major compound (88a),
while forming only a minor amount of the -substitution product (88b) (combined yield
54 %; 88a:88b () = 3:1). The results of the Nicholas reaction of cation (63) with
various nucleophilic species are summarized in (Scheme 2.8).
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Scheme 2.8 Summary of reactions of carbocation (63) with various nucleophiles.
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Theoretically, the stabilization in the -substituted product could be ascribed to
two main sources: first, the conjugation between the -systems of the alkene function and
the complexed alkyne unit (in the seven-membered ring), and secondly the lack of steric
bulk, since the dicobalt hexacarbonyl group and the incoming nucleophile are positioned
far apart from one another. On the other hand, conjugation is also a major player in
stabilizing the product. As a matter of fact, it is thought to be of a more pronounced
effect since the double bond of the substituted product is in conjugation with the 6system of the fused benzene ring. This point can be validated by examining the outcome
of the reaction scheme presented earlier (Scheme 2.5), where the alcohol precursor (74)
unambiguously underwent an acid-induced isomerization (on silica gel) to the more
conjugated alkene (75). That is to say that the thermodynamic product is actually the
substituted product.
Having established that product is thermodynamically favoured, results
deduced from the reactivity studies clearly support that substitution reactions involving
the Nicholas cation (63) cation and various carbon-based nucleophiles were not under
thermodynamic control; this was evident by the predominance of the formation of the
product (either as the major or exclusive product). However, a reversed pattern was
observed when using an oxygen-based nucleophile, methanol, which delivered a higher
ratio of -product (Scheme 2.8). This suggests that the nucleophilic substitution by
MeOH was most likely operating under thermodynamic control, that is to say that the
attack occurred reversibly under the given reaction conditions. This behaviour can be
attributed to the presence of an easily protonated oxygen in the product formed initially,
hence providing a pathway for cation re-formation.
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By reviewing the relevant literature,19,22 Nicholas reactions of a cation that is both
propargylic to an alkyneCo2(CO)6 group and also allylic have been well known to
favour the -site attack (i.e. the terminus remote to the alkyne–Co2(CO)6 unit) over -site
for most nucleophiles (especially for lower reactivity nucleophiles) for reasons that are
not exactly well-understood. This observation has been proven to be consistent in
acyclic19 and cyclic systems22 as well. Stemming from these facts, we see that the
reactivity/selectivity pattern in cation (63) is no exception. Despite the inability of
drawing a clear-cut trend that relates the nucleophilicity (Mayr's N value) to the resultant
 substitution ratio, it's evident that the -product is the preferred product. Additionally,
the reactivity studies of the benzodehydrotropylium cation clearly indicated the relatively
strong electrophilicity of the cation as proved by its ability to react with nucleophiles
ranging from moderate (Mayr's N value = 1.79), to ones that are more nucleophilic (N =
6.22). However, it can be argued that the results of Nicholas reaction with the selected
nucleophiles was not truly conclusive since it lacked a wider scope of nucleophiles,
including heteroatomic-based ones which could absolutely provide a better evidence for
reactions reversibility (as witnessed by the methanol nucleophile).
The rationale behind the preference for nucleophiles to attack the remote site of
the cation (63) could also be backed up by investigating the sterics involved in the cation
system. Namely, the presence of the methyl group in the propargylic site (i.e. C-7) is
likely inhibiting addition to the position of the cation.
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2.4

Computational Assessment of the Cation's Aromaticity

The concept of aromaticity is undoubtedly among the most fundamental tools for
understanding organic chemistry. Among the available criteria, the nucleus independent
chemical shift (NICS), which was first introduced by Schleyer et al.59 in 1996, has
recently became the most widely used magnetic index of aromaticity, mainly due to its
simplicity and efficiency.60 This method allows the evaluation of aromaticity, antiaromaticity, and non-aromaticity of monocyclic systems and individual rings in
polycyclic systems (local aromaticities). By definition, NICS is the magnetic shielding
tensor measured for an arbitrary "ghost atom" which is placed in the middle of the ring of
interest; this measures NICS (0) value.59 Other known key modifications in the
calculation of NICS include placing the aforementioned "ghost atom" 1 Å above the
molecular plane of the ring to avoid any potential interaction with the -framework
electrons; this give NICS (1) values.61 Rings with an aromatic character have a significant
negative NICS values as a result of the diatropic ring current, whereas rings with antiaromatic character give rise to positive NICS values due to the existence of paratropic
ring current; non-aromatic systems have NICS values of zero.
In the quest for a better understanding of this concept, we wished to investigate
whether benzodehydrotropyliumCo2(CO)6 ion possessed any aromaticity, and whether
this could lead us to draw conclusions about the potential ion's stabilization
(computational studies were conducted by Dr. Eric Bushnell in Professor James Gauld's
group).
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In this study, the geometries of the benzodehydrotropyliumCo2(CO)6 ion were
first optimized at the B3LYP/6-311+ G(d,p) level of theory (Figure 2.1).

Figure 2.1 Optimized geometry of cation (63) with basis set B3LYP/6-311+G(d,p), and
selected measured bond lengths in Å.

NICS (1) Studies
The NICS measurements were obtained by calculating NMR shielding values at
the gauge independent atomic orbital (GIAO) HF/6-311+G(d,p)//B3LYP/6-311+G(d,p)
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level. By examining the optimized structure generated for the benzodehydrotropylium
complex (63), it was noted that the cobalt-cobalt vertex and the cycloheptadienyl unit
were not perpendicular to one another, hence it was legitimate to place an arbitrary atom
at two different locations48: 1 Å above and 1 Å below the center of the ring, and
therefore, two different NICS (1) values may be computed. Given that the cation has two
annulated rings, this would give rise to a total of four NICS (1) values. For the benzene
ring, the two NICS (1) values were -9.4491 and -8.4815, and those measured for the
seven-membered ring were -4.8798 and -2.0318. Since the environments at points 1 Å
above and below the ring centres are not equivalent in the cycloheptyne ring, the
averaged values were used for NICS (1) values which were calculated to be -3.5 (A-ring)
and -8.96 (B-ring) as seen in the structure below (Figure 2.2).

Figure 2.2 NICS (1) values of both rings of cation (63).
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To put these measurements in perspective, the literature values of NICS (1)
reported for some known aromatic rings are shown below (Figure 2.3).

Figure 2.3 Literature NICS (1) values of (structures from left to right): tropylium ion,
dehydtrotropylium-Co2(CO)6 ion, benzotropylium ion, and benzene (at
B3LYP/6-311+G(d,p) level, except benzene).

The instant conclusion that can be drawn is that the negative sign of NICS (1)
values of (63) is clearly indicative of the presence of "slight" aromatic character in the
cation. To be more specific, it can also be noted that the aromaticity of the benzene-ring
of the cation, i.e. B-ring, whose average NICS (1) is ca. 9.0, is reasonably comparable to
that of the monocyclic benzene (10.40, computed at the same level of theory62). On the
other hand, the average NICS (1) values of the A-ring is 3.5, which suggests that
aromaticity of this annulated seven-membered ring is significantly reduced in comparison
to the monocyclic tropylium cation (in literature, NICS (1) value of tropylium ion ranges
from 9.2 to 11.2, depending on the basis set,63 however, it was previously measured in
our group48 using B3LYP/6-311+G(d,p) basis set, and was found to be 10.5).
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In

summary,

by

establishing

that

the

aromaticity

of

the

benzodehydrotropyliumCo2(CO)6 ion (63) is highly influenced by the local ring current
of the seven-membered ring, it can be reasonably stated that cation (63) is closely
comparable to the computed aromaticity of dehydrotropyliumCo2(CO)6 ion complex
(NICS (1) values of 3.5 and 2.92 respectively). The slight increase in aromaticity of
(63) may be attributed to the annulation to the benzene ring which itself has a significant
local aromaticity. Furthermore, its NICS (1) measurements suggests that (63) possess
roughly 33 % of the aromaticity of tropylium cation.

Bond Length Alternation
Bond length equalization is characteristic for aromatic compounds, whereas large
bond length alternation (∆r) is found in anti-aromatic compounds; the bigger the (∆r) of a
specific ring is, the less aromatic the system becomes.65 Bond lengths in the sevenmembered ring of the bicyclic cation were computed as depicted in (Figure 2.1). With the
exclusion of the carbon-carbon triple bond (C1-C2) due to its understandable deviation
from ideal benzenoid bond length of 1.397 Å, bond length calculations show moderate
bond length alternation, from 1.385 Å (C4-C5) to 1.437 Å (C6-C7), giving ∆r = 0.052 Å
(at the B3LYP/6-311+G(d,p) level), where ∆r here refers to the difference between the
longest and shortest bond in the seven-membered ring (A-ring).
In the previous work of Amiralaei and Green,48 the bond length calculations of
dehydrotropyliumCo2(CO)6 complex ion were implemented to further assess the
system's aromaticity using HOMA (the harmonic oscillator model of aromaticity)
method. In brief, HOMA is one of the most simple and common structure-based indices
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of aromaticity measurements. It takes into account both deviations from ideal aromatic
bond lengths (EN) and bond alternation (GEO) according to the following relationship: 66
HOMA = 1  EN  GEO

HOMA values calculated for dehydrotropyliumCo2(CO)6 complex cation were shown to
be not useful in quantitative evaluations of the ion's aromaticity. Based on this result, we
envisioned that the aromaticity assessment of our current system, cation (63), using
HOMA values will be highly inaccurate; hence, no further bond length-based calculations
were carried out.
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CHAPTER 3: CONCLUSIONS

In this study, we investigated the chemistry of a novel Nicholas carbocation,
namely the benzo-homologue of the dehydrotropylium complex cation, known as
benzodehydrotropyliumCo2(CO)6 cation. The required alcohol precursor, benzocycloheptadienynolCo2(CO)6 complex, was prepared from commercially available
starting materials. The desired benzo-fused dehydrotropyliumCo2(CO)6 complex cation
was generated in situ upon ionization of the parent alcohol precursor with a Lewis acid
(namely BF3-OEt2). Due to the delocalization of the positive charge in the sevenmembered ring through resonance, this created two possible electrophilic sites in the
molecule. The cation was trapped with a number of nucleophiles ranging in
nucleophilicity from moderate to strong (N = 1.79 to 7.54 on the Mayr scale) which
reacted with the carbocation through intermolecular Nicholas reactions. The main feature
of reactivity was that nucleophiles predominantly attacked the -site of the cation, that is
the site remote to the cobalt-alkyne unit, to give the -substituted products as the major
ones, mixed with a minor ratio of -product (the outcome of the attack on the -site). An
oxygen-based nucleophile, methanol, was the only exception, where it formed the product as the major one, which was ascribed to possible reversibility of the reaction
hence leading to the formation of the thermodynamic product. On the other hand, a few
nucleophiles did not react with the cation and instead the elimination product was
isolated. Finally, the aromaticity of benzodehydrotropyliumCo2(CO)6 cation was
assessed using computational methods, namely NICS (1) values. The calculated NICS (1)
value of the seven-membered ring was found to be 3.5 which is indicative of modest
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aromatic character. It can be said that it is ca. one third the aromaticity of tropylium
cation and reasonably close to that of the dehydrotropyliumCo2(CO)6 cation.
The synthetic methodology for preparing annulated cycloheptyneCo2(CO)6
complexes was proven to be of a decent applicability. In addition to the facile formation
of benzene annulated cycloheptyne complex (i.e. the cation's alcohol precursor), the
chemistry of seven-membered ring formation was further extended to other analogues.
Heteroaryl-based systems (thiophene, furan, and indole) were also capable of
participating in the formation of the corresponding fused cycloheptyne complexes.
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CHAPTER 4: EXPERIMENTAL

General Methods and Materials: All reagents, unless otherwise noted, were
purchased from Aldrich. Trimethylsilylacetylene was purchased from GFS Chemicals.
Dicobalt octacarbonyl was purchased from Strem. 3-Bromo-2-formylfuran was purchased
from Frontier Scientific. All reactions were run under a nitrogen atmosphere using ovendried glassware (110 C, > 1h). All reaction solvents were directly obtained from solvent
purification system (Innovative Technologies). Commercial BF3-OEt2 was distilled and
stored under nitrogen. The term “conventional workup” refers to extraction of the product
from the aqueous layer with an organic solvent (such as dichloromethane or diethyl
ether), drying of the combined organic layers with anhydrous magnesium sulfate and
filtration of the resultant mixture, followed by evaporation of the volatiles under reduced
pressure to obtain the crude product(s).
Instrumentation: Flash chromatography was performed using silica gel 60 (230400 mesh). Analytical thin layer chromatography (TLC) was performed on silica gel 60
F254 sheets from Silicycle. Preparative TLC was carried out over silica gel GF-254 plates
from Silicycle. Low-resolution mass spectra were recorded at 20eV on a Varian CP3800/1200L GC/MS. High- Resolution Mass Spectrometry (HRMS) results were
obtained by means of a Direct Insertion Probe-Electron Ionization method (70 eV), on a
Waters/ Micromass GCT (GC-EI/CI Time of Flight Mass Spectrometer) performed at the
McMaster Regional Centre for Mass Spectrometry. Proton nuclear magnetic resonance
(1H NMR) data were obtained either on Bruker Avance 300 or 500 MHz spectrometers.
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Chemical shifts are reported in delta ( units, parts per million (ppm), relative to the
singlet at 7.26 ppm for chloroform-dl, unless otherwise indicated. Coupling constants are
reported in Hertz (Hz). Carbon-13 nuclear magnetic resonance (13C NMR) data were
obtained on Bruker Avance 75 or 125 MHz spectrometers. Infrared Spectroscopy (IR)
data were recorded on a Burker Vector 22 FT-IR spectrophotometer using KBr plates.
The reported IR data reflects the frequencies of the distinctive functional group stretches
only.

2-Bromo-3-(trimethylsilyl)-1-propene (68)

Compound (68) was prepared using the method reported by Trost et al.67 The
product showed spectroscopic data identical with the literature (isolated in 71 % yield).
3-Bromothiophene-2-carbaldehyde (76b)

Compound (76b) was prepared from 3-bromothiophene in a sequence involving
selective lithiation with LDA at the 2-position and formylation using excess DMF. The
experimental procedure followed was adapted from literature.68
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(3-Bromothiophene was distilled under nitrogen prior to use; diisopropylamine was
freshly distilled with CaH2 under nitrogen before use). 3-Bromothiophene (0.501 g, 3.067
mmol) was added dropwise to a stirred solution of lithium diisopropylamide (LDA)
[prepared by addition of n-butyllithium (1.8 M in THF, 1.70 mL, 3.067 mmol) to
diisopropylamine (0.433 mL, 3.067 mmol)] in anhydrous THF (10 mL) at 0 C and the
resulting mixture was stirred for a further 30 min at this temperature. Then, DMF (0.47
mL, 0.448 g, 6.133 mmol) was added dropwise over a period of 20 min. The mixture was
stirred further until TLC analysis indicated that all the starting material had been
consumed (ca. 3 h) when an excess of 20% aqueous ammonium chloride was added to it.
Extraction of the mixture with ether gave 3-bromothiophene-2-carbaldehyde as dark oil.
The product showed spectroscopic data identical with the literature68 (77 % yield).

3-Bromo-1-methyl-1H-indole-2-carbaldehyde (76d)

To a solution of 1-methylindole-2-carbaldehyde (0.507 g, 3.185 mmol) in
anhydrous THF was added N-bromosuccinimide (NBS) (0.60 g, 3.371 mmol) portionwise. The solution was stirred for 2 h at room temperature. Then, a 2.0 M aqueous NaOH
solution was added to the reaction mixture, followed by the addition of brine solution.
Next, the mixture was subjected to a conventional extractive workup using ethyl acetate,
to afford (76d) as yellow solid. No chromatographic purification was needed; the product

57

obtained was found to be pure enough to be used in subsequent reactions (> 98 % purity).
The product showed spectroscopic data identical with the literature69 (0.743 g, 98 %
yield), mp 86-88 C (lit. mp 86-89 C).69b
2-Ethynylbenzaldehyde (67)

Compound (67) was prepared using the method reported by Fujii and Ohno.70 The
product showed spectroscopic data identical with the literature (96 % yield from 2bromobenzaldehyde); mp 6061.5 C (lit. mp 60-61 C).70
2-Ethynyl-5-methoxybenzaldehyde (78a)

Compound (78a) was prepared using the method reported by Fujii and Ohno.70
The product showed spectroscopic data identical with the literature (77 % yield from 2bromo-5-methoxybenzaldehyde), mp 96-97 C (lit. 98 C).70

58

3-Ethynylthiophene-2-carbaldehyde (78b)

(3-Bromothiophene-2-carbaldehyde (76b) was subjected to Sonogashira coupling
method following a procedure that was adapted from Eberbach,71 to give 3((trimethylsilyl) ethynyl)thiophene-2-carbaldehyde (77b) in 82 % yield. To a solution of
77b (0.1092 g, 0.525 mmol) in methanol (3 mL) was added a catalytic amount
(unweighed) of anhydrous potassium carbonate at room temperature. The reaction was
stirred until starting material has been completely consumed, as judged by TLC using 2:1
petroleum ether/Et2O (30 min). The reaction mixture was concentrated under reduced
pressure until most of the methanol has evaporated. To the resulting oily crude product
was added water and Et2O (1:1), and a conventional work-up was performed. The crude
product was purified by flash chromatography (2:1 petroleum ether/Et2O) to give (78b) as
yellow oil (0.071 g, 99 % yield). The product showed spectroscopic data identical to
literature.71
3-Ethynylfuran-2-carbaldehyde (78c)
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(3-Bromofuran-2-carbaldehyde (76c) was subjected to Sonogashira coupling
method following a procedure that was adapted from Eberbach,72 to give 3((trimethylsilyl) ethynyl)furan-2-carbaldehyde (77c) in 85 % yield. To a solution of 77c
(0.191 g, 0.99 mmol) in methanol (4.6 mL), anhydrous potassium carbonate (0.127 g)
was added in one portion. The reaction was stirred until starting material has been
completely consumed; judged by TLC using 5:1 petroleum ether/ether (5–10 min). The
reaction mixture was concentrated under reduced pressure until most of the methanol has
evaporated. The resulting oily crude product was washed with water/ether (1:1) solution.
The organic ether layer was washed with saturated NH4Cl aqueous solution and brine
solution. The combined organic layer was dried with anhydrous MgSO4. After removing
the volatiles, compound (78c) was afforded as brown solid (0.103 g, 86 % yield), mp 4546 C (lit.72 mp 45 C). The product showed spectroscopic data identical to a previous
report in literature.
3-Ethynyl-1-methyl-1H-indole-2-carbaldehyde (78d)

3-Bromo-1-methyl-1H-indole-2-carboxaldehyde 76d (0.570 g, 2.39 mmol, 1
equiv.) and trimethylsilylacetylene (0.38 g, 3.87 mmol, 1.6 equiv.) were dissolved in
degassed triethylamine (30 mL). This solution was stirred at room until a clear
homogenous solution was obtained. Then, Pd(PPh3)4 (0.138 g, 5 mol %) and CuI (0.045
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g, 10 mol %) were added quickly to the reaction mixture. The solution was stirred for 1.5
h at 60 C. After cooling the reaction to room temperature, a saturated solution of
aqueous ammonium chloride was added and the mixture was subjected to a conventional
work-up using diethyl ether. The dark oil was purified by flash chromatography (5:1
petroleum ether/Et2O) to give pure 1-methyl-3-trimethylsilylethynyl-1H-indole-2carboxaldehyde (77d) as yellow solid (0.601 g, 98 %). The spectroscopic data were
identical to a former report by Barluenga et al.73
A solution of 77d (0.741 g, 2.90 mmol) in anhydrous THF (25 mL) was treated
with a solution of TBAF (1.0 M in THF, 2.9 mL, 1 equiv.) at room temperature. When
the reaction was judged complete by TLC (5 min), it was quenched with a saturated
solution of ammonium chloride and subjected to conventional work-up using diethyl
ether. No further purification was required. Compound (78d) was collected as a yellow
solid (0.5122 g, 95 % yield), mp 122-123 C. IR (KBr) max 3284, 2102, 1669, 1476 cm-1;
1

H NMR (500 MHz, CDCl3) 10.21 (s, 1H), 7.84 (dt, J= 1.0, 8.0, 1H), 7.47 (apparent td,

J= 1.0, 8.0, 1H), 7.40 (apparent dt, J= 1.0, 8.5, 1H), 7.26 (td, J= 1.0, 7.5, 1H), 4.09 (s,
3H), 3.53 (s, 1H); 1H NMR (500 MHz, CD2Cl2)  10.20 (s, 1H), 7.82 (d, J= 8.1, 1H),
7.49-7.43 (m, 2H), 7.26 (td, J= 7.0, 1.0, 1H), 4.07 (s, 3H), 3.61 (s, 1H);

13

C NMR (75

MHz, CDCl3)  182.3, 139.3, 136.5, 128.0, 127.8, 122.1, 121.9, 110.6, 110.3, 84.7, 74.8,
31.8; HRMS m/e for C12H9NO calcd 183.0684, found 183.0684.
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2-(3-((Trimethylsilyl)methyl)but-3-en-1-yn-1-yl)benzaldehyde (69)

General Procedure A: (THF and diisopropylamine were well-degassed with a
stream of nitrogen for 1 h prior to use in Sonogashira coupling). 2-Ethynylbenzaldehyde
(67, 0.543 g, 4.18 mmol) and 2-bromo-3-(trimethylsilyl)-1-propene (68, 0.807 g, 4.18
mmol) were dissolved in a (5:1) solvent mixture of diisopropylamine/THF (40 mL). This
solution was stirred at room temperature until a clear homogenous solution was obtained.
Then, Pd(PPh3)4 (0.241 g, 5 mol %) and CuI (0.080 g, 10 mol %) were added quickly to
the reaction mixture. The solution was stirred for 2 h at room temperature. A saturated
aqueous solution of ammonium chloride was added and the mixture was subjected to a
conventional work-up using diethyl ether. The dark oil was purified by flash
chromatography (25:1 petroleum ether/Et2O) to give pure product 69 (0.719 g, 71 %) as a
yellow oil. IR (KBr) max 2927, 1700, 1599 cm-1; 1H NMR (500 MHz, CDCl3)  10.53
(d, J= 0.5, 1H), 7.91 (m, 1H), 7.53 (m, 2H), 7.41 (m, 1H), 5.37 (d, J= 2.0, 1H), 5.18 (d,
J= 1.5, 1H), 1.79 (d, J= 0.5, 2H), 0.11 (s, 9H);

13

C NMR (75 MHz, CDCl3)  192.0,

135.9, 133.9, 133.2, 128.6, 128.4, 127.3, 127.2, 120.8, 98.7, 83.8, 28.1, -1.5; HRMS m/e
for C15H18OSi calcd 242.1127, found 242.1130.
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5-Methoxy-2-(3-((trimethylsilyl)methyl)but-3-en-1-yn-1-yl)benzaldehyde (79a)

Procedure A was followed using 2-ethynyl-5-methoxybenzaldehyde (78a, 0.147
g, 1.1 equiv) and 2-bromo-3-(trimethylsilyl)-1-propene (68, 0.1616 g, 0.836 mmol). Flash
chromatography (5:1 petroleum ether/Et2O) gave pure product 79a (0.166 g, 73 %) as a
yellow oil. IR (KBr) max 2955, 2200, 1690, 1601, 1493 cm-1; 1H NMR (500 MHz,
CDCl3)  10.49 (s, 1H), 7.45 (d, J= 8.5, 1H), 7.39 (d, J= 3.0, 1H), 7.10 (dd, J= 3.0, 8.5,
1H), 5.33 (s, 1H), 5.14 (s, 1H), 3.86 (s, 3H), 1.78 (s, 2H), 0.11 (s, 9H);

13

C NMR (125

MHz, CD2Cl2)  191.3, 159.8, 137.2, 134.5, 132.0, 128.6, 121.3, 119.6, 109.8, 96.9, 83.6,
55.7, 27.9, -2.0; HRMS m/e for C16H20O2Si calcd 272.1233, found 272.1239.
3-(3-((Trimethylsilyl)methyl)but-3-en-1-yn-1-yl)thiophene-2-carbaldehyde (79b)

Procedure A was followed using 3-ethynylthiophene-2-carbaldehyde (78b,
0.1425 g, 1.05 mmol) and 2-bromo-3-(trimethylsilyl)-1-propene (68, 0.2035 g, 1.05
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mmol). The reaction mixture was stirred for 2 h at 50 C. Flash chromatography (2:1
petroleum ether/ether) afforded compound 79b (0.165 g, 63 % yield) as yellow oil.
IR (KBr) max 2955, 2925, 2195, 1668, 1418, 1248 cm-1; 1H NMR (500 MHz, CDCl3) 
10.12 (d, J= 1.0, 1H), 7.66 (dd, J= 1.0, 5.0, 1H), 7.15 (d, J= 5.0, 1H), 5.38 (d, J= 1.5,
1H), 5.20 (d, J= 1.5, 1H), 1.78 (s, 2H), 0.11 (s, 9H); 13C NMR (75 MHz, CDCl3)  183.1,
143.4, 134.0, 131.6, 128.2, 121.3, 110.3, 98.3, 80.5, 28.1, -1.5; HRMS m/e for
C13H16OSSi calcd 248.0691, found 248.0673.
3-(3-((Trimethylsilyl)methyl)but-3-en-1-yn-1-yl)furan-2-carbaldehyde (79c)

Procedure A was followed using 3-ethynylfuran-2-carbaldehyde (78c, 0.0737 g,
0.61 mmol) and 2-bromo-3-(trimethylsilyl)-1-propene (68, 0.1185 g, 0.61 mmol). Flash
chromatography (5:1 petroleum ether/ Et2O) gave compound 79c (0.0939 g, 66 % yield)
as yellow oil. IR (KBr) max 2956, 1683, 1420, 1250 cm-1; 1H NMR (500 MHz, CDCl3) 
9.77 (d, J= 1.0, 1H), 7.61 (apparent dd, J= 1.5, 2.8, 1H), 6.58 (d, J= 3.0, 1H), 5.38 (d, J=
1.5, 1H), 5.21 (d, J= 1.5, 1H), 1.77 (d, J= 0.5, 2H), 0.10 (s, 9H);

13

C NMR (125 MHz,

CD2Cl2)  176.2, 153.0, 148.0, 128.6, 121.4, 120.0, 115.5, 99.8, 77.5, 28.1, -1.7; HRMS
m/e calcd for C13H16O2Si: 232.0920; found: 232.0925.
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1-Methyl-3-(3-((trimethylsilyl)methyl)but-3-en-1-yn-1-yl)-1H-indole-2-carbaldehyde
(79d)

Procedure A was followed using 3-ethynyl-1-methyl-1H-indole-2-carbaldehyde
(78d, 0.512 g, 2.79 mmol) and 2-bromo-3-(trimethylsilyl)-1-propene (68, 0.539 g, 2.79
mmol). The reaction mixture was stirred for 30 min at room temperature. Flash
chromatography (5:1 petroleum ether/Et2O) gave pure product 79d (0.595 g, 72 %) as a
yellow oil. IR (KBr) max 2954, 2200, 1668, 1476 cm-1; 1H NMR (500 MHz, CDCl3) 
10.18 (s, 1H), 7.83 (d, J= 8.0, 1H), 7.46 (td, J= 1.0, 7.5, 1H), 7.37 (d, J= 8.5, 1H), 7.24
(apparent dd, 1H), 5.39 (d, J= 2.0, 1H), 5.17 (s, 1H), 4.08 (s, 3H), 1.84 (s, 2H), 0.14 (s,
9H);

13

C NMR (75 MHz, CDCl3)  182.4, 139.6, 135.4, 128.8, 127.8, 127.7, 122.3,

121.6, 119.7, 112.2, 110.5, 99.3, 79.2, 31.8, 28.3, -1.5; HRMS m/e for C18H21NOSi calcd
295.1392, found 295.1384.
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Hexacarbonyl [μ-η4-(2-(3-((trimethylsilyl)methyl)but-3-en-1-yn-1-yl)benzaldehyde)]
dicobalt (70)

General Procedure B: Compound 69 (0.132 g, 0.55 mmol) was dissolved in
anhydrous Et2O and cooled to 0 C in an ice bath. An unweighed amount of dicobalt
octacarbonyl (excess) was added and the reaction was stirred while maintaining the
temperature at 0 C. After 1.5 h, the mixture was concentrated under reduced pressure in
a cold water bath. The crude brown-coloured material was purified on a plug of silica
(using 100% hexanes to remove the unreacted dicobalt octacarbonyl, and then switching
to 100% diethyl ether to elute the final product). Compound (70) was obtained as dark
brown oil (0.230 g, 80 % yield). IR (KBr) max 2925, 2852, 2092, 2055, 2022, 1693, 1593
cm-1; 1H NMR (500 MHz, CDCl3)  10.37 (s, 1H), 7.94 (d, J= 7.8, 1H), 7.68 (d, J= 7.5,
1H), 7.61 (td, J= 1.25, 7.5, 1H), 7.46 (t, J= 7.7, 1H), 5.48 (d, J= 1.0, 1 H), 5.35 (d, J= 1.0,
1H), 1.72 (d, J= 1.0, 2H), 0.10 (s, 9H);

13

C NMR (75 MHz, CDCl3)  199.0, 191.1,

143.7, 141.5, 134.7, 133.5, 132.6, 128.2, 117.3, 101.9, 88.6, 26.5, -0.8; HRMS m/e for
C21H18Co2O7Si [M+ - 2CO] calcd 471.9587, found 471.9604.
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Hexacarbonyl[μ-η4-(5-methoxy-2-(3-((trimethylsilyl)methyl)but-3-en-1-yn-1-yl)
benzaldehyde)]dicobalt (80a)

A solution of 79a (0.155 g, 0.57 mmol) in anhydrous Et2O (40 mL) was subjected
to Procedure B to afford product 80a (0.238 g, 75 % yield) as a dark brown oil. IR (KBr)
max 2959, 2090, 2055, 1689, 1599, 1481 cm-1; 1H NMR (500 MHz, CDCl3)  10.36 (s,
1H), 7.60 (d, J= 8.5, 1H), 7.43 (d, J= 2.5, 1H), 7.18 (dd, J= 2.5, 8.5, 1H), 5.48 (s, 1H),
5.34 (s, 1H), 3.89 (s, 3H), 1.71 (s, 2H), 0.10 (s, 9H); 13C NMR (75 MHz, CDCl3)  199.2,
190.9, 159.7, 143.8, 135.2, 133.8, 133.5, 122.5, 117.3, 110.6, 101.6, 89.1, 55.8, 26.4, -0.8;
HRMS m/e for C22H20Co2O8Si [M+ - 4CO] calcd 445.9795, found 445.9785.
Hexacarbonyl [μ-η4-(3-(3-((trimethylsilyl)methyl)but-3-en-1-yn-1-yl)thiophene-2carbaldehyde)]dicobalt (80b)

A solution of 79b (0.0165 g, 0.066 mmol) in anhydrous Et2O (15 mL) was
subjected to Procedure B to afford product 80b (0.0273 g, 77 % yield) as a dark brown
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oil. IR (KBr) max 2957, 2925, 2855, 2092, 2056, 2026, 1721, 1664, 1461 cm-1; 1H NMR
(500 MHz, CDCl3)  10.08 (s, 1H), 7.71 (d, J= 5.0, 1H), 7.23 (d, J= 5.0, 1H), 5.48 (s,
1H), 5.33 (s, 1H), 1.77 (s, 2H), 0.11 (s, 9H); 13C NMR (75 MHz, CDCl3)  198.8, 182.4,
147.3, 143.5, 137.2, 134.7, 132.9, 117.0, 99.9, 81.4, 26.3, -0.9; HRMS m/e for
C19H16Co2O7SSi [M+ - CO] calcd 505.9101, found 505.9100.
Hexacarbonyl [μ-η4-(3-(3-((trimethylsilyl)methyl)but-3-en-1-yn-1-yl)furan-2carbaldehyde)] dicobalt (80c)

A solution of 79c (0.0305 g, 0.131 mmol) in anhydrous Et2O (35 mL) was
subjected to Procedure B to afford product 80c (0.058 g, 85 % yield) as a dark brown oil.
IR (KBr) max 2958, 2094, 2056, 2026, 1679, 1477, 1251 cm-1; 1H NMR (300 MHz,
CDCl3)  9.84 (d, J= 0.6, 1H), 7.65 (apparent dd, J= 0.6, 1.8, 1H), 6.64 (d, J= 1.8, 1H),
5.46 (d, J= 0.9, 1H), 5.29 (d, J= 0.9, 1H), 1.78 (d, J= 0.6, 2H), 0.10 (s, 9H);

13

C NMR

(125 MHz, CD2Cl2)  199.0, 176.2, 147.9, 146.6, 143.5, 136.1, 116.5, 115.6, 100.1, 77.9,
26.0, -1.3; HRMS m/e for C19H16Co2O8Si [M+ - CO] calcd 489.9329, found 489.9312.
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Hexacarbonyl[μ-η4-(1-methyl-3-(3-((trimethylsilyl)methyl)but-3-en-1-yn-1-yl)-1Hindole-2-carbaldehyde)]dicobalt (80d)

A solution of 79d (0.0918 g, 0.311 mmol) in CH2Cl2 (30 mL) was subjected to
Procedure B to afford product 80d (0.146 g, 81 % yield) as a dark green oil. IR (KBr)
max 2926, 2854, 2088, 2053, 2025, 1728, 1667, 1472 cm-1; 1H NMR (500 MHz, CDCl3)
 10.52 (s, 1H), 7.90 (d, J= 8.0, 1H), 7.41-7.48 (m, 2H), 7.23-7.24 (m, 1H), 5.58 (s, 1H),
5.39 (d, J= 1.0, 1H), 4.12 (s, 3H), 1.73 (s, 2H), 0.11 (s, 9H); 13C NMR (75 MHz, CDCl3)
 199.7, 182.5, 127.9, 122.5, 121.7, 117.2, 110.9, 91.6, 84.8, -0.5; HRMS m/e for
C24H21Co2NO7Si [M+ - 3CO] calcd 496.9904, found 496.9911.
Hexacarbonyl [μ-(8,9-dehydro-7-methylene-6,7-dihydro-5H-benzo[7]annulen-5ol)]dicobalt (71)
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General Procedure C: To a solution of 70 (0.2177 g, 0.410 mmol) in anhydrous
CH2Cl2 (25 mL) at 0 C was added BF3-OEt2 (0.051 mL, 0.41 mmol, 1.0 equiv). After
stirring for 20 min at the same temperature, saturated NaHCO3(aq) was added to the
mixture and a conventional extractive workup using CH2Cl2 followed. After the removal
of volatiles under reduced pressure, the crude dark oil was purified by flash
chromatography (2:1 petroleum ether/Et2O) to afford alcohol (71) as dark brown solid
(0.1415 g, 75 % yield). IR (KBr) max 3438, 2090, 2055, 2022, 1633 cm-1; 1H NMR (500
MHz, CDCl3)  7.77 (d, J= 7.5, 1H), 7.31-7.41 (m, 3H), 5.86 (s, 1H), 5.70 (s, 1H), 4.98
(q, J= 4.0, 1H), 3.11 (d of 0.5 ABq, J= 8.0, 14.5, 1H), 2.88 (0.5 ABq, J= 14.5, 1H), 1.76
(d, J= 4.0, 1H); 13C NMR (75 MHz, CDCl3)  199.2, 143.0, 141.3, 135.8, 134.3, 129.4,
129.2, 128.5, 123.4, 88.4, 88.0, 73.3, 41.3; HRMS m/e for C18H10Co2O7 [M+] calcd
455.9090, found 455.9085.
Hexacarbonyl [μ-(8,9-dehydro-3-methoxy-7-methylene-6,7-dihydro-5Hbenzo[7]annulen-5-ol)]dicobalt (81a)

Following Procedure C, a solution of compound 80a (0.1445 g, 0.259 mmol) in
anhydrous CH2Cl2 (30 mL) was treated with BF3-OEt2 (32.8 µL, 0.259, 1.0 equiv). The
reaction was judged to be complete after 5 min where all the starting material was
consumed (by TLC). The crude compound was purified by flash chromatography (5:1
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petroleum ether/Et2O) to afford pure compound 81a (0.0901 g, 72 % yield) as dark brown
solid. IR (KBr) max 3413, 2923, 2088, 2051, 2021 cm-1; 1H NMR (300 MHz, CDCl3) 
7.69 (d, J= 8.4, 1H), 6.92 (dd, J= 2.7, 8.4, 1H), 6.89 (d, J= 2.7, 1H), 5.84 (s, 1H), 5.67
(d, J= 0.9, 1H), 4.91 (dd, J= 4.5, 7.5, 1H), 3.85 (s, 3H), 3.09 (d of 0.5 ABq, J= 7.8, 14.5,
1H), 2.88 (0.5 ABq, J= 14.5, 1H), 1.84 (d, J= 4.5, 1H);

13

C NMR (75 MHz, CDCl3) 

199.4, 159.9, 143.1, 135.9, 127.4, 123.1, 114.7, 114.5, 88.8, 88.6, 73.3, 55.5, 41.7;
HRMS m/e for C19H12Co2O8 [M+] calcd 485.9196, found 485.9202.
Hexacarbonyl [μ-(7,8-dehydro-6-methylene-6H-cyclohepta[b]thiophen-8-ol)]dicobalt
(81b)

A solution of compound 80b (0.0165 g, 0.031 mmol) in anhydrous CH2Cl2 (8 mL)
was treated with BF3-OEt2 (3.48 µL, 0.031 mmol, 1.0 equiv) as described in Procedure C.
The crude compound was purified by flash chromatography (2:1 petroleum ether/Et2O) to
afford pure compound 81b (0.0131 g, 91 % yield) as brown oil. IR (KBr) max 3398,
2926, 2855, 2090, 2055, 2022, 1715, 1625 cm-1; 1H NMR (500 MHz, CDCl3)  7.29 (d,
J= 5.5, 1H), 7.25 (d, J= 5.0, 1H), 5.85 (s, 1H), 5.70 (s, 1H), 5.05 (m, 1H), 3.00 (d of 0.5
ABq, J= 14.0, 1H), 2.87 (0.5 ABq, J= 14.0, 1H), 2.04 (d, J= 6.5, 1H);

13

C NMR (125

MHz, CDCl3)  199.2, 143.5, 142.3, 133.4, 130.9, 125.7, 124.2, 89.3, 82.3, 68.2, 41.7;
HRMS m/e for C16H8Co2O7S [M+] calcd 461.8655, found 461.8652.
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Hexacarbonyl [μ-(7,8-dehydro-6-methylene-6H-cyclohepta[b]furan-8-ol)]dicobalt
(81c)

A solution of compound 80c (0.041 g, 0.079 mmol) in anhydrous CH2Cl2 (15 mL) was
treated with BF3-OEt2 (9.8 µL, 0.079 mmol, 1.0 equiv) as described in Procedure C. The
crude compound was purified by flash chromatography (2:1 petroleum ether/Et2O) to
afford pure compound 81c (0.0208 g, 60 % yield) as brown oil. IR (KBr) max 3390,
2094, 2056, 2026 cm-1; 1H NMR (500 MHz, CDCl3) 7.43 (s, 1H), 6.62 (s, 1H), 5.85 (s,
1H), 5.70 (s, 1H), 5.02 (m, 1H), 2.99 (dd, J= 6.0, 14.0, 1H), 2.77 (d, J= 14.5, 1H), 1.85
(d, J= 7.0, 1H); HRMS m/e for C16H8Co2O8 [M+ - 2CO] calcd 389.8985, found 389.8989.
Hexacarbonyl [μ-(9,10-dehydro-5-methyl-8-methylene-5,6,7,8-tetrahydrocyclohepta[b]indol-6-ol)]dicobalt (81d)
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A solution of compound 80d (0.0664 g, 0.114 mmol) in anhydrous CH2Cl2 (15
mL) was treated with BF3-OEt2 (14.0 µL, 0.114 mmol, 1.0 equiv) as described in
Procedure C. The crude compound was purified by flash chromatography (2:1 petroleum
ether/Et2O) to afford pure compound 81d (0.0132 g, 54 % yield) as black/ dark green
solid. IR (KBr) max 3561, 2921, 2086, 2036, 2000, 1720 cm-1; 1H NMR (500 MHz,
CDCl3)  7.87 (d, J= 8.0, 1H), 7.38 (d, J= 8.0, 1H), 7.34 (td, J= 1.0, 7.0, 1H), 7.27 (td, J=
1.0, 7.0, 1H), 5.91 (s, 1H), 5.71 (d, J= 1.5, 1H), 5.22 (apparent dd, J= 1.5, 2.0, 1H), 3.84
(s, 3H), 3.15 (d of 0.5 ABq, J= 5.5, 14.0, 1H), 2.90 (0.5 ABq, J= 14.0, 1H), 1.70 (d, J=
10.0, 1H); 13C NMR (75 MHz, CDCl3)  199.9, 142.1, 138.3, 137.7, 128.4, 123.7, 123.3,
121.0, 119.8, 110.1, 109.6, 92.1, 83.0, 63.5, 40.3, 29.6; HRMS m/e for C21H13Co2NO7
[M+] calcd 508.9356, found 508.9352.
Hexacarbonyl [μ-(8,9-dehydro-7-methylene-6,7-dihydro-5H-benzo[7]annulen-5one)]dicobalt (72)

To a solution of alcohol 71 (0.248 g, 0.544 mmol) in anhydrous CH2Cl2,
manganese oxide (MnO2) powder (0.2364 g, 2.720 mmol, 5 equiv.) was added in one
portion at -5 C. Following stirring for 1 h at this temperature, the solution was filtered to
remove the excess solid. The filtrate was concentrated under reduced pressure and was
subjected to flash chromatography (5:1 petroleum ether/ Et2O) to give the sequential
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elution of ketone 72 (0.0691 g, 28 % yield, 43 % based on recovered 71) and starting
material 71 (0.0868 g, 35 % recovery). IR (KBr) max 2926, 2095, 2057, 2026, 1682,
1596 cm-1; 1H NMR (500 MHz, CDCl3)  7.75 (d, J= 7.5, 1H), 7.68 (dd, J= 1.5, 7.7, 1H),
7.56 (td, J= 1.5, 7.7, 1H), 7.41 (td, J= 1.0, 7.7, 1H), 5.77 (s, 1H), 5.75 (s, 1H), 3.76 (s,
2H); 13C NMR (125 MHz, CD2Cl2)  198.8, 198.3, 139.1, 138.6, 136.8, 133.4, 132.6,
128.9, 128.4, 122.3, 87.8, 87.4, 51.9; HRMS m/e for C18H8Co2O7[M+] calcd 453.8934,
found 453.8914.
Hexacarbonyl [μ-(8,9-dehydro-7-methyl-5H-benzo[7]annulen-5-one)]dicobalt (73)

To a stirred ice cold solution of 72 (80.9 mg, 0.20 mmol) in anhydrous CH2Cl2 (10
mL) was added H2SO4 (3 drops in 2 mL of anhydrous CH2Cl2) in a dropwise fashion over
a period of 20 min. Following stirring for 2 h at 0 C, water was added, and the mixture
was subjected to a conventional extractive workup using dichloromethane. The isolated
crude extract was subjected to flash chromatography (5:1 petroleum ether/Et2O) to afford
pure 73 (70.8 mg, 88 % yield). IR (KBr) max 2918, 2095, 2057, 2031, 1730, 1605, 1582
cm-1; 1H NMR (300 MHz, CDCl3)  8.25 (dd, J= 1.2, 8.1, 1H), 7.87 (dd, J= 1.2, 7.6,
1H), 7.66 (td, J= 1.2, 7.5, 1H), 7.53 (td, J= 1.2, 7.5, 1H), 6.67 (d, J= 1.2, 1H), 2.43 (d, J=
1.2, 3H); 13C NMR (75 MHz, CD2Cl2)  198.5, 189.3, 149.5, 137.8, 136.7, 133.6, 133.5,
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132.4, 131.4, 129.1, 85.4, 83.7, 23.6; HRMS m/e for C18H8Co2O7 [M+] calcd 453.8934,
found 453.8941.
Hexacarbonyl [μ-(8,9-dehydro-7-methyl-7H-benzo[7]annulen-7-ol)]dicobalt (74)

Compound 73 (52 mg, 0.11 mmol) was dissolved in anhydrous CH2Cl2 (7 mL)
and the solution was cooled to -78 C. DIBAL-H (0.46 mL of a 1.0 M solution in THF,
0.46 mmol, 4 equiv.) was added dropwise and the solution was stirred for 1 h at the same
temperature. Then, a saturated aqueous solution of NH4Cl was added and the reaction
mixture was subjected to a conventional extractive workup using dichloromethane.
Removal of the volatiles under reduced pressure afforded a crude mixture which was
subjected to flash chromatography (5:1 petroleum ether/Et2O) to afford alcohol
compounds 74 and 75 (inseparable by chromatography) and the elimination product 83
(14.0 mg, 29 % yield). The isolated mixture containing (74) and (75) was mixed with
silica in hexanes. After stirring for 1 h, the silica was filtered off and the collected filtrate
was concentrated under reduced pressure to afford alcohol (75) exclusively (35.5 mg, 68
% yield from ketone 73). Compound 75: IR (KBr) max 3448, 2924, 2853, 2092, 2055,

75

2024, 1723 cm-1; 1H NMR (500 MHz, CDCl3)  7.67 (m, 1H), 7.34 (m, 2H), 7.18 (m,
1H), 6.38 (d, J= 12.5, 1H), 6.13 (d, J= 12.5 Hz, 1H), 2.23 (s, 1H), 1.54 (s, 3 H);

13

C

NMR (75 MHz, CD2Cl2)  199.3, 139.6, 135.9, 135.4, 133.0, 131.2, 128.8, 128.2, 125.4,
90.8, 88.0, 71.6, 22.7; HRMS m/e for C18H10Co2O7 [M+ - 2CO] calcd 399.9192, found
399.9196. Resonances from (83) could be detected at: 1H NMR (300 MHz, CDCl3) 
7.68 (m, 1H), 7.28 (m, 2H), 7.13 (m, 1H), 6.37 (d, J= 7.5, 1H), 6.32 (d, J= 7.5, 1H), 5.69
(s, 1H), 5.61 (s, 1H).

General Procedure D: To a solution of (75) in anhydrous dichloromethane at
0 C, an excess amount of the nucleophile (5-8 equiv.) was added. Then, BF3-OEt2 (3
equiv.) was added dropwise while maintaining the temperature at 0 C. The solution was
stirred for 30 min (TLC monitoring). The reaction was quenched with a saturated aqueous
sodium bicarbonate solution, and was followed with a conventional aqueous workup
using dichloromethane. The crude mixture was purified by flash chromatography (100:1
petroleum ether/Et2O) to afford the final product.
Hexacarbonyl [μ-(8,9-dehydro-5-allyl-7-methyl-5H-benzo[7]annulene)]dicobalt (84a
and 84b)
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A solution of alcohol compound 75 (11.41 mg, 0.0250 mmol) in CH2Cl2 (7 mL)
was subjected to Procedure D using allyltrimethylsilane (22.81 mg, 0.201 mmol, 8
equiv.) to afford a (6:1) mixture of 84a and 84b (9.943 mg, 83 % total yield 84a + 84b).
IR (KBr) max 2924, 2854, 2088, 2048, 2015, 1445, 1102 cm-1; 1H NMR (500 MHz,
CDCl3) (major product, 84a) 7.68 (d, J= 6.5, 1H), 7.30-7.35 (m, 2H), 7.20 (d, J= 7.5,
1H), 5.73-5.79 (m, 2H), 5.06-5.13 (m, 2H), 3.13 (m, 1H), 2.66 (m, 2H), 2.14 (s, 3H);
resonances from the minor product (84b) could be detected at 6.37 (d, J= 12.0, 1H), 5.86
(d, J= 12.0, 1H), 3.65 (br s, 2H);

13

C NMR (75 MHz, CDCl3) (major product, 84a)

199.7, 139.3, 137.4, 136.5, 135.4, 132.9, 131.4, 128.5, 127.0, 126.2, 117.0, 92.8, 89.4,
38.2, 29.7, 23.0; resonances from the minor product (84b) could be detected at 49.5,
118.7, 129.8, 133.9, 140.3; HRMS m/e for C21H14Co2O6 [M+] calcd 479.9454, found
479.9440.
Hexacarbonyl [μ-(8,9-dehydro-7-methyl-5-(2-methylallyl)-5H-benzo[7]annulene)]
dicobalt (85a and 85b)

A solution of alcohol compound 75 (25.6 mg, 0.056 mmol) in CH2Cl2 (10 mL)
was subjected to Procedure D using methallyltrimethylsilane (36.1 mg, 0.280 mmol, 5
equiv.) to afford a (6:1) mixture of 85a and 85b (18.25 mg, 66 % total yield 85a + 85b).
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IR (KBr) max 2956, 2922, 2852, 2094, 2055, 2011, 1601, 1463 cm-1; 1H NMR (500
MHz, CDCl3) (major product, 85a)  7.69 (d, J= 7.5, 1H), 7.29-7.35 (m, 2H), 7.21 (d, J=
7.5, 1H), 5.71 (d, J= 4.5, 1H), 4.86 (s, 1H), 4.77 (s, 1H), 3.23 (apparent t, J= 4.5, 1H),
2.60-2.66 (m, 2H), 2.13 (s, 3H), 1.68 (s, 3H); resonances from the minor product (85b)
could be detected at 6.37 (d, J= 12.0, 1H), 5.94 (d, J= 12.0, 1H);

13

C NMR (75 MHz,

CDCl3) (major product, 85a) 199.2, 143.1, 139.5, 135.3, 133.1, 131.2, 128.6, 127.1,
126.0, 113.3, 94.5, 89.0, 42.3, 40.9, 23.1, 22.3; HRMS m/e for C22H16Co2O6 [M+ - 2CO]
calcd 437.9713, found 437.9720.
Hexacarbonyl[μ-(8,9-dehydro-2-(7-methyl-5H-benzo[7]annulen-5-yl)-1
phenylethanone)]dicobalt (86a and 86b)

A solution of alcohol compound 75 (30.10 mg, 0.066 mmol) in CH2Cl2 (10 mL)
was subjected to Procedure D using trimethyl((1-phenylvinyl)oxy)silane (76.86 mg,
0.396 mmol, 6 equiv.) to afford a 4:1 mixture of 86a and 86b (estimated yield based on
1

H NMR spectrum is 55 % total yield 86a + 86b). IR (KBr) max 2923, 2853, 2088, 2050,

2017, 1688, 1449 cm-1; 1H NMR (500 MHz, CDCl3) (major product, 86a)  8.00 (d, J=
7.5, 2H), 7.15-7.70 (m, 7H), 5.84 (d, J= 5.5, 1H), 4.03 (m, 1H), 3.53 (m, 1H), 3.46 (d, J=
5.0, 1H), 2.12 (s, 3H); resonances from the minor product (86b) could be detected at 6.69
78

(s, 1H), 6.35 (d, J= 12.0, 1H), 6.29 (d, J= 12.0, 1H), 3.43 (d, J= 5.0, 1H); 13C NMR (75
MHz, CDCl3) (major product, 86a) δ 199.9, 197.9, 140.7, 138.8, 137.4, 137.1, 135.3,
131.7, 130.8, 129.8, 129.2, 128.9, 128.3, 127.7, 127.2, 89.0, 83.3, 44.5, 29.6, 23.3;
HRMS m/e for C26H16Co2O7 [M+ - 6CO] calcd 389.9865, found 389.9844.
Hexacarbonyl [μ-(8,9-dehydro-1-methyl-3-(7-methyl-5H-benzo[7]annulen-5-yl)-1Hpyrrole)]dicobalt (87)

A solution of alcohol compound 75 (10.20 mg, 0.0224 mmol) in CH2Cl2 (5 mL)
was subjected to Procedure D using N-methylpyrrole (9.085 mg, 0.112 mmol, 5 equiv.)
to afford product 78 (9.358 mg, 81 % yield). IR (KBr) max 3434, 2918, 2090, 2051,
2021, 1641 cm-1; 1H NMR (300 MHz, CD2Cl2)  7.71 (dd, J= 1.5, 7.5, 1H), 7.28 (m,
1H), 7.21 (td, J= 1.8, 7.5, 1H), 6.64 (apparent t, J= 2.1, 1H), 6.34 (m, 1H), 6.30 (m, 1H),
6.25 (m, 1H), 6.19 (td, obscured, 1H), 4.38 (d, J= 2.1, 1H), 3.20 (s, 3 H), 2.21 (t, J= 2.8,
3H);

13

C NMR (75 MHz, CD2Cl2)  199.5, 139.7, 137.1, 136.3, 132.8, 132.7, 130.2,

128.7, 127.2, 126.5, 122.0, 108.1, 106.9, 92.8, 89.4, 41.8, 33.5, 22.8; HRMS m/e for
C23H15Co2NO6 [M+ - 2CO] calcd 462.9665, found 462.9662.

79

Hexacarbonyl [μ-(8,9-dehydro-7-methoxy-7-methyl-7H-benzo[7]annulene)]dicobalt
(88a and 88b)

A solution of alcohol compound 75 (17.4 mg, 0.0381 mmol) in 10 mL of (1:1)
CH2Cl2/MeOH solvent was subjected to Procedure D to afford a 3:1 mixture of 88a and
88b (9.7 mg, 54 % total yield 88a + 88b). IR (KBr) max 3395, 2924, 2091, 2053, 2020,
1576, 1081 cm-1; 1H NMR (500 MHz, CD2Cl2) (major product, 88a) δ 7.69 (m, 1H), 7.34
(m, 2H), 7.22 (m, 1H), 6.47 (d, J= 12.5, 1H), 6.05 (d, J= 12.5, 1H), 3.42 (s, 3H), 1.49 (s,
3H); resonances from the minor product (88b) could be detected at 7.74-7.79 (m, 2H),
6.61 (d, J= 12.5, 1H), 6.12 (dd, J= 1.0, 5.5, 1H), 4.53 (d, J= 6.0, 1H), 3.21 (s, 3H), 1.50
(s, 3H); 13C NMR (75 MHz, CD2Cl2) (major product, 88a) δ 199.7, 138.2, 136.0, 132.2,
131.6, 129.6, 128.7, 128.1, 127.7, 88.0, 78.2, 50.9, 28.2; resonances from the minor
product (88b) could be detected at 133.3, 128.3, 81.0, 56.3, 29.7;

13

C NMR (75 MHz,

CDCl3) δ 199.3, 138.1, 136.0, 132.1, 131.6, 131.5, 129.8, 128.8, 128.0, 91.0, 78.4, 51.1,
28.5; resonances from the minor product (88b) could be detected at 133.3, 81.2, 53.4,
29.7; HRMS m/e for C19H12Co2O7 [M+ - CO] calcd 441.9298, found 441.9299.
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PART II

CHAPTER 1: INTRODUCTION

1.1

Colchicine and Allocolchicinoids

1.1.1 (–)-Colchicine
(aR,7S)-Colchicine [(–)-colchicine] (100), (Figure 1.6), the principal alkaloid of
the poisonous plant meadow saffron (Colchicum autumnale), is one of the oldest known
natural products. It was first isolated in its pure state by Pelletier and Caventou1 in the
19th century, but it was not until 1959 when Eschenmoser and co-workers2 reported the
first successful total synthesis of colchicine. For thousands of years, colchicine has been
considered a well-known ancient remedy for treating acute gout, Mediterranean fever,
and liver cirrhosis.3 In 2009, colchicine became officially approved by FDA and was
patented as brand-name "Colcrys".4

Figure 1.6 Structure of ()-(aR, 7S) colchicine and its numbering system.
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Colchicine has gained increased interest due to its antitumor activity; it was shown
to be effective in inhibiting the proliferation of cancer cells in mice and inducing tumor
regression.5-7 Like other tubulin-binding natural products such as taxol and epothilones,
colchicine exhibits great pharmaceutical potential and has experienced a renaissance in
interest in the last few years.8 The mechanism of action of this alkaloid involves binding
to the intracellular protein tubulin (which is the main constitutive protein of
microtubules), hence disrupting the microtubule-dependent functions in the cell. Due to
the essential role of the mitotic spindle in cell division, the microtubule dynamic is still
regarded as one of the most relevant drug targets for the treatment of cancer.5 Tubulin
consists of α and β protein subunits which combine to form a heterodimer. These
heterodimers polymerize in a helical fashion to form long tubes known as microtubules.9
Microtubules are known to be responsible for a multitude of cellular functions including:
formation of the cytoskeleton to maintain the cellular shape, transport systems for moving
material around inside the cell, and most importantly, the formation of the mitotic spindle
during cell division. Colchicine (100) disrupts these activities by binding to the tubulin
heterodimer and preventing polymerization to form microtubules. This leads to the
termination of the cell cycle in the G2/M phase, ultimately resulting in apoptotic cell
death.8
Despite colchicine's intriguing anti-proliferative properties, and following many
years of clinical research, its high cytotoxicity in chemotherapy has precluded further
development of the drug as a potential antitumor agent. It was found that its therapeutic
effects are only observed at toxic or nearly toxic doses, hence rendering it clinically
unusable for cancer treatment.10 Nevertheless, owing to its unique tricyclic-based
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structure, colchicine has became a useful structural reference for the search of other
tubulin-targeting antitumor compounds. This prompted researchers to find alternative
structural analogues that possess similar structural features to the parent alkaloid but also
provide a lower systemic toxicity.5

1.1.2 Allocolchicinoids

Among several classes of structurally related compounds, allocolchicinoids; or
allocolchicines, (the terms will be used interchangeably hereafter), have been identified
as promising candidates for further development (Figure 1.7). These are compounds with
an altered C-ring, where the tropolone ring has been replaced by an aryl moiety.11

Figure 1.7 Numbering system of allocolchicinoids.

There is a myriad of naturally occurring allocolchicinoids (Figure 1.8) such as
(–)-allocolchicine

(101,

isolated

from

Colchicum

cornigerum

and

Colchicum

autumnale),12 (–)-colchibiphenyline (105) and (–)-androbiphenyline (106) (both from
Colchicum ritchii),13 and (–)-jerusalemine (107, derived from Colchicum decaisnei).14 In
addition, there are also semi-synthetic congeners such as N-acetylcholchinol (NAC,
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102)15 and its water-soluble form known as ZD6126 (104), and synthetic ones such as Nacetylcolchinol-O-methylether (103, NCME or NSC 51046).16
Like colchicine, allocolchicinoids such as allocolchicine (101) and Nacetylcolchinol ZD6126 (104) have also shown anticancer activity owing to their ability
to arrest cellular mitosis by inhibiting tubulin polymerization.17 Most importantly, they
possess the added feature of owning reduced toxicity compared to colchicine, the parent
alkaloid. This has led to an increasing interest in the development of synthetic protocols
to provide allocolchicine and its derivatives for biological evaluation.

Figure 1.8 Common allocolchicinoids.
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1.2

Literature Overview and Previous Syntheses

1.2.1 Preparation of Allocolchicine Derivatives from Natural Colchicine

For a long time, allocolchicinoids have been typically obtained by synthetic
transformation of colchicine (100), which itself is isolated on a commercial scale for
treating acute gout. This resulted in limiting the range of structural variation of novel
derivatives which possess reduced toxicity. Several approaches have been reported for the
partial synthesis of allocolchicine or derivatives. For example, N-acetylcolchicinol (102)
has been obtained by treatment of colchicine with 30 % hydrogen peroxide.18 Thereafter,
an O-methylation under standard conditions provided N-methyl ether acetylcolchicinol
(102) with a total yield of 33 %. Alternatively, a different method to derive (102) with a
total yield of 40 % over two steps, featured photooxygenation of colchicine followed by
triphenylphosphine-assisted rearrangement to give (102).19

Scheme 1.20 Obtaining allocolchicine by derivatization of colchicine.
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Another example in this field is the work of Davis and co-workers17a who reported
the synthesis of compound ZD6126 (104) by deriving it from natural colchicine (100),
using a series of three transformations as shown in (Scheme 1.21).

Scheme 1.21 Obtaining compound ZD6126 (104) by derivatization of colchicine.

1.2.2 Total Syntheses of N-Acetylcolchinol
N-Acetylcolchinol, (NAC, 102) is an allocolchicine derivative whose popularity is
mainly attributed to its phosphate pro-drug, (ZD6126, 104). Sponsored by the
AstraZeneca company, the results of Phase I clinical trials showed that ZD6126 has
promising properties as a novel vascular targeting agent for the therapy of solid tumors.20
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In fact, it induced tumor cells necrosis in in-vivo mouse models of a number of human
cancer cell lines (such as lung, breasts, and ovarian tumor). Unfortunately, a few years
later, further studies were ceased in Phase II clinical trials due to cardiotoxicity and
critical side effects observed in humans when the required dose of the drug was
administered. In view of this pharmaceutical potential, much attention has been dedicated
to developing effective ways of obtaining NAC (102) itself.

Sawyer and Macdonald's Method
In 1988, Sawyer and Macdonald21 performed the first total synthesis of racemic
NAC (102). Using thallium (III) to mediate an intramolecular non-phenolic coupling
reaction of the protected 1,3-diarylpropyl acetamide (108), the seven membered B-ring
was constructed and the biaryl linkage was created simultaneously.

Scheme 1.22 The first asymmetric synthesis of N-acetylcolchinol, (NAC), by Sawyer
and Macdonald.21
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Stemming from Sawyer and Macdonald's synthetic strategy, Kocienski and coworkers22 developed an asymmetric version of the synthesis of NAC (102). The key
distinction was the use of phenyliodonium bis(trifluoroacetate) as an oxidant in the final
step.

Scheme 1.23 Kocienski's asymmetric synthesis of NAC.22

Using Biaryl Reductive Coupling
In 2007, Leonard et al.23 reported an alternative synthetic approach to (S)-Nacetylcolchinol. The authors devised a modified Ziegler-Ullmann process as the key step
in the total synthesis of allocolchicine (102) by allowing the formation of the biaryl
product, which in turn was readily cyclized under basic conditions. With the tricyclic core
system in hand, the asymmetric hydrogentation of the enamide (109) was achieved using
ruthenium catalyst, namely FerroTANE-based catalyst. The retrosynthetic analysis is
given in (Scheme 1.24).
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Scheme 1.24 Retrosynthesis of NAC by Leonard et al.23

1.2.3 Methods for Allocolchicine Synthesis
Wulff's Method

The first total synthesis of (–)-(7S)-allocolchicine (101) was performed in 2003 by
Wulff's group24 at the University of Michigan, by employing Diels-Alder reaction for
constructing the C-ring around the A-B-framework (Scheme 1.25). The key step was
employing the bicyclic diene (110) to undergo a regioselective Diels-Alder reaction in the
presence of methyl propiolate as dienophile. The diene was first protected with TBDMS
group which the authors propose as a necessary step not only for alcohol protection, but
also as a major player in regiocontrol during the DA cycloaddition reaction. To complete
the synthesis of dibenzoheptanone compound, a sequence of deprotection and oxidation
steps were conducted, which gave (111), which in turn was asymmetrically reduced with
(+)-TarB-NO2/LiBH4. Inversion of stereochemistry at C7 with concomitant introduction
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of the requisite nitrogen functionality was achieved by Mitsunobu reaction with
Zn(N3)2-2Py as azide source, generating the desired natural (–)-allocolchicine (101).

Scheme 1.25 Wulff's total synthesis of ()-allocolchicine (101).24

Fagnou and Leblanc's Method
In 2005, Fagnou and Leblanc25 reported an enantioselective formal synthesis of
(–)-allocolchicine (101). Their novel approach involved employing a palladium-catalyzed
intramolecular direct arylation of aryl chloride (112) to forge the key A-C biaryl carboncarbon bond needed to the construct seven-membered ring (i.e. B ring) of allocolchicine's
tricyclic core (113). Deprotection of the OMOM group followed by employing Wulff's
method to introduce the acetamide group at C7 completed the formal total synthesis of the
natural product (101).
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Scheme 1.26 Formal synthesis of allocolchicine (101) by Fagnou and Leblanc.25

Unlike Wulff24 who established the chiral center in the allocolchicine after
constructing the tricyclic core, Fagnou's strategy was to introduce the molecule's chirality
in the early stages of the synthesis before forming the tricyclic framework. This method
presented itself as a new and unique strategy in the asymmetric allocolchicinoid synthetic
work.

1.2.4 Syntheses of NCME or NSC 51046

Several total syntheses of allocolchicine have been reported in literature, however,
there are considerably fewer methods for synthesis of NCME (103). In fact, this
allocolchicinoid possesses tubulin inhibition activity that is greater than that of colchicine
itself,26 yet researchers have only recently started to show some synthetic interest.
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DeShong Synthesis
In 2006, DeShong's group27 from the University of Maryland published a novel
and versatile approach to the allocolchicine carbocyclic skeleton. First, the A-C biaryl
ring system was accessed using a palladium catalyzed siloxane coupling method; this was
followed by ring expansion reaction of substituted MOM-protected phenanthrol (114) as
the key step for the construction of tricyclic skeleton of N-acetylcolchinol-O-methyl
ether. The authors implemented this strategy to accomplish the first total synthesis of
racemic NCME (103).

Scheme 1.27 Retrosynthesis of NCME (rac-103) by DeShong and Seganish.27
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Green's Synthesis of NCME and iso-NSC 51046 via Nicholas Reaction Chemistry

Central to the Green group's research interests is the synthesis of 6,7,6-containing
compounds, primarily by utilizing Nicholas reaction chemistry for the construction of the
seven-membered ring core. From previous research performed by Green's group, it was
evident that intramolecular Nicholas reactions constitute a reliable approach towards the
synthesis of dibenzocycloheptanone, ultimately leading to achieving an enantioselective
synthesis of N-acetyl-O-methylcolchinol (NSC 51046 or NCME, 103).
In the synthesis of Djurdjevic and Green28 (Scheme 1.28), the biaryl propargyl
acetate hexacarbonyldicobalt complex (115a) underwent a Lewis acid intramolecular
Nicholas reaction to afford dibenzocycloheptadienyneCo2(CO)6 complex (116a). This
latter compound was in turn readily reductively decomplexed by hydrosilylation-acidic
desilylation method, followed by hydroboration and oxidation reactions to afford the C-7
ketone (117). Compound (117a) was subsequently subjected to a sequence of
transformations that were analogous to those previously employed by Wulff24 in his
asymmetric total synthesis of (103).
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Scheme 1.28 Green's synthesis of allocolchicine NCME via Nicholas reaction
chemistry.28

In addition, this approach was further extended to prepare a novel allocolchicine
analogue (118), namely (S)-3,8,9,10-tetramethoxy (A-ring) regioisomer of NSC 51046
(103). Compound (118) will be referred to as iso-NSC 51046 hereafter, and will be
presented in more detail in CHAPTER 2 (vide infra).
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1.3

Modified Allocolchicinoids
Besides the synthesis of conventional allocolchicine derivatives, novel targets that

include allocolchicinoids analogues with modified B-, C-, and B,C-ring29 systems have
also been synthesized and tested for biological activity. Some relevant selected examples
will be discussed in the following section.
Boyer and Hanna have developed a synthetic strategy which was based on a
conceptually similar approach to Wulff’s work24 in synthesizing allocolchicine
derivatives. Using [4+2]cycloaddition, structural analogues of allocolchicine were
obtained with an altered position of the ester group in the C-ring, namely at the C-10 and
C-11 positions30 (Figure 1.9; 119a/b and 120, respectively). In their most recent work,
Boyer's group31 were involved in the synthesis of allocolchicinoids derivatives with Band C-ring variations via sequential enyne-metathesis/Diels-Alder reactions. These
compounds were evaluated for their tubulin assembly inhibition effects. Some of the
noteworthy results of these evaluations revealed that allocolchicine (119a) with methyl
ester at C-10 had a comparable biological activity in comparison to natural colchicine
alkaloid. However, complete activity loss was observed for allocolchicine (120) with a
methyl ester at C-11 of the C-ring.30,31

Figure 1.9 Examples of C-ring modified allocolchicines.
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Seitz and co-workers32 have synthesized two series of novel B-ring modified
allocolchicinoid congeners that mimic the structure of (S)-N-acetylcolchinol-O-methyl
ether (103, NCME). The first series of NCME variants (121) included a nitrogen
containing eight membered B-ring, whereas in the second series (122), the sevenmembered B-ring of NCME was modified by annulation with a heterocyclic ring system.
These novel heterocyclic-fused seven membered B-ring allocolchicinoids were found to
be highly potent antimicrotubule agents.

Figure 1.10 Examples of B-ring modified allocolchicines.

Recently, Fedorov and co-workers33-35 reported the synthesis and biological
assessment of a group of heterocyclic allocolchicine variants in which the C-ring of the
parent allocolchicine is fused to an indole, furan-, or pyrrolo-derived core. Selected
examples are shown in (Figure 1.11).
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Figure 1.11 Heterocyclic allocolchicinoids.

The indole-derived allocolchicine analogues33a (123a) and (123b) are considered
the first examples of heteroarene-based allocolchicines. Biological evaluation studies
revealed that these individual derivatives exhibited pronounced anti-proliferative activity,
and were also capable of inducing apoptosis in different lymphoma cells. Although their
unspecific cytotoxicity was found to be low, they were effective in very small nanomolar
concentration (and even in sub-nanomolar levels).33
In their most recent work, Fedorov et al.34 also reported the synthesis of pyrroloallocolchicinoids of type (124), which are in fact constitutional isomers of (123a) and
(123b). They, too, possessed anti-proliferative and pro-apoptotic activities which were
very comparable to that of the indole-based analogues (123a/b). The authors also
extended their studies where they reported a semi-synthetic route to furan-based
allocolchicinoids. After preparing a set of furan-based allocolchicinoids of type (125), in
vitro studies showed that the most potent compound is when R = CH2-OH, where it was
found to be a more effective tubulin inhibitor than colchicine.35
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1.4 Arene-Enone Conjugate Addition Reactions
In addition to allocolchicines derivatives, the 6,7-ring framework is a commonly
encountered motif in many other natural products. Amongst the remarkable number of
approaches available in literature, conjugate addition chemistry lends itself as a valuable
and versatile means to access 6,7-bicyclic systems. Several methodologies have been
developed in which activated arenes were used as Michael donors in conjugate addition
reactions. Of note, the work of Majetich36 provides excellent and relevant examples that
fit very well in this topic.
The

Majetich

group

has

elaborately

employed

Lewis

acid

mediated

cycloalkylation reactions in the synthesis of natural products based on 6,7-ring systems.
Their debut work36a in this area was reported in 1993, where they prepared the [6-7-6]
tricyclic compounds via Lewis acid catalyzed intramolecular alkylation of electron-rich
arenes with conjugated dienones (Scheme 1.29). Two series of arene-dienones were
employed (2-arene-dienones and 4-arene-dienones), and they were both shown to be
effective in providing the corresponding 6,7,6-fused tricycles.
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Scheme 1.29 Construction of 6,7,6-tricylic compounds via Lewis acid mediated
cycloalkylation by Majetich et al.36a

These results prompted Majetich to apply the aforementioned approach in
synthesizing a significant number of natural products, such as (±)-barbatusol, (±)pisiferin, (±)-deoxofaveline, (±)-xochitlolone, and (±)-faveline.36b Despite the versatility
of Majetich's Friedel-Crafts alkylation method, the published cases to date required either
stoichiometric or super-stoichiometric amounts of Lewis acid; in addition, the 6,7,6systems of the allocolchicines derivatives have not been among the reported synthetic
targets.
Another relevant example in literature was provided by the Chen group.37 In their
recent work, Chen et al. reported the synthesis of dibenzocycloheptenones, the core
structure

of

allocolchicine,

via

a

stoichiometric

IClmediated

electrophilic

iodocyclization.
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1.5 Origin of Current Project and Proposed Research
The search for novel allocolchicinoids with improved antitumor properties
remains an ongoing quest for synthetic chemists. With the exception of our group's
previous work28 (Djurdjevic and Green's synthesis), allocolchicinoid analogues with a
modified A-ring are non-existent in literature. As stated earlier, Green's approach using
Nicholas reaction chemistry was successfully implemented in preparing two
allocolchicinoids derivatives (NSC 51046 and iso-NSC 51046), whose biological
properties were underexplored for the most part.
Dr. Siyaram Pandey, a prominent biochemist in our Department of Chemistry and
Biochemistry, became interested in studying the biological properties (namely the
anticancerous activity) of these two closely related allocolchicine derivatives. In a recent
publication, Pandey38 and his group have reported the detailed findings of their study of
these compounds. NSC 51046 was found to be non-selective as it induced apoptosis in
both BxPC-3 and PANC-1 pancreatic cancer cells and in normal human fibroblasts.
Interestingly, it was found that iso-NSC 51046 was able to induce pro-death autophagy in
these pancreatic cancer cells and E6-1 leukemia cells but not in normal human fibroblasts.
Unlike colchicine and NSC 51046, iso-NSC 51046 did not appear to affect tubulin
polymerization, indicating that it has a different molecular target. It also caused increased
reactive oxygen species (ROS) production in mitochondria isolated from pancreatic
cancer cells. Furthermore, in vivo studies revealed that it was well tolerated in mice.38
These findings suggested that a small change in the structure of the parent allocolchicine
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derivative can presumably change the mechanism of action and improve selectivity. This
may also lead to better selective treatments in cancer therapy.
Despite the significance of the aforementioned Nicholas reaction synthetic
approach, there were two main drawbacks in using this method, particularly if the
synthesis was carried on a larger scale. The first issue is attributed to the use of excess
(greater than stoichiometric) amounts of dicobalt octacarbonyl reagent, which may pose
an environmental concern if the synthesis was scaled-up. The other shortcoming was the
length of the synthesis. The overall total synthesis was carried out in 11 steps and
afforded the allocolchicine in an overall yield of 14 %. Specifically, there were a total of
8 steps required to arrive at the dibenzocycloheptanone, followed by an additional 3 steps
to furnish the end product.
Conjugate addition reactions (both intermolecular and intramolecular) are
amongst the most efficient tools for C-C formation in organic synthesis. However, in
most cases strong Brønsted or Lewis acid reagents are required in stoichiometric or
excess amounts, and many of them require the use of rare (hence cost ineffective) metals.
Herein we report the construction of tricyclic framework of various allocolchicinoids via
intramolecular Michael-type Friedel-Crafts alkylation to form the seven-membered ring.
This process requires an appropriate Lewis acid that's capable of catalytic turnover.
On the basis of our group's continuing interest in constructing 6-7-6 tricyclic core
systems, and given the biological significance of allocolchicine analogues that were
alluded to earlier, we envisioned that a short, atom-economical, catalytic, and overall
more efficient synthesis of the relevant dibenzocycloheptanone (en route to iso-NSC
51046 synthesis and other A-ring modified allocolchicines) would be worth investigating.
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CHAPTER 2: RESULTS AND DISCUSSION

In continuation of our group's interest in the synthesis of seven-membered ring
containing compounds, herein we report a short and efficient synthesis of allocolchicine
derivatives under mild conditions. From a synthetic perspective, the dibenzocycloheptanone represents a key intermediate en route to numerous allocolchicine
analogues. Having stated that, the key step in this synthetic approach can be viewed as the
construction of the seven membered B-ring using an appropriate catalyst. The
methodology will also be expanded to other related substrates with variable substituents.

2.1

General Synthetic Strategy
Multiple strategies to access the tricyclic fused ring system of allocolchicinoids

analogues have been developed to date. To access the desired dibenzocycloheptanone, the
synthetic strategy depicted in (Scheme 2.9) was investigated. The synthetic plan first
features a facile preparation of the biarylcarboxaldehyde by means of Suzuki-Miyaura
coupling chemistry. Conversion of the biarylcarboxaldehyde into the corresponding
alkenones or alkynones could be accomplished by nucleophilic addition of the proper
Grignard reagent followed by alcohol oxidation to the corresponding ketone. At this
point, closure of the cycloheptane (or cycloheptene) would be assessed by screening
several Lewis acids, primarily to seek a Lewis acid reagent that can effectively catalyze
the ring closure process using a minimum catalytic loading. Once obtained, the
cycloheptanone can be readily converted to the corresponding allocolchicine, such as
allocolchicine iso-NSC 51046 (118) shown in (Scheme 2.9) as a general example, by
implementing a series of previously reported protocols.
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Scheme 2.9 Proposed retrosynthetic approach to dibenzoheptanone and ultimately to
allocolchicine iso-NSC 51046 (118).

From a synthetic point of view, two plausible routes can provide access to the
intended dibenzocycloheptanone (117b) as depicted in (Scheme 2.10). The synthetic
scheme following (Route A) involves obtaining the biaryl compound (128) which may be
further derivatized to get the alkynone cyclization precursor (130). Catalyzed by the
proper Lewis or Brønsted acid, it was envisioned that the ring closure step could
potentially take place to yield the dibenzocycloheptenone B-ring (131). This step would
be followed by subsequent reduction of the C=C bond which in turn forms the intended
dibenzocycloheptanone species (117b). Alternatively, (Route B) was also proposed as
another means of reaching the cycloheptanone. Through the steps indicated in (Scheme
109

2.10), the biaryl compound could be converted to the corresponding enone substrate
(133). The next step would involve subjecting the acyclic enone to the proper catalytic
condition (Lewis or Brønsted acid) to directly furnish the intended cycloheptanone
(117b). If completed successfully, this would constitute the tricyclic core of a group of
the allocolchicinoids (which will be discussed later in this section).

Scheme 2.10 Two proposed routes to construct the tricyclic core of allocolchicinoids via
intramolecular conjugate addition reaction.

Our initial proposal was to obtain the desired tricyclic framework via ring closure
of corresponding alkynone (128). To access the cyclization precursor, the first synthetic
task involved obtaining a biaryl carboxaldehyde by utilizing the Suzuki-Miyaura coupling
reaction. This specific step was duplicated from the previous allocolchicine synthesis
reported by our group (Djurdjevic and Green).28 Using the Fürstner39 conditions, the
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Suzuki cross-coupling reaction of 5-methoxy-2-bromobenzaldehyde (126) and 3,4,5trimethoxyphenylboronic acid (127) furnished the desired biaryl product (128) in 88 %
yield (Scheme 2.11).

Scheme 2.11 Suzuki-Miyuara cross-coupling reaction.

To proceed further with the preparation of the precursor required for (Route A)
synthetic pathway, the biarylcarboxaldehyde substrate (128) was then subjected to
reaction with ethynylmagnesium bromide to afford the corresponding propargylic alcohol
(129) in 97 % yield. The latter compound was converted to the corresponding ketone
using MnO2 oxidation to attain the intended acyclic alkynone (130) in 57 % yield
(Scheme 2.12).

Scheme 2.12 Preparation of alkynone cyclization precursor (Route A).
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With substrate (130) in hand, a number of protocols were investigated to carry out
the key conjugate addition reaction towards the construction of the seven membered ring.
To achieve this, a Lewis acid is necessary to catalyze the cyclization, namely the 7-endodig process. The first attempt to induce the cyclization reaction was using "carbophilic" or
"-electrophilic" Lewis acid.
The use of gold (I) and (III) salts has dramatically increased in organic syntheses
due to their unique Lewis acidic nature.40 Specifically, gold (III) compounds have been
used as potential Lewis acids by virtue of their ability to activate bonds under
extremely mild conditions. In light of the versatility and fascinating reactivity of gold
catalysis in modern organic transformations, we chose AuCl3 as the first catalyst. The
soft, carbophilic Au(III) Lewis acid didn't prove to be effective in promoting cyclization
of the alkynone. Upon adding 10 mol % loading of AuCl3, an immediate degradation of
the starting material was evident. A similar observation was noted when using GaCl3,
which is known to be as both a powerful and Lewis acid,41 under similar reaction
conditions (Table 2.5).
Table 2.5 Attempts to induce the cyclization using alkynone as substrate.

Lewis acid Catalyst loading Conditions

Observations

AuCl3

10 mol %

CH2Cl2, rt

immediate decomposition

GaCl3

10 mol %

CH2Cl2, rt

immediate decomposition
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Faced with the inability to prepare the desired cycloheptanone via (Route A), our
attention was turned to the alternative approach (Route B), starting with the same starting
materials (126 and 127), and following an analogous strategy to assemble of the biaryl
unit via the Suzuki cross-coupling reaction. The corresponding allylic alcohol (132) was
generated as a result of the nucleophilic attack of a vinyl Grignard reagent on the
relatively electron deficient carbon of the aldehyde (128). Subsequently, the allylic
alcohol was subjected to oxidation to give the enone (133) which is the intended
precursor for the cyclization reaction (Scheme 2.13).

Scheme 2.13 Preparation of alkenone cyclization precursor (Route B).

2.2

Lewis Acid Alkylation of Electron-Rich Arenes
In the given enone (133), the electron-rich trioxygenated A-ring (nucleophilic

species) and the , β-unsaturated ketone (Michael acceptor, i.e. electrophile) are the two
components of the conjugate addition process. To achieve the B-ring closure, the
cyclization can proceed only if activated by an appropriate Lewis acid as suggested in the
proposed mechanism (Scheme 2.14). In view of the availability of a wide array of Lewis
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acidic metal reagents, it was deemed logical to assess two types of Lewis acids:
carbophilic (or π-selective) and oxophilic.

Scheme 2.14 Proposed cyclization mechanism.

Attempts at cyclization reactions of (133) by the use of π-selective Lewis acids
met with limited success (Table 2.6). The use of 10 mol % loading of gold (III) chloride
(AuCl3) enabled the complete consumption of the starting material, however it led to a
poor yield (31 %) and extensive baseline material. On the other hand, treating the same
substrate with the carbophilic gold (I) Lewis acid (AuCl(SMe)2) in the presence of AgBF4
gave similar results. It's worth noting that in the absence of Au(I), the reaction progress
appeared to be unaffected, which suggested that the Ag(I) was in fact the active catalytic
species in the cyclization reaction. Other metal salts were also explored, and they showed
somewhat limited effectiveness in promoting the conjugate addition reaction. Both FeCl3
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and InCl3 gave only a small amount of (117b). Furthermore, Sc(OTf)3, an oxophilic
Lewis acid, led to the complete decomposition of the substrate once added to the reaction
mixture. Likewise, PtCl4 also resulted in unproductive decomposition when 30 mol %
loading was introduced to the substrate. Conversely, using SnCl4 gave relatively
respectable yields (based on the percent conversion) but it lacked the catalytic turnover
which rendered the reagent less useful in our studies.

Table 2.6 Screening Lewis acids as catalysts for conjugate addition reaction.

Lewis acid

Catalytic loading

Conditions

Yield (%)

AuCl3

10 mol %

acetonitrile [0.003 M], rt, 3h

31

5 mol %

CH2Cl2 [0.005 M], rt, 24h

23

AgBF4

5 mol %

CH2Cl2 [0.005 M], rt, 24h

25

FeCl3

45 mol %

CH2Cl2 [0.005 M], rt, 24h

15

InCl3

10 mol %

CH2Cl2 [0.005 M], rt, 24h

11

SnCl4

50 mol %

CH2Cl2 [0.005 M], rt, 3h

51

GaCl3

10 mol %

CH2Cl2 [0.002 M], rt, 3h

52

Sc(OTf)3

10 mol %

CH2Cl2 [0.005 M], rt

(a)

PtCl4

30 mol %

CH2Cl2 [0.005 M], rt

(a)

AuCl(SMe)2 +
AgBF4

a

Immediate decomposition of starting material.
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Given the limited success achieving a truly catalytic cyclization reaction, a test
reaction was run using the most conventional and commonly used Lewis acid in the
Green lab, BF3-OEt2. There has been wide success in previous projects in our group with
employing boron trifluoride to mediate the formation of 7-membered rings (albeit being
used in stoichiometric amounts). In view of these facts, the first cyclization reaction was
conducted using 1.5 equiv. of BF3-OEt2 to a dichloromethane solution of enone. To our
surprise, the reaction furnished the intended cyclized product in good yield (75 %). This
outcome encouraged additional experiments with lower loadings of the Lewis acid to
bring the cyclization reaction to the catalytic domain.

Table 2.7 Optimization of cyclization reaction catalyzed by BF3-OEt2.

Lewis acid Catalyst loading

BF3-OEt2

a

Conditions

Yield/ conversion

1.5 equiv

CH2Cl2 [0.005 M], 24h, 0C-rt

75 %

50 mol %

CH2Cl2 [0.005 M], 24h, 0C-rt

65 %

25 mol %

CH2Cl2 [0.005 M], 12h, 0C-rt

78 %

10 mol %

CH2Cl2 [0.005 M], 3h, 0C-rt

71 %

10 mol %

CH2Cl2 [0.002 M], 3h, 0C-rt

83 %

5 mol %

CH2Cl2 [0.002 M], 4h, 0C-rt

3 mol %

CH2Cl2 [0.002 M], 24h, 0C-rt

75 %
90 % conversion(a);
65 % yield

Incomplete conversion.
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Indeed, the results were comparably successful even when using substoichiometric amount of Lewis acid, where good yields were maintained at 25 mol %
and only slightly compromised at 10 mol % loadings (Table 2.7). To further validate our
original proposal in developing an atom-economic and "genuinely" catalytic synthesis,
the catalyst loading was reduced further. Upon exposure to 5 mol % of BF3-OEt2 catalyst,
complete conversion from (133) to (117b) was realized with an isolated yield of 75 %.
Lower amounts of the catalyst resulted in incomplete conversion and thus it was
determined that the lower limit of the BF3-OEt2 was 5 mol %. In addition, the
concentration of the reaction mixture was noted to play a significant role. In fact, the
optimal yield was obtained when running the reaction under high dilution conditions
(0.0002 M) in the presence of the Lewis acid. It's also worth noting that the reaction
outcome may be slightly jeopardized if the reaction time was longer than 4 hours,
possibly due to gradual product decomposition that could be taking place.

2.2.1 Reaction Scope

Having established the optimized conditions of the cycloalkylation reaction, the
next stage was to explore the reaction's scope and to investigate substituent effects on the
ring closure step in particular. Using Suzuki coupling reaction, a series of biaryl
compounds were readily prepared (135a-g) in yields ranging from 74 to 94 %. The results
are summarized in (Table 2.8).
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Table 2.8 Suzuki-Miyaura cross-coupling reaction.

a

Entry

R1

R2

R3

Product/ Yield

1

H

H

H

135a/ 86 %

2

H

CO2Me

H

135b/ 81 %

3

H

F

H

135c/ 94 %

4

H

OBn

H

135d/ 91 %

5

H

H

OMe

135e/ 79 %

6

H

-OCH2O-

7

OMe

OMe

135f/ 86 %
H

135g/ (45 %)a

Yield in parentheses is based on recovered starting material (134g).

In accordance with the reaction sequence provided earlier in (Scheme 2.13), the
addition of vinylmagnesium bromide to the corresponding aldehydes (135a-g) readily
afforded the allylic alcohol compounds (136a-g). The reaction conditions were analogous
in all substrates and a summary of the formed compounds is given in (Table 2.9).
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Table 2.9 Synthesis of allylic alcohol compounds (136a-g)

Entry

R1

R2

R3

Product/ Yield

1

H

H

H

136a/ 82 %

2

H

CO2Me

H

136b/ 82 %

3

H

F

H

136c/ 90 %

4

H

OBn

H

136d/ 80 %

5

H

H

OMe

136e/ 80 %

6

H

-OCH2O-

7

OMe

OMe

136f/ 72 %
H

136g/ 96 %

The resultant allylic alcohols were subsequently oxidized to the corresponding
ketones. Some substrates were oxidized with manganese (IV) oxide (MnO2) as a mild
oxidant (entries 2, 4, and 7; Table 2.10). In other cases, oxidation with MnO2 was less
successful, with low yields being obtained; hence we resorted to other choices of
oxidants, namely tetrapropylammonium perruthenate (TPAP) in combination with Nmethylmorpholine N-oxide (NMO), to give the corresponding enones in respectable
yields (entries 1, 3, 5, and 6; Table 2.10).
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Table 2.10 Oxidation reaction to form acyclic enones.

Entry

R1

R2

R3

[O]

Product/ Yield

1

H

H

H

TPAP (cat.), NMO

137a/ 80 %

2

H

CO2Me

H

MnO2

137b/ 90 %

3

H

F

H

TPAP (cat.), NMO

137c/ 66 %

4

H

OBn

H

MnO2

137d/ 70 (81 %) a

5

H

H

OMe

TPAP (cat.), NMO

137e/ 70%

6

H

-OCH2O-

TPAP (cat.), NMO

137f/ 68 %

7

OMe

MnO2

137g/ 95 %

a

OMe

H

Yields in parentheses are based on recovered starting material (136d).

After preparing a series of various enones (137a-g), these substrates were submitted to the
previously optimized conditions: BF3-OEt2 (5 mol %) and 0.002 M concentration or
closely related conditions. The results are summarized in (Table 2.11).
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Table 2.11 Cyclization of enones using BF3-OEt2.

a
b

Entry

R1

R2

R3

Conditions

Product/Yield

1

H

H

H

CH2Cl2 [0.002 M], 12h, 0C-rt

138a/ 81 %

2(a)

H

CO2Me

H

CH2Cl2 [0.002 M], 48h, 0C-rt

138b/ 68 %

3

H

F

H

CH2Cl2 [0.001 M], 48h, 0C-rt

138c/ 68 %

4

H

OBn

H

CH2Cl2 [0.002 M], 48h, 0C-rt

138d/ 81 %

5

H

H

OMe CH2Cl2 [0.001 M], 12h, 0C-rt

138e/ 70 %

6

H

-OCH2O-

CH2Cl2 [0.002 M], 72h, 0C-rt

138f/ 63 %

7

OMe

CH2Cl2

(b)

OMe

H

Reaction complete using 10 mol% of BF3-OEt2
No reaction. Immediate decomposition of the reaction mixture

The presence of either electron donating or electron withdrawing substituents on
the C-ring was well tolerated. Benzyloxy-substituted (137d) afforded (138d, 81 % yield,
48 h, Table 2.11, entry 4). The methylenedioxy-substituted (137f) successfully converted
into (138f, 63 %, 72 h, Table 2.11, entry 6). Among the most interesting cases was the
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ester-substituted substrate. The acyclic alkenone (137b) was successfully cyclized to the
corresponding benzosuberone (138b). Even though an incomplete consumption of (137b)
at the 5 mol % loading of BF3-OEt2 was observed, complete conversion to the intended
product was realized by doubling the amount of BF3-OEt2 to 10 mol % (138b, 68 %, 48 h,
Table 2.11, entry 2). The significance of this particular substrate is mainly owing to the
fact that (138b) can be regarded as the precursor of the A-ring isomer of the natural
occurring alkaloid ()-allocolchicine (101). Furthermore, by using 5 mol % of BF3-OEt2,
the fluorinated product (138c) was obtained in 47 % yield in 48 h at 0.002 M, but the
yields were improved when the concentration was dropped to 0.001 M (138c, 68%, 48 h,
Table 2.11, entry 3). Placing a methoxy substituent in C-5 position of the C-ring did not
adversely affect the yields of cyclization either. The cyclization product was readily
obtained in 70 % yield when subjected to 5 mol % of BF3-OEt2 (138e, Table 2.11, entry
5). Also, among the targeted examples was a substrate devoid of C-ring substitution
(137a, Table 2.11, entry 1). Optimal yields of the cyclized compound (138a) were
realized in 81 % yield using 5 mol % BF3-OEt2, and complete conversion required
relatively long reaction time (12 h). Regarding the last entry (137g, entry 7, Table 2.11),
it can be observed that the presence of a methoxy substituent in R1 position led to the
deactivation of the 7-endo-trig cyclization process. Despite attempting this reaction
multiple times, it was evident that the starting material underwent complete degradation
instantly once the Lewis acid was added. This was also reinforced by the appearance of
deep dark purple color which is usually indicative of decomposition.
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2.3

Heterocyclic Analogues
Given the recent prominence of heterocyclic-based allocolchicinoids as potential

antitumor agents32-35 (by mimicking the colchicine mode of action), we wanted to prove
the viability of our methodology in accessing heterocyclic analogues of cycloheptanones.
Following our established approach, the preparation of thiophene-based cycloheptanone
was initiated by assembling the 3,4,5-trimethoxyphenylboronic acid (127) and 2-bromo3-thiophenecarboxaldehyde (134h) to yield the heterocyclic biaryl system (135h) in 40 %
yield. In accordance with the vinyl Grignard addition protocols applied earlier with other
substrates, the allylic alcohol compound (136h) was obtained in 85 % yield, which was
subsequently oxidized with MnO2 to give the thiophene-based enone in 71 % yield
(Scheme 2.15).

Scheme 2.15 Preparation of C-ring thiophene-based cycloheptanone (138h).
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Lewis acid mediated cyclization of (137h) was first attempted using BF3-OEt2.
The thiophene-based enone was fully converted to the cyclic compound (138g) in the
presence of a full equivalent of the Lewis acid (61 % yield). However, BF3-OEt2 proved
to be not effective in catalytic loadings (incomplete conversion) as shown in (Table
2.12). Fortunately, GaCl3 provided a decent catalytic turnover in the 7-endo-trig
cyclization process. After adding 0.25 equivalent of Ga(III), the reaction proceeded
smoothly and the product was obtained in 70 % yield.

Table 2.12 Screening Lewis acids for cyclization of (137h) to (138g).

Lewis acid Catalytic loading

2.4

Conditions

Yield (%)

BF3-OEt2

20 mol %

CH2Cl2, 12h

incomplete conversion

BF3-OEt2

40 mol %

CH2Cl2, 12h

incomplete conversion

BF3-OEt2

1 equiv.

CH2Cl2, 4h

61

GaCl3

25 mol %

CH2Cl2, 24h

70

Completion of Enantioselective Synthesis of Allocolchicines
After successfully arriving at the intended cycloheptanone, there remained 3 steps

to complete the synthesis of allocolchicine compound iso-NSC 5146 (118). As shown
previously (Scheme 1.28), these synthetic steps had already been successfully established
in the previous work of Green.28 Hence, the preparation of (117b) constitutes a formal
synthesis of (118). In view of the success of using Wulff's24 approach in our group's
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previous synthesis of allocolchicinoids, it was logical to adopt a similar approach in this
current work. The asymmetric reduction of the ketone was achieved using Singaram44 and
co-workers' method where the substrate was exposed to reducing agent LiBH4 in the
presence of 2-(3-nitrophenyl)-1,3,2-dioxaborolane-4R,5R-dicarboxylic acid [(+)-TarBNO2, 139] as a chiral Lewis acid (Scheme 2.16). The reduction of (117b) under these
conditions proceeded with an excellent yield (97%) and high enantioselectivity (99 % ee),
as determined by means of HPLC with a chiral stationary phase. To incorporate the
correct stereochemistry of the molecule, the chirality at C-7 of (140) was inverted (R- to
S-) using a Mitsunobu reaction; the nucleophilic displacement of the hydroxy group by an
azide (Zn(N3)2-2Py as azide source) was crucial to introduce the nitrogen function needed
in the molecule. The reaction proceeded smoothly giving (141) in 77 % yield.
Subsequently, the reduction of (141) to the corresponding amine was achieved via
hydrogenolysis using Lindlar's catalyst. This step was followed promptly by acetylation
of the amine to afford the acetamide functionality at C-7 of the intended allocolchicine.
The enantiomeric purity of (118) was measured to be 98% ee. After a single
recrystallization, the purified compound was obtained, and it showed identical physical
properties to the previously synthesized allocolchicine (mp, spectroscopic data).28
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Scheme 2.16 Completion of enantioselective formal synthesis of iso-NSC 51046 (118).

Two other dibenzocycloheptanones, unsubstituted (138a) and ester-substituted Cring (138b) substrates, were chosen for further derivatization, where they were subjected
to analogous conditions to arrive at the corresponding allocolchicine (Scheme 2.17).
Singaram's method44 worked smoothly and the benzylic chiral alcohols were obtained in
98% (142a) and 80% (142b) yield and 99% ee for both (142a) and (142b). The
subsequent step (Mitsunobu reaction) proved to be effective in giving the azide
containing compounds in 72% (143a) and 77% (143b) yield. Subjecting the formed
azides to hydrogenolysis using Lindlar's catalyst followed by acetylation gave the
corresponding allocolchicines (71% yield of (144) and 57% yield of (145)) in high
enantiomeric excess (98% ee for (144) and 99% ee for (145)). Since these allocolchicine
126

derivatives have not been reported in literature previously, this work constitutes total
syntheses of two novel allocolchicines analogues of the iso-NSC 51046 series.

Scheme 2.17 Completion of enantioselective total synthesis of allocolchicinoids (144)
and (145).
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2.5

Targeting Dibenzocycloheptanone Precursor en route to NSC
51046 Synthesis

Encouraged by the results obtained in synthesis of iso-NSC 51046, it was
envisioned that providing access to compounds with "allocolchicine-like" trimethoxy
arrangement is very desirable mainly since they provide greater resemblance to the
naturally occurring family of allocolchicines. Targeting the precursors needed for
synthesis of the natural alkaloid ()-allocolchicine is recognized as logical, since it serves
to provide a more generalized substrate scope and complements the applicability of our
Nicholas chemistry-based methodology.
Following an analogous sequence of transformations in preparing the previously
reported cyclization precursors, the corresponding enone substrate (146a) was
synthesized

via

Suzuki

cross-coupling

reaction,

followed

by

reaction

with

vinylmagnesium bromide to afford the allylic alcohol which was subsequently subjected
to oxidation to obtain the enone of interest (Scheme 2.18).

Scheme 2.18 Preparation of acyclic enone (146a) as cyclization reaction precursor.

128

To carry out the ring closing step, a set of Lewis acid mediated conjugate addition
protocols were surveyed to achieve an efficient synthesis of dibenzocycloheptanone
(117a) bearing a 2,3,4-trimethoxy substituted A-ring. The complete list of results is
summarized in (Table 2.13).

Table 2.13 Screening Lewis acids as catalysts for conjugate addition reaction of (146a).

a

Lewis Acid

Catalyst Loading

Solvent

Yield/conversion

BF3-OEt2

1.0 equiv

CH2Cl2

74 %

BF3-OEt2

20 mol %

CH2Cl2

(a)

BF3-OEt2

50 mol %

CH2Cl2

50 % conv.

InCl3

30 mol %

CH2Cl2, 24h, rt

45 % conversion

FeCl3

25 mol %

CH2Cl2, 24h, rt

29 % conversion

AuCl3

30 mol %

CH2Cl2

50 % conversion

GaCl3

50 mol %

CH2Cl2, rt

72%

GaCl3

25 mol %

CH2Cl2, ∆

62 %

GaCl3

10 mol %

CH2Cl2, ∆

50 % conversion

No conversion was obtained; only starting material was recovered.
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While BF3-OEt2 proved to be superior to other Lewis acids in the synthesis of isoNSC 51046 and other substrates with analogous A-ring substitution pattern, it wasn't
shown to be effective at catalytic loadings for the current system. The first attempt to
induce the cyclization reaction was by using BF3-OEt2. Starting with 1.0 equiv. of Lewis
acid, the conversion was complete in 48h with 74 % yield of a compound initially
assigned as (117a). However, the catalytic turnover didn't occur and hence, using substoichiometric amounts of BF3-OEt2 led to incomplete conversion. InCl3, FeCl3, and
AuCl3 also showed low potential for catalysis. In the continuing search for suitable
catalytic Lewis acid metal reagent, gallium trichloride was tested next. We were delighted
to see that it showed a potential to give catalytic turnover to the process, and gave
acceptable yields at 25 mol % loading in refluxing methylene chloride (62 %, 48 h, Table
2.13).
Having the end product in hand, a quick comparison of the experimental data
(spectroscopic information and the melting point) of the newly formed cyclized
compound with those previously reported in literature revealed that the identity of the
cyclic compound was assigned incorrectly. In fact, the obtained data were unambiguously
identical to those of compound (117b). To better understand the reaction outcome, a
plausible mechanism was proposed that accounts for the formation of the spirocyclic
compound via an ipso-cyclization. As shown in (Scheme 2.19), once the Lewis acid
complexes to the oxygen of the enone, two reaction pathways are potentially possible: I) a
6-endo trig ipso-cyclization and II) an 8-endo-trig cyclization.
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Scheme 2.19 A plausible mechanism for the Lewis acid induced rearrangement of
cycloheptanone.
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Due to the presence of three electron-donating methoxy substituents on the A ring,
electronic effects will presumably play a major role in the reaction outcome. To start with
the carbon in the ipso position (a), the orthomethoxy group (i.e. ortho relative to ipsocarbon) can donate electron density to it through resonance effects. In addition, the high
electron content in the ipso position is even further amplified due to the presence of
another EDG in the para-position (methoxy group). This means that the ipso position has
become "doubly" activated to engage in pathway (I) cyclization to form the spiro 6membered ring intermediate species via a 6-endo-trig path. On a similar note, position (b)
(i.e. carbon in the meta position relative to the 1,1'-diphenyl bond) is also activated by
two methoxy groups through resonance effects. This leads to a high electron density on
this position which can potentially undergo an 8-endo-trig cyclization (pathway II). In
spite the fact that both the ipso and the meta positions on the A ring are equally activated
(based on electronics), yet the formation of 8-membered ring sizes is known to be
thermodynamically and kinetically unfavourable process. As a result, the outcome of the
given reaction will be likely dominated by pathway (I) and the spirocyclic compound is
thought to be the immediate product formed in the first step of the conjugate addition
reaction. The ipso attack is followed by a skeletal rearrangement (1,2-aryl group
migration) which results in ring expansion and, upon loss of a proton, affords the
observed dibenzocycloheptanone.
An additional closely related analogue (bearing an 9,10,11-trimethoxy substituted
A-ring and an unsubstituted C-ring) was investigated. After preparing the alkenone
compound, we wanted to assess whether it was a suitable substrate for cyclization
reaction.
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This particular example proved to be the most stubborn case in undergoing the
cyclization step. Upon subjecting the enone to an array of commercially available Lewis
acids, we had limited success in achieving the sought after transformation. In most cases,
the consumption of the starting material was not evident even after long reaction times,
and one case resulted in immediate decomposition of the substrate.

Table 2.14 Screening Lewis acids as catalysts for conjugate addition reaction of (146b).

Lewis acid

Catalyst loading

Yield/ conversion

BF3-OEt2

10 mol %

no reaction

BF3-OEt2

1 equiv.

no reaction

GaCl3

25 mol %

side product (147)

AuCl3

decomposition

AuClPPh3 +
10 mol %

no reaction

AlCl3

1 equiv.

45 % (138a)

AlCl3

excess

52 % (138a)

AgBF4
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In an attempt to accomplish the reaction under the same conditions that were
found to be optimal in the previous example (i.e. using GaCl3), the intended product
(138a) was not formed, but instead, an unexpected side-product was isolated. After
carefully examining the NMR spectroscopic data of the compound, the absence of one
singlet peak (which represents OCH3 protons) revealed that a demethoxylation process
has been involved. We speculated that a quinone-like spiroconjugated compound (147)
was the side product in hand.
During further testing of other Lewis acids, the aluminum based Lewis acid,
AlCl3, showed to be ultimately somewhat successful. By subjecting the enone substrate to
an excess amount (6 equiv.) of AlCl3 in nitrobenzene, we were delighted to finally see
complete consumption of the starting material, and the product (138a) was obtained in 52
% yield. It's worth noting that this Lewis acid did not appear to have catalytic turnover,
where the lowest loading required to fully drive the reaction to completion was 1 equiv;
the yield was slightly compromised (45 %) presumably due to the longer reaction time.
On the other hand, both BF3-OEt2 and AuClPPh3 (with AgBF4) were not able to promote
the cyclization reaction as seen in (Table 2.14). Also, AuCl3 led to complete degradation
of starting material. It's worth highlighting that the location of the methoxy groups in the
cyclic compound was analogous to the case reported earlier, where similar aryl migration
was expected to have occurred resulting in the formation of the rearranged
cycloheptanone in lieu of the predicted cyclized species (Scheme 2.19).
The formation of spirocyclic compounds in intramolecular arene-enone reactions
has been encountered in several cases in literature.37,42 Perhaps the most relevant example
was the one reported by Majetich et al.36b during their investigations of the substituents'
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effect on the outcome of cycloalkylation of dienones with activated arenes (Scheme
2.20). When the methoxy substituent was located at the 3' position of the arene (148), the
reaction pathway went through 7-endo trig cyclization to furnish the dibenzocycloheptane
product (149). However, placing the methoxy group on position 2' (150) dictated a
different reaction pathway, where an ipso-attack formed a cyclohexane intermediate,
followed by demethylation to ultimately give the spiro-fused enone (151). The authors
attributed the different outcomes of the two reactions to the stability of the involved
cations in each case; that is to say that the six-membered ring formation led to
carbocation (150a) is more stabilized than the cation formed by cycloheptane formation
(150b).

Scheme 2.20 Examples by Majetich36b demonstrating the substituents' effect in the
formation of spiro-fused enone compound (151).
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CHAPTER 3: CONCLUSIONS AND FUTURE OUTLOOK

3.1 Conclusions
We have elaborated a conveniently short, efficient, atom-economical, and more
environmentally benign synthetic route to iso-(aR,7S)-()-N-acetylcolchinol or iso-NSC
51046 (an A-ring isomer of allocolchicine NSC 51046), exploiting a Lewis acid catalyzed
Friedel-Crafts intramolecular cyclalkylation. In the key step, the seven-membered ring
(B-ring) was efficiently constructed under mild conditions, where BF3-OEt2 was found to
be a privileged catalyst in this process. A 7-step asymmetric synthesis of iso-NSC 51046
from

commercially

available

5-methoxy-2-bromobenzaldehyde

and

3,4,5-

trimethoxyphenylboronic acid was accomplished in 20 % overall yield. In comparison,
this is considered a significant improvement over our group's previous method which
provided an 11-step synthesis for an overall yield of 14 % of iso-NSC 51046.
Specifically, there were a total of 8 steps required to arrive at the dibenzocycloheptanone
followed by an additional 3 steps to furnish the end product. As a result, the current
methodology makes the present route better suited to larger scale syntheses, and it paves
the way to a rather broad variety of new allocolchicinoids. The synthetic accessibility and
significant antitumor activity exhibited by the new colchicinoids described here make
them promising objects for more detailed biological investigations. We consider the Aring modified allocolchicinoids of type iso-NSC 51046 as promising lead in the search for
novel anticancer agents with improved properties.
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3.2 Future Outlook
Having a group of synthesized dibenzoheptanones in hand (138c-g), it can be
envisioned that an analogous chemistry can be extended to these substrates to ultimately
attain a reasonable library of compounds of the iso-NSC 51046 series. They can be
subsequently submitted for biological evaluations.
In 1991, Barry M. Trost43 introduced the concept of "atom economy" in an
attempt to prompt synthetic organic chemists to adopt 'greener chemistry'. Simply stated,
atom economy is a calculation which measures “how much of the reactants remain in the
final product”.43 Hence, a chemical transformation is considered to have an ideal atom
economy if all reactant atoms are found in the end product. By examining our proposed
Lewis acid catalyzed cyclization (which is the key transformation in the synthesis), it is
evident that there are no "wasted" atoms in the process, and all the atoms of the acyclic
enone are seen in the produced dibenzocycloheptanone, which makes this process atom
economical. To increase the efficiency of our reported protocol in preparing the tricyclic
core of allocolchicinoids, we foresee that the ring-closing process can be made even
"greener". One major consideration would be to replace the chlorinated solvent
(dichloromethane) with greener solvent alternatives that can still solvate the reaction
substrates and the involved catalyst. The careful choice of alternative solvents should
mainly avoid ones that contain "basic" or nucleophilic atoms which can potentially pair
with the Lewis acid. Solvents such as hexanes or cyclohexane seem to be logical choices
and worth investigating in the future.
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CHAPTER 4: EXPERIMENTAL

General Methods and Materials: All reagents, unless otherwise noted, were
purchased from Aldrich. 2,3,4-Trimethoxyphenylboronic acid was purchased from Alfa
Aesar. All reactions were run under a nitrogen atmosphere using oven-dried glassware
(110 C, > 1h). All reaction solvents (except 1,2-dimethoxyethane, DME) were directly
obtained from solvent purification system (Innovative Technologies). Commercial
BF3-OEt2 was distilled and stored under nitrogen. The term “conventional workup” refers
to the extraction of the product from the aqueous layer with an organic solvent (such as
dichloromethane or diethyl ether), drying the combined organic layers with anhydrous
magnesium sulfate and filtration of the resultant mixture, followed by evaporation of the
volatiles under reduced pressure to obtain the crude product(s).
Instrumentation: Flash chromatography was performed using silica gel 60 (230400 mesh). Analytical thin layer chromatography (TLC) was performed on silica gel 60
F254 sheets from Silicycle. Preparative TLC was carried out over silica gel GF-254 plates
from Silicycle. High- Resolution Mass Spectrometry (HRMS) results were obtained by
means of a Direct Insertion Probe-Electron Ionization method (70 eV), on a Waters/
Micromass GCT (GC-EI/CI Time of Flight Mass Spectrometer) performed at the
McMaster Regional Centre for Mass Spectrometry. Proton nuclear magnetic resonance
(1H NMR) data were obtained either on Bruker Avance 300 or 500 MHz spectrometers.
Chemical shifts are reported in delta ( units, parts per million (ppm), relative to the
singlet at 7.26 ppm for chloroform-d, unless otherwise indicated. Coupling constants are
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reported in Hertz (Hz). Carbon-13 nuclear magnetic resonance (13C NMR) data were
obtained on Bruker Avance 75 MHz or 125 MHz spectrometers. Infrared Spectroscopy
(IR) data were recorded on a Bruker alpha-ATR FT-IR spectrometer. The reported IR
data (neat) reflects the frequencies of the distinctive functional group stretches only.
Melting points were measured with a Thomas Hoover, Uni-Melt© capillary point
apparatus.

3',4',5'-Trimethoxy-[1,1'-biphenyl]-2-carbaldehyde (135a)

Title compound was prepared according to the procedure reported by Kundu,45
starting with 2-bromobenzaldehyde (2.0 g, 10.81 mmol) and 3,4,5-trimethoxyphenylboronic acid (2.52 g, 11.89 mmol) to yield 2.56 g of compound (135a) as a white
solid (86 % yield), mp 92-93 C (lit. 102-106 C). The spectroscopic data matched the
ones reported in the literature.45
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Methyl 2-formyl-3',4',5'-trimethoxy-[1,1'-biphenyl]-4-carboxylate (135b)

repared according to the

rstner39 method, where methyl 4-bromo-3-

formylbenzoate (1.40 g, 5.78 mmol) afforded the title compound (135b) as a colorless
powder (1.54 g, 81 % yield), 137-139 C. IR (neat) max 2942, 2839, 1719, 1689, 1119,
765.6 cm-1; 1H NMR (500 MHz, CDCl3) δ 10.03 (s, 1H), 8.65 (d, J= 2.0, 1H), 8.28 (dd,
J= 1.5, 8.0, 1H), 7.56 (d, J= 8.0, 1H), 6.57 (s, 2H), 3.98 (s, 3H), 3.92 (s, 3H), 3.89 (s, 6H);
13

C NMR (125 MHz, CDCl3) δ 191.5, 166.1, 153.3, 149.7, 138.5, 133.9, 132.4, 130.8,

129.8, 129.1, 107.3, 61.0, 56.3, 52.5; HRMS m/e for C18H18O6 calcd 330.1103, found
330.1100.
4-Fluoro-3',4',5'-trimethoxy-[1,1'-biphenyl]-2-carbaldehyde (135c)
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(The preparation method of this compound was adapted from a literature protocol).46
To a 100 mL oven-dried flask, was added 3,4,5-trimethoxyphenylboronic acid
(1.3 g, 5.07 mmol), 2-bromo-5-fluorobenzaldehyde (1.13 g, 5.58 mmol), Pd(PPh3)4 (0.4
g, 6 mol %), and Na2CO3 (1.13 g, 2 equiv.). Then, the flask was evacuated and refilled
with nitrogen gas (x 3). The flask was then placed under nitrogen and 52 mL of degassed
dioxane/water/ethanol was added via syringe (5:1:1). The reaction mixture was heated at
reflux for 12 h. After cooling the reaction to room temperature, the dioxane was removed
under reduced pressure. The resulting residue was then dissolved in dichloromethane and
washed with water/brine. The organic layer was separated, and dried with anhydrous
magnesium sulfate. The volatiles were removed under reduced pressure and the residue
was purified by flash chromatography (3:1 hexanes/ diethyl ether) to afford compound
(135c) as a white solid (1.53 g, 94 % yield), mp 132-134C. IR (neat) max 2956, 1675,
1582, 1486, 1237, 1127 cm-1; 1H NMR (500 MHz, CDCl3) δ 9.85 (d, J= 3.0, 1H), 7.51
(dd, J= 2.8, 8.8, 1H), 7.39 (dd, J= 5.5, 8.5, 1H), 7.23 (td, J= 3.0, 8.0, 1H), 6.48 (s, 2H),
3.82 (s, 3H), 3.80 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 191.0, 162.0 (d, JC,F = 247.5),
153.1, 142.0 (d, JC,F = 3.0), 138.1, 135.3 (d, JC,F = 6.1), 132.5 (d, JC,F = 7.3), 132.3, 120.6
(d, JC,F = 21.9), 113.3 (d, JC,F = 22.0), 107.4, 60.8 (d, JC,F = 1.4), 56.1 (d, JC,F = 1.1);
HRMS m/e for C16H15FO4 calcd 290.0954, found 290.0949.
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4-(Benzyloxy)-3',4',5'-trimethoxy-[1,1'-biphenyl]-2-carbaldehyde (135d)

repared

according

to

the

rstner39

method,

where

5-benzyloxy-2-

bromobenzaldehyde (1.05 g, 3.6 mmol) afforded the title compound (135d) as a viscous
yellow oil (1.24 g, 91 % yield). IR (neat) max 2934, 2839, 1711, 1684, 1583, 1486, 1239,
1123 cm-1; 1H NMR (500 MHz, CDCl3) δ 9.98 (s, 1H), 7.58 (d, J= 3.0, 1H), 7.34-7.48
(m, 6H), 7.26 (dd, J= 3.0, 8.5, 1H), 6.53 (s, 2H), 5.17 (s, 2H), 3.91 (s, 3H), 3.87 (s, 6H);
13

C NMR (125 MHz, CDCl3) δ 192.3, 158.3, 153.1, 139.3, 137.8, 136.3, 134.6, 133.1,

131.9, 128.7, 128.2, 127.6, 121.9, 110.9, 107.5, 70.3, 61.0, 56.2; HRMS m/e for
C23H22O5 calcd 378.1467, found 378.1456.
3',4',5,5'-Tetramethoxy-[1,1'-biphenyl]-2-carbaldehyde (135e)
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repared

according

to

rstner39

the

method,

where

2-bromo-4-

methoxybenzaldehyde (1.03 g, 4.79 mmol) afforded (135e) as a colorless solid (1.15 g, 79
% yield), mp 128-130 C. IR (neat) max 2926, 1675, 1602, 1580, 1236, 1120 cm-1;
1

H NMR (500 MHz, CDCl3) δ 9.98 (s, 1H), 7.49 (d, J= 2.5, 1H), 7.38 (d, J= 8.5, 1H),

7.19 (dd, J= 3.0, 8.5, 1H), 6.53 (s, 2H), 3.91 (s, 6H), 3.88 (s, 6H);

13

C NMR (125 MHz,

CDCl3) δ 192.3, 159.2, 153.1, 139.1, 137.8, 134.7, 133.2, 131.8, 121.3, 109.7, 107.6,
61.0, 56.2, 55.7; HRMS m/e for C17H18O5 calcd 302.1154, found 302.1146.
6-(3,4,5-Trimethoxyphenyl)benzo[d][1,3]dioxole-5-carbaldehyde (135f)

repared

according

to

the

rstner39

method,

where

6-

bromobenzo[d][1,3]dioxole-5-carbaldehyde (0.214 g, 0.934 mmol) afforded the title
compound (135f) as a colorless powder (0.254g, 86 % yield) after column
chromatography (3:1 hexanes/ diethyl ether); mp: 154-155 C. IR (neat) max 2956, 2916,
1674, 1580, 1120 cm-1; 1H NMR (500 MHz, CDCl3) δ 9.79 (s, 1H), 7.45 (s, 1H), 6.86 (s,
1H), 6.53 (s, 2H), 6.09 (s, 2H), 3.90 (s, 3H), 3.87 (s, 6H); 13C NMR (125 MHz, CDCl3) δ
190.7, 153.0, 152.0, 147.8, 143.6, 133.1, 128.9, 110.1, 107.4, 106.2, 102.1, 61.0, 56.2;
HRMS m/e for C17H16O6 calcd 316.0947, found 316.0942.
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3,3',4,4',5'-Pentamethoxy-[1,1'-biphenyl]-2-carbaldehyde (135g)

repared

according

to

the

rstner39

method,

where

6-bromo-2,3-

dimethoxybenzaldehyde (1.433 g, 5.847 mmol) afforded (135g) as a yellow solid (0.67 g,
35 % yield, or 45 % brsm), mp 86-87.5 C (Et2O). IR (neat) max 2934, 2836, 1690, 1584,
1565, 1484, 1225 cm-1; 1H NMR (500 MHz, CDCl3) δ 10.03 (s, 1H), 7.13 (d, J= 8.5, 1H),
7.11 (d, J= 8.5, 1H), 6.47 (s, 2H), 3.96 (s, 3H), 3.93 (s, 3H), 3.88 (s, 3H), 3.85 (s, 6H);
13

C NMR (75 MHz, CDCl3) δ 191.9, 153.0, 152.7, 149.5, 137.6, 137.1, 134.1, 129.4,

126.1, 116.2, 107.1, 62.4, 61.1, 56.3; HRMS m/e for C18H20O6 calcd 332.1260, found
332.1245.
3-(3,4,5-Trimethoxyphenyl)thiophene-2-carbaldehyde (135h)

Prepared according to the

rstner39 method, where 3-bromothiophene-2-

carbaldehyde (0.36 g, 1.884 mmol) afforded the title compound (135h) as an off-white
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powder (0.206 g, 40 % yield) after column chromatography (3:1 hexanes/ diethyl ether);
mp 127.5129 C. IR (neat) max 2930, 1647, 1583, 1415, 1237, 1123 cm-1; 1H NMR
(300 MHz, CDCl3) δ 9.93 (s, 1H), 7.73 (apparent dd, J= 1.0, 5.0, 1H), 7.22 (d, J= 4.8,
1H), 6.66 (s, 2H), 3.91 (s, 3H), 3.89 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 184.4, 153.5,
151.6, 138.8, 138.6, 134.3, 130.7, 129.6, 107.0, 61.1, 56.4; HRMS m/e for: C14H14O4S
calcd 278.0613, found 278.0613.
2',3',4'-Trimethoxy-[1,1'-biphenyl]-2-carbaldehyde (135i)

repared according to the

rstner39 method, starting with 2-bromobenzaldehyde

(1.59 g, 8.59 mmol) and 2,3,4-trimethoxyphenylboronic acid (2.00 g, 9.43 mmol) to
afford compound 135i (1.83 g, 78 % yield) as a white solid (mp 95-96 C; lit. mp 98-99
C). The product showed spectroscopic data identical with the literature.39

General Procedure E: A solution of the biaryl compound (1 equiv.) in anhydrous
diethyl ether was cooled down in an ice-bath to 0 C. Then, vinylmagnesium bromide
solution (2.0 equiv. of 1.0 M in THF solution) was added in dropwise fashion while
stirring. The reaction mixture was stirred further for 1-2 h (TLC control). Upon the
complete consumption of the starting material, the reaction was quenched with a saturated
145

solution of ammonium chloride and extracted with diethyl ether (2 times). The organic
layer was separated and dried with anhydrous magnesium sulfate. The volatiles were
removed under reduced pressure and the residue was purified by flash chromatography to
afford the final product.
1-(3',4,4',5'-Tetramethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-ol (132)

Title compound was prepared by following General Procedure E. Column
chromatography (3:1 diethyl ether/hexanes) yielded compound (132) as a yellow viscous
oil (76% yield). IR (neat) max 3455, 2938, 1708, 1607, 1583, 1488, 1234, 1122, 728
cm-1; 1H NMR (300 MHz, CDCl3) δ 7.19 (d, J= 8.4, 1H), 7.10 (d, J= 2.4, 1H), 6.87 (dd,
J= 2.4, 8.4, 1H), 6.54 (s, 2H), 6.05 (ddd, J= 5.3, 10.3, 17.1, 1H), 5.30 (d, J= 5.1, 1H),
5.22 (d, J= 17.1, 1H), 5.17 (d, J= 10.3, 1H), 3.88 (s, 6H), 3.84 (s, 3H), 3.83 (s, 3H), 1.99
(br s, 1H);

13

C NMR (125 MHz, CDCl3) δ 159.3, 152.7, 141.1, 140.5, 136.9, 136.1,

133.8, 131.0, 115.0, 113.4, 111.8, 106.8, 71.3, 60.94, 60.93, 56.1, 56.09, 55.4; HRMS
m/e for C19H22O5 calcd 330.1467, found 330.1463.
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1-(3',4',5'-Trimethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-ol (136a)

Title compound was prepared by following General Procedure E. Column
chromatography (3:1 diethyl ether/hexanes) yielded compound (136a) as a yellow solid
(82 % yield), mp 80-83C. IR (neat) max 3434, 2937, 1707, 1583, 1408, 1343, 1235,
1121, 998, 764 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.57 (dd, J= 1.5, 8.0, 1H), 7.40
(apparent dt, J= 1.5, 7.5, 1H), 7.33 (apparent dt, J= 1.5, 7.5, 1H), 7.57 (dd, J= 1.5, 7.5,
1H), 6.57 (s, 2H), 6.08 (ddd, J= 5.5, 10.5, 17.5, 1H), 5.32 (br s, 1H), 5.23 (apparent td, J=
1.5, 17.5, 1H), 5.18 (apparent td, J= 1.5, 10.5, 1H), 3.90 (s, 3H), 3.85 (s, 6H), 1.92 (d, J=
4.0, 1H); 13C NMR (75 MHz, CDCl3) δ 152.9, 141.3, 140.8, 139.9, 137.2, 136.4, 129.9,
128.1, 127.6, 127.1, 115.0, 106.8, 71.4, 61.1, 56.2; HRMS m/e for C18H20O4 calcd
300.1362, found 300.1366.
Methyl 2-(1-hydroxyallyl)-3',4',5'-trimethoxy-[1,1'-biphenyl]-4-carboxylate (136b)
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Title compound was prepared by following General Procedure E. Column
chromatography (3:1 diethyl ether/hexanes) yielded compound (136b) as a yellow
viscous oil (82 % yield). IR (neat) max 3473, 2947, 1718, 1583, 1232, 1120 cm-1;
1

H NMR (500 MHz, CDCl3) δ 8.25 (d, J= 1.5, 1H), 7.98 (dd, J= 1.5, 8.0, 1H), 7.35 (d, J=

8.0, 1H), 6.56 (s, 2H), 6.09 (ddd, J= 5.5, 10.5, 17.0, 1H), 5.34 (br m, 1H), 5.20-5.27 (m,
2H), 3.94 (s, 3H), 3.90 (s, 3H), 3.85 (s, 6H), 1.99 (d, J= 4.0, 1H); 13C NMR (125 MHz,
CDCl3) δ 166.8, 152.9, 145.7, 140.2, 137.5, 135.2, 130.1, 129.7, 128.6, 128.5, 115.6,
106.4, 71.1, 61.0, 56.2, 52.2; HRMS m/e for C20H22O6 calcd 358.1416, found 358.1431.
1-(4-Fluoro-3',4',5'-trimethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-ol (136c)

Title compound was prepared by following General Procedure E. Column
chromatography (3:1 diethyl ether/hexanes) yielded compound (136c) as a yellow viscous
oil (90 % yield). IR (neat) max 3459, 2936, 1709, 1580, 1485, 1403, 1232, 1118, 993
cm-1; 1H NMR (300 MHz, CDCl3) δ 7.19-7.24 (m, 2H), 6.99 (ddd, J= 2.8, 8.3, 8.3 (JH,F)
1H), 6.50 (s, 2H), 6.00 (ddd, J= 5.3, 10.3, 17.4, 1H), 5.26 (d, J= 5.0, 1H), 5.20 (apparent
td, J= 1.4, 10.3, 1H), 5.15 (apparent td, J= 1.4, 17.4, 1H), 3.87 (s, 3H), 3.82 (s, 6H), 2.21
(br s, 1H);

13

C NMR (75 MHz, CDCl3) δ 162.5 (d, JC,F = 245), 153.0, 142.3 (d, JC,F =

6.7), 140.2, 137.4, 137.1, 135.5, 131.5 (d, JC,F = 8.2), 115.5, 114.5 (d, JC,F = 21.0), 113.8
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(d, JC,F = 22.5), 106.9, 71.2, 61.0, 56.2; HRMS m/e for C18H19FO4 calcd 318.1267, found
318.1259.
1-(4-(Benzyloxy)-3',4',5'-trimethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-ol (136d)

Title compound was prepared by following General Procedure E. Column
chromatography (3:1 diethyl ether/hexanes) yielded compound (136d) as a yellow
viscous oil (80 % yield). IR (neat) max 3455, 2935, 1606, 1583, 1487, 1233, 1123, 728
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.34-7.45 (m, 5H), 7.21 (d, J= 8.5, 1H), 7.19 (d, J=
2.5, 1H), 6.94 (dd, J= 2.5, 8.5, 1H), 6.54 (s, 2H), 6.04 (ddd, J= 5.5, 10.2, 17.2, 1H), 5.30
(br s, 1H), 5.23 (dt, J= 1.5, 17.0, 1H), 5.18 (dt, J= 1.5, 10.4, 1H), 5.11 (s, 2H), 3.89 (s,
3H), 3.84 (s, 6H), 1.98 (d, J= 3.5, 1H);

13

C NMR (125 MHz, CDCl3) δ 158.5, 152.8,

141.1, 140.4, 137.0, 136.9, 136.0, 134.1, 131.0, 128.6, 128.1, 127.6, 115.0, 114.2, 113.0,
106.8, 71.3, 70.1, 61.0, 56.1; HRMS m/e for C25H26O5 calcd 406.1780, found 406.1764.
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1-(3',4',5,5'-Tetramethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-ol (136e)

Title compound was prepared by following General Procedure E. Column
chromatography (3:1 diethyl ether/hexanes) yielded compound (136e) as a yellow viscous
oil (80 % yield). IR (neat) max 3447, 2936, 1707, 1607, 1583, 1488, 1235, 1122, 729
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.20 (d, J= 8.5, 1H), 7.10 (d, J= 2.8, 1H), 6.88 (dd,
J= 2.8, 8.5, 1H), 6.54 (s, 2H), 6.06 (ddd, J= 5.5, 10.5, 17.0, 1H), 5.30 (br m, 1H), 5.24
(dt, J= 1.5, 17.0, 1H), 5.19 (apparent td, J= 1.5, 10.5, 1H), 3.89 (s, 3H), 3.85 (s, 3H), 3.84
(s, 6H), 1.90 (d, J= 3.5, 1H);

13

C NMR (75 MHz, CDCl3) δ 159.4, 152.8, 141.2, 140.6,

137.0, 136.2, 133.9, 131.1, 115.1, 113.6, 111.9, 106.9, 71.5, 61.1, 56.2, 55.5; HRMS m/e
for C19H22O5 calcd 330.1467, found 330.1458.
1-(6-(3,4,5-Trimethoxyphenyl)benzo[d][1,3]dioxol-5-yl)prop-2-en-1-ol (136f)

Title compound was prepared by following General Procedure E. Column
chromatography (3:1 diethyl ether/hexanes) yielded the product (136f) as an off-white
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solid (72 % yield), mp 93-95 C. IR (neat) max 3254, 2967, 2938, 1582, 1479, 1227,
1115, 1010, 921, 849 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.01 (s, 1H), 6.73 (s, 1H), 6.52
(s, 2H), 6.03 (ddd, J= 5.5, 11.0, 17.0, 1H), 5.98 (s, 2H), 5.16-5.25 (m, 3H), 3.88 (s, 3H),
3.84 (s, 6H), 1.86 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ 152.8, 147.3, 146.8, 140.6,
137.1, 136.1, 135.1, 133.5, 114.8, 109.7, 107.0, 106.7, 101.3, 71.1, 60.9, 56.1; HRMS
m/e for C19H20O6 calcd 344.1260, found 344.1243.
1-(3,3',4,4',5'-Pentamethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-ol (136g)

Title compound was prepared by following General Procedure E. Column
chromatography (3:1 diethyl ether/hexanes) yielded compound (136g) as a viscous paleyellow oil (96 % yield). IR (neat) max 3520, 2939, 2836, 1582, 1484, 1454, 1404, 1124
cm-1; 1H NMR (500 MHz, CDCl3) δ 6.98 (d, J= 8.0, 1H), 6.90 (d, J= 8.5, 1H), 6.48 (s,
2H), 6.21-6.27 (m, 1H), 5.13-5.19 (m, 3H), 3.92 (s, 3H), 3.90 (s, 3H), 3.87 (s, 3H), 3.82
(s, 6H); 13C NMR (75 MHz, CDCl3) δ 152.8, 152.1, 147.5, 142.2, 137.2, 136.2, 134.7,
133.7, 125.5, 114.1, 111.8, 106.8, 72.3, 61.1, 61.0, 56.2, 56.0; HRMS m/e for C20H24O6
calcd 360.1573, found [M+  H2O] 342.1466.
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1-(3-(3,4,5-Trimethoxyphenyl)thiophen-2-yl)prop-2-en-1-ol (136h)

Title compound was prepared from compound 135h (0.154 g, 0.555 mmol) by
following General Procedure E. Column chromatography (3:1 diethyl ether/hexanes)
yielded compound (136h) as a viscous colorless oil (0.141 g, 85 % yield). IR (neat) max
3447, 2937,1583, 1502,1453, 1240, 1124 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.31 (d, J=
5.0, 1H), 7.06 (dd, J= 1.5, 5.0, 1H), 6.69 (s, 2H), 6.19 (ddd, J= 5.5, 10.0, 17.2, 1H), 5.53
(br s, 1H), 5.40 (dd, J= 1.0, 17.0, 1H), 5.26 (dd, J= 1.0, 10.0, 1H), 3.89 (s, 3H), 3.87 (s,
6H), 2.16 (br s, 1H);

13

C NMR (125 MHz, CDCl3) δ 153.1, 140.6, 140.3, 139.8, 137.3,

131.7, 129.2, 124.7, 115.5, 106.1, 68.9, 61.0, 56.2; HRMS m/e for C16H18O4S calcd
306.0926, found 306.0911.
1-(2',3',4,4'-Tetramethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-ol (136i)
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Title compound was prepared by following General Procedure E. Column
chromatography (3:1 diethyl ether/hexanes) yielded compound (136i) as a yellow viscous
oil (70 % yield). IR (neat) max 3459, 2937, 2836, 1710, 1598, 1483, 1460, 1408, 1092,
1076, 1001, 804 cm-1; 1H NMR (500 MHz, CDCl3) (two diastereomers on NMR time
scale, major isomer reported, 23 C) δ 7.13 (d, J= 8.5, 1H), 7.06 (d, J= 2.5, 1H), 6.88 (m,
2H), 6.75 (d, J= 8.5, 1H), 5.90 (ddd, J= 4.3, 10.6, 17.3, 1H), 5.33 (dt, J= 1.7, 17.2, 1H),
5.16 (dt, J= 1.7, 10.6, 1H), 5.03 (m, 1H), 3.93 (s, 3H), 3.90 (s, 3H), 3.85 (s, 3H), 3.54 (s,
3H);

13

C NMR (125 MHz, CDCl3) δ 159.5, 153.2, 151.0, 143.0, 142.4, 139.1, 131.3,

129.3, 127.7, 125.5, 114.1, 113.6, 112.1, 108.1, 71.5, 61.1, 56.1, 55.2; HRMS m/e for
C19H22O5 calcd 330.1467, found 330.1478.
1-(2',3',4'-Trimethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-ol (136j)

Title compound was prepared from compound 135i (1.83 g, 6.72 mmol) by
following General Procedure E. Column chromatography (3:1 diethyl ether/hexanes)
yielded compound (136j) as a yellow oil (1.46 g, 73 % yield). IR (neat) max 3350, 2932,
2840, 1598, 1461,1408,1289, 1092 cm-1; 1H NMR (500 MHz, CDCl3) (two diastereomers
on NMR time scale, major isomer reported, 23 C) δ 7.53 (dd, J= 1.0, 8.0, 1H), 7.40
(apparent td, J= 1.0, 8.0, 1H), 7.33 (apparent td, J= 1.5, 7.5, 1H), 7.21 (dd, J= 1.5, 7.5,
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1H), 6.89 (d, J= 8.5, 1H), 6.77 (d, J= 8.5, 1H), 5.93 (ddd, J= 4.5, 11.0, 17.4, 1H), 5.32
(apparent dt, J= 2.0, 17.0, 1H), 5.16 (apparent dt, J= 1.5, 10.5, 1H), 5.06 (m, 1H), 3.94 (s,
6H), 3.54 (s, 3H);

13

C NMR (75 MHz, CDCl3) (two diastereomers on NMR time scale,

major isomer reported, 23 C) δ 153.5, 150.8, 141.7, 139.2, 130.3, 128.3, 128.0, 127.5,
127.4, 125.4, 114.2, 108.1, 71.4, 61.4, 61.2, 56.2; HRMS m/e for C18H20O4 calcd
300.1362, found 300.13.

General Procedure F: After dissolving the vinyl alcohol compound in anhydrous
dichloromethane, an excess amount of activated manganese (IV) dioxide was added in
one portion. After stirring the reaction mixture at room temperature for 1-3 h (TLC
control), it was filtered through Celite which was washed with dichloromethane. The
filtrate was concentrated under reduced pressure to yield the crude compound which was
purified using flash chromatography to afford the , β-unsaturated ketone compounds
(137a-h and 146a-b).

1-(3',4,4',5'-Tetramethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-one (133)

To a solution of 132 (0.1435 g, 0.435 mmol) in anhydrous dichloromethane (20
mL) were added 4 Å molecular sieves, N-methylmorpholine N-oxide (0.153 g, 1.30
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mmol).

After

stirring

the

solution

for

5

minutes

at

room

temperature,

tetrapropylammonium perruthenate (0.010 g, 0.0028 mmol) was added. The reaction was
stirred for 2 h, then it was filtered through Celite and washed with diethyl ether. After
removing the volatiles under reduced pressure, the obtained crude sample was purified by
column chromatography (1:1 diethyl ether/hexanes) to afford the product (133) as a
yellow solid (0.107 g, 75 % yield), mp 99-100 C. IR (neat) max 2937, 2836, 1711, 1665,
1583, 1484, 1240, 1121, 1005, 821 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.38 (d, J= 8.5,
1H), 7.05-7.08 (m, 2H), 6.47 (s, 2H), 6.18 (dd, J= 10.5, 17.5, 1H), 6.00 (dd, J= 1.5, 17.5,
1H), 5.56 (dd, J= 1.5, 10.5, 1H), 3.86 (s, 6H), 3.82 (s, 6H); 13C NMR (125 MHz, CDCl3)
δ 197.0, 158.9, 153.2, 140.1, 137.5, 135.8, 135.5, 133.4, 130.9, 128.8, 117.2, 113.1,
106.4, 61.0, 56.1, 55.6; HRMS m/e for C19H20O5 calcd 328.1311, found 328.1307.
1-(3',4',5'-Trimethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-one (137a)

To a solution of 136a (0.0455 g, 0.151 mmol) in anhydrous dichloromethane (10
mL) were added 4 Å molecular sieves, N-methylmorpholine N-oxide (0.053 g, 0.455
mmol).

After

stirring

the

solution

for

5

minutes

at

room

temperature,

tetrapropylammonium perruthenate (0.0033 g, 0.0095 mmol) was added. The reaction
was stirred for 12 h, then it was filtered through Celite and washed with diethyl ether.
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After removing the volatiles under reduced pressure, the obtained crude sample was
purified by column chromatography (1:1 diethyl ether/hexanes) to afford the product
(137a) as a yellow solid (80 % yield), mp 68-70 C. IR (neat) max 2938, 2835, 1658,
1582, 1455, 1406, 1344, 1239, 1122, 994, 729 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.417.46 (m, 2H), 7.51-7.54 (m, 2H), 6.51 (s, 2H), 6.20 (dd, J= 10.5, 17.5, 1H), 5.98 (dd, J=
1.5, 17.5, 1H), 5.57 (dd, J= 1.5, 10.5, 1H), 3.87 (s, 3H), 3.82 (s, 6H);

13

C NMR (125

MHz, CDCl3) δ 197.3, 153.3, 140.7, 139.2, 137.8, 136.0, 135.8, 130.7, 129.6, 128.8,
128.7, 127.4, 106.4, 61.0, 56.1; HRMS m/e for C18H18O4 calcd 298.1205, found
298.1213.
Methyl 2-acryloyl-3',4',5'-trimethoxy-[1,1'-biphenyl]-4-carboxylate (137b)

Title compound was prepared by following General Procedure F. Column
chromatography (2:1 diethyl ether/hexanes) yielded the product (137b) as a yellow
viscous oil (90 % yield). IR (neat) max 2937, 2839, 1719, 1661, 1598, 1284, 1092 cm-1;
1

H NMR (500 MHz, CDCl3) δ 8.18 (s, 1H), 8.17 (d, J= 1.5, 1H), 7.54 (d, J= 8.0, 1H),

6.52 (s, 2H), 6.23 (dd, J= 10.5, 17.0, 1H), 5.99 (dd, J= 1.0, 17.5, 1H), 5.65 (dd, J= 1.0,
10.5, 1H), 3.95 (s, 3H), 3.88 (s, 3H), 3.83 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 196.5,
166.2, 153.4, 144.9, 139.2, 138.4, 135.8, 134.7, 131.5, 130.0, 129.9, 129.6, 129.2, 106.3,
61.0, 56.2, 52.4; HRMS m/e for C20H20O6 calcd 356.1260, found 356.1251.
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1-(4-Fluoro-3',4',5'-trimethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-one (137c)

To a solution of 136c (0.171 g, 0.538 mmol) in anhydrous dichloromethane (10
mL) were added 4 Å molecular sieves, N-methylmorpholine N-oxide (0.189 g, 1.614
mmol).

After

stirring

the

solution

for

5

minutes

at

room

temperature,

tetrapropylammonium perruthenate (0.028 g, 0.081 mmol) was added. The reaction was
stirred for 1 h, then it was filtered through Celite and washed with diethyl ether. After
removing the volatiles under reduced pressure, the obtained crude sample was purified by
column chromatography (1:1 diethyl ether/hexanes) to afford the product (137c) as a
yellow solid (0.112 g, 66 % yield), mp 73-74.5 C. IR (neat) max 2941, 2836, 1659,1575,
1482, 1453, 1304, 1241, 1122, 827 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.37 (m, 1H),
7.15-7.18 (m, 2H), 6.42 (s, 2H), 6.13 (dd, J= 10.5, 17.4, 1H), 5.94 (dd, J= 1.5, 17.4, 1H),
5.56 (dd, J= 1.5, 10.2, 1H), 3.81 (s, 3H), 3.77 (s, 6H);

13

C NMR (125 MHz, CDCl3) δ

195.7, 161.8 (d, JC,F = 247), 153.3, 140.6 (d, JC,F = 6.1), 137.9, 136.8, 136.8, 135.5, 134.7,
131.5 (d, JC,F = 7.7), 129.4, 117.6 (d, JC,F = 21.1), 115.4 (d, JC,F = 22.7), 106.5, 61.0, 56.1;
HRMS m/e for C18H17FO4 calcd 316.1111, found 316.1107.
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1-(4-(Benzyloxy)-3',4',5'-trimethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-one (137d)

Title compound was prepared by following General Procedure F. Column
chromatography (1:1 diethyl ether/hexanes) yielded the product (137d) as a yellow solid
(70 %, 81 % brsm), mp 97-98.5 C. IR (neat) max 2964, 2935, 1712, 1674, 1585, 1488,
1228, 1190, 1123, 1001 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.33-7.46 (m, 6H), 7.127.16 (m, 2H), 6.47 (s, 2H), 6.18 (dd, J= 10.5, 17.5, 1H), 6.00 (dd, J= 1.5, 17.5, 1H), 5.57
(dd, J= 1.5, 10.5, 1H), 5.13 (s, 2H), 3.87 (s, 3H), 3.82 (s, 6H);

13

C NMR (75 MHz,

CDCl3) δ 197.0, 158.2, 153.3, 140.2, 137.7, 136.6, 136.0, 135.6, 133.8, 131.1, 129.0,
128.8, 128.3, 127.7, 118.0, 114.4, 106.5, 70.4, 61.1, 56.2; HRMS m/e for C25H24O5 calcd
404.1624, found 404.1609.
1-(3',4',5,5'-Tetramethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-one (137e)
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To a solution of 136e (0.0522 g, 0.158 mmol) in anhydrous dichloromethane (10
mL) were added 4 Å molecular sieves, N-methylmorpholine N-oxide (0.055 g, 0.474
mmol).

After

stirring

the

solution

for

5

minutes

at

room

temperature,

tetrapropylammonium perruthenate (0.0035 g, 0.001 mmol) was added. The reaction was
stirred for 30 min, and then it was filtered through Celite and washed with diethyl ether.
After removing the volatiles under reduced pressure, the obtained crude sample was
purified by column chromatography (1:1 diethyl ether/hexanes) to afford the product
(137e) as a yellow solid (0.0365 g, 70 % yield), mp 98-100 C. IR (neat) max 2935, 1681,
1583, 1488, 1235, 1124, 998 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.38 (d, J= 8.5, 1H),
7.07 (m, 2H), 6.47 (s, 2H), 6.19 (dd, J= 10.5, 17.5, 1H), 6.01 (dd, J= 1.5, 17.5, 1H), 5.57
(dd, J= 1.5, 10.5, 1H), 3.87 (s, 3H), 3.87 (s, 3H), 3.83 (s, 6H);

13

C NMR (125 MHz,

CDCl3) δ 197.0, 158.9, 153.2, 140.1, 137.5, 135.8, 135.5, 133.4, 130.9, 128.8, 117.2,
113.1, 106.4, 61.0, 56.1, 55.6; HRMS m/e for C19H20O5 calcd 328.1311, found 328.1318.
1-(6-(3,4,5-Trimethoxyphenyl)benzo[d][1,3]dioxol-5-yl)prop-2-en-1-one (137f)

To a solution of 136f (0.0935 g, 0.271 mmol) in anhydrous dichloromethane (20
mL) were added 4 Å molecular sieves, N-methylmorpholine N-oxide (0.095 g, 0.814
mmol).

After

stirring

the

solution

for

5

minutes

at

room

temperature,

tetrapropylammonium perruthenate (0.0143 g, 0.041 mmol) was added. The reaction was
159

stirred for 1 h at room temperature, and then it was filtered through Celite and washed
with diethyl ether. After removing the volatiles under reduced pressure, the obtained
crude sample was purified by column chromatography (2:1 diethyl ether/hexanes) to yield
the product (137f) as colorless solid (68 %), mp 136-138 C. IR (neat) max 2937, 1662,
1575, 1479, 1244, 1233, 1117 cm-1; 1H NMR (500 MHz, CD2Cl2) δ 7.04 (s, 1H), 6.91 (s,
1H), 6.46 (s, 2H), 6.10 (dd, J= 10.3, 17.3, 1H), 6.07 (s, 2H), 5.97 (dd, J= 1.8, 17.3, 1H),
5.46 (dd, J= 1.8, 10.3, 1H), 3.79 (s, 6H), 3.78 (s, 3H);

13

C NMR (125 MHz, CD2Cl2) δ

194.9, 153.3, 149.7, 147.1, 136.9, 135.8, 135.7, 133.2, 127.1, 109.5, 108.8, 106.7, 102.1,
60.6, 56.0; HRMS m/e for C19H18O6 calcd 342.1103, found 342.1107.
1-(3,3',4,4',5'-Pentamethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-one (137g)

Title compound was prepared by following General Procedure F. Column
chromatography (2:1 hexanes/diethyl ether) yielded the product (137g) as a yellow oil (95
% yield). IR (neat) max 2958, 2932, 2838, 1652, 1582, 1482, 1458, 1402, 1255, 1124
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.12 (d, J= 8.5, 1H), 7.00 (d, J= 8.5, 1H), 6.46 (s,
2H), 6.36 (dd, J= 11.0, 17.5, 1H), 5.85 (d, J= 10.5, 1H), 5.83 (d, J= 17.5, 1H), 3.91 (s,
3H), 3.83 (s, 3H), 3.82 (s, 3H), 3.80 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 197.4, 153.1,
152.1, 146.1, 138.1, 137.3, 135.1, 133.8, 132.9, 131.3, 125.3, 113.2, 106.4, 61.9, 61.0,
56.2, 56.1; HRMS m/e for C20H22O6 calcd 358.1416, found 358.1414.
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1-(3-(3,4,5-Trimethoxyphenyl)thiophen-2-yl)prop-2-en-1-one (137h)

Title compound was prepared from compound 136h (0.0840 g, 0.274 mmol) by
following General Procedure F. Column chromatography (2:1 diethyl ether/hexanes)
yielded the product (137h) as a yellow oil (0.0587 g, 71 % yield). IR (neat) max 2956,
2915, 2871, 1643, 1583, 1497, 1127 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.60 (d, J= 5.0,
1H), 7.13 (d, J= 5.0, 1H), 6.59 (s, 2H), 6.41 (dd, J= 9.5, 17.0, 1H), 6.35 (dd, J= 2.5, 17.0,
1H), 5.56 (dd, J= 2.5, 9.5, 1H), 3.91 (s, 3H), 3.85 (s, 6H); 13C NMR (125 MHz, CDCl3) δ
184.6, 153.1, 146.5, 139.7, 138.2, 133.8, 131.7, 131.4, 131.36, 128.2, 106.8, 61.0, 56.2;
HRMS m/e for C16H16O4S calcd 304.0769, found 304.0756.
1-(2',3',4,4'-Tetramethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-one (146a)

Title compound was prepared by following General Procedure F. Column
chromatography (1:1 diethyl ether/hexanes) yielded the product (146a) as a yellow oil (73
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% yield). IR (neat) max 2937, 2837, 1668, 1599, 1482, 1463, 1414, 1291, 1272, 1087,
1014 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.30 (d, J= 8.5, 1H), 7.15 (d, J= 2.5, 1H), 7.07
(dd, J= 3.0, 8.5, 1H), 6.88 (d, J= 8.0, 1H), 6.68 (d, J= 8.5, 1H), 6.29 (dd, J= 10.3, 17.3,
1H), 6.10 (dd, J= 1.5, 17.5, 1H), 5.56 (dd, J= 1.5, 10.0, 1H), 3.88 (s, 3H), 3.87 (s, 3H),
3.84 (s, 3H), 3.57 (s, 3H);

13

C NMR (125 MHz, CDCl3) δ 195.1, 158.6, 153.5, 151.1,

142.1, 140.2, 135.2, 132.3, 129.3, 128.4, 126.9, 125.0, 117.1, 113.1, 107.2, 61.0, 60.4,
56.0, 55.5; HRMS m/e for C19H20O5 calcd 328.1311, found 328.1318.
1-(2',3',4'-Trimethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-one (146b)

Title compound was prepared from compound 136j (1.31 g, 4.36 mmol) by
following General Procedure F. Column chromatography (1:1 diethyl ether/hexanes)
yielded the product (146b) as a yellow oil (1.17 g, 90 % yield). IR (neat) max 3057, 2937,
1668, 1599, 1500, 1464, 1406, 1292, 1268, 1214, 1095 cm-1; 1H NMR (500 MHz,
CDCl3) δ 7.62 (apparent dd, J= 1.0, 8.0, 1H), 7.52 (td, J= 1.5, 7.5, 1H), 7.42 (td, J= 1.5,
7.5, 1H), 7.38 (apparent dd, J= 1.0, 8.0, 1H), 6.91 (d, J= 8.5, 1H), 6.70 (d, J= 8.5, 1H),
6.33 (dd, J= 10.5, 17.0, 1H), 6.09 (dd, J= 1.5, 17.5, 1H), 5.59 (dd, J= 1.5, 10.5, 1H), 3.89
(s, 3H), 3.85 (s, 3H), 3.58 (s, 3H);

13

C NMR (75 MHz, CDCl3) δ 195.4, 153.9, 151.1,

142.3, 139.4, 137.1, 135.5, 131.2, 130.8, 128.7, 128.5, 127.4, 127.2, 125.1, 107.3, 61.1,
60.6, 56.1; HRMS m/e for C18H18O4 calcd 298.1205, found 298.12.
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General Procedure G: A dilute solution of , β-unsaturated ketone compound
(133, 146a, and 137a-h) in anhydrous dichloromethane (concentration = 0.002 M) was
cooled to 0 C. Then, a solution of boron trifluoride diethyl ethereate (cat. loading 5 mol
%) in dichloromethane, was slowly added to the reaction solution. Stirring was continued
and the mixture was allowed to gradually warm to room temperature. Upon the complete
consumption of the starting material (3-24 h), the reaction was quenched with a saturated
solution of sodium bicarbonate and extracted with dichloromethane (twice). The organic
layer was separated and dried with anhydrous magnesium sulfate. The volatiles were
removed under reduced pressure and the residue was purified by flash chromatography to
afford the tricyclic ketone products (117b and 138a-g).
3,8,9,10-Tetramethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-one (117b)

(117b) from (133): Compound 133 (0.0408 g, 0.12 mmol) was subjected to the
reaction conditions given under General Procedure G (4 h). Column chromatography
(2:1 diethyl ether/hexanes) afforded title compound (117b) as a colorless solid (0.0307 g,
75 % yield); mp 123-124 C (lit.28 123-125 C). Spectral data are in agreement with those
reported in literature.
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(117b) from (146a): To a solution of 146a (0.0374 g, 0.114 mmol) in anhydrous
dichloromethane (60 mL) was added GaCl3 (4.0 mg, 2.3 x 105 mmol). The mixture was
heated to reflux until disappearance of starting material was evident by TLC (48 h).
Following the addition of water and a conventional extractive workup (dichloromethane),
preparative TLC (1:1 diethyl ether/hexanes) afforded 117b (0.0232 g, 62 % yield).
8,9,10-Trimethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-one (138a)

(138a) from (137a): Compound 137a (0.0408 g, 0.124 mmol) was subjected to
the reaction conditions given under General Procedure G (12 h). Column
chromatography (1:1 diethyl ether/hexanes) yielded the title compound (138a) as a
viscous yellow oil (81 % yield). IR (neat) max 2958, 2923, 2853, 1679, 1455, 1259,
1109, 1019, 800 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.56-7.62 (m, 2H), 7.40-7.43 (m,
2H), 6.73 (s, 1H), 3.93 (s, 3H), 3.89 (s. 3H), 3.88 (s, 3H), 2.92-3.00 (m, 4H);

13

C NMR

(125 MHz, CDCl3) δ 206.8, 152.4, 150.3, 142.2, 139.0, 138.8, 134.7, 132.0, 129.1, 128.4,
127.8, 125.6, 109.4, 61.5, 61.0, 56.2, 47.7, 20.6; HRMS m/e for C18H18O4 calcd
298.1205, found 298.1200.
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(138a) from (146b): To a solution of 146b (0.0280 g, 0.093 mmol) in anhydrous
toluene (30 mL) was added 0.10 mL (0.093 mmol, 1 equiv.) of AlCl3 (1.0 M in
nitrobenzene). The mixture was heated to reflux until disappearance of starting material
was evident by TLC (24 h). Following the addition of water and a conventional extractive
workup, preparative TLC (1:1 diethyl ether/hexanes) afforded 138a (0.0125 g, 45 %
yield).
Methyl 8,9,10-trimethoxy-5-oxo-6,7-dihydro-5H-dibenzo[a,c][7]annulene-3
carboxylate (138b)

Compound 137b (0.0794 g, 2.23 mmol) was subjected to the reaction conditions
given under General Procedure G (the catalytic loading of BF3-OEt2 for this reaction was
10 mol %; reaction time 48 h). Column chromatography (2:1 diethyl ether/hexanes)
yielded the title compound (138b) as a colorless solid (68 % yield), mp 109-110.5 C;
IR (neat) max 2935, 1728, 1676, 1237, 1108 cm-1; 1H NMR (300 MHz, CDCl3) δ 8.26 (d,
J= 1.5, 1H), 8.21 (dd, J= 1.8, 8.1, 1H),7.50 (d, J= 8.1, 1H) 6.73 (s, 1H), 3.94 (s, 3H), 3.93
(s, 3H), 3.89 (s, 3H), 3.89 (s, 3H), 2.97 (br m, 4H); 13C NMR (125 MHz, CDCl3) δ 205.8,
166.1, 152.6, 150.4, 143.0, 142.8, 139.1, 133.7, 132.6, 129.8, 129.6, 129.4, 125.9, 109.4,
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61.5, 61.0, 56.2, 52.4, 47.4, 20.5; HRMS m/e for C20H20O6 calcd 356.1260, found
356.1260.
3-Fluoro-8,9,10-trimethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-one (138c)

Compound 137c (0.0413 g, 0.131 mmol) was subjected to the reaction conditions
given under General Procedure G (48 h) with the exception of a doubling of solvent
volume. Column chromatography (1:1 diethyl ether/hexanes) afforded the title compound
(138c) as a viscous yellow oil (68 % yield). IR (neat) max 2936, 2838, 1680, 1480, 1452,
1410, 1342, 1251, 1196, 1105, 796 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.42 (dd, J= 5.4,
8.4, 1H), 7.24-7.34 (m, 2H), 6.68 (s, 1H), 3.92 (s, 3H), 3.89 (s, 3H), 3.88 (3, 3H), 2.913.00 (m, 4H); 13C NMR (125 MHz, CDCl3) δ 205.2, 162.0 (d, JC,F = 248), 152.5, 150.3,
142.2, 140.5 (d, JC,F = 6.4), 135.0 (d, JC,F = 3.5), 133.7, 131.2 (d, JC,F = 7.0), 125.5, 119.0
(d, JC,F = 21.0), 115.1 (d, JC,F = 22.7), 109.3, 61.4, 60.9, 56.2, 47.3, 20.5; HRMS m/e for
C18H17FO4 calcd 316.1111, found 316.1102.
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3-(Benzyloxy)-8,9,10-trimethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-one
(138d)

Compound 137d (0.0702 g, 0.174 mmol) was subjected to the reaction conditions
given under General Procedure G (reaction time: 48 h). Column chromatography (1:1
diethyl ether/hexanes) yielded the title compound (138d) as a yellow solid (81 % yield);
mp 109-111C. IR (neat) max 2928, 1851, 1675, 1600, 1453, 1411, 1108, 1008, 699 cm-1;
1

H NMR (500 MHz, CDCl3) δ 7.46 (m, 2H), 7.41 (t, J= 7.3, 2H), 7.35-7.37 (m, 2H), 7.24

(d, J= 3.0, 1H), 7.19 (dd, J= 3.0, 8.5, 1H), 6.69 (s, 1H), 5.13 (s, 2H), 3.92 (s, 3H), 3.89 (s,
3H), 3.88 (s, 3H), 2.92-3.00 (m, 4H); 13C NMR (125 MHz, CDCl3) δ 206.3, 158.3, 152.3,
150.3, 141.8, 139.9, 136.5, 134.5, 131.8, 130.7, 128.7, 128.2, 127.6, 125.4, 119.6, 113.3,
109.2, 70.2, 61.5, 61.0, 56.2, 47.5, 29.7, 20.6; HRMS m/e for C25H24O5 calcd 404.1624,
found 404.1621.
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2,8,9,10-Tetramethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-one (138e)

Compound 137e (0.0600 g, 0.183 mmol) was subjected to the reaction conditions
given under General Procedure G (12 h). Column chromatography (2:1 diethyl
ether/hexanes) yielded the title compound (138e) as a colorless solid (70 % yield), mp
120-122 C. IR (neat) max 2928, 1727, 1678, 1482, 1457, 1413, 1255, 1103, 1031 cm-1;
1

H NMR (500 MHz, CDCl3) δ 7.36 (m, 1H), 7.13 (m, 2H), 6.69 (s, 1H), 3.92 (s, 3H),

3.89 (s, 3H), 3.87 (s, 6H), 2.94 (m, 4H);

13

C NMR (125 MHz, CDCl3) δ 206.4, 159.1,

152.3, 150.3, 141.8, 139.8, 134.5, 131.6, 130.6, 125.4, 119.0, 112.2, 109.2, 61.4, 61.0,
56.2, 55.5, 47.5, 20.6; HRMS m/e for C19H20O5 calcd 328.1311, found 328.1310.
2,3,4-Trimethoxy-5H-benzo[3',4']cyclohepta[1',2':4,5]benzo[1,2-d][1,3]dioxol-7(6H)one (138f)
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Compound 137f (0.0510 g, 0.149 mmol) was subjected to the reaction conditions
given under General Procedure G (72 h). Column chromatography (2:1 diethyl
ether/hexanes) yielded the title compound (138f) as a solid (63 % yield), mp 145-147 C.
IR (neat) max 2922, 2851, 1730, 1655, 1498, 1478, 1457, 1250, 1101, 1021 cm-1;
1

H NMR (500 MHz, CDCl3) δ 7.12 (s, 1H), 6.88 (s, 1H), 6.65 (s, 1H), 6.06 (s, 2H), 3.92

(s, 3H), 3.88 (s, 3H), 3.87 (s, 3H), 2.97 (m, 2H), 2.87 (m, 2H);

13

C NMR (125 MHz,

CDCl3) δ 204.9, 152.3, 150.9, 150.1, 147.3, 142.0, 134.9, 134.4, 133.1, 125.7, 109.4,
109.1, 108.6, 101.9, 61.4, 60.9, 56.2, 47.3, 20.6; HRMS m/e for C19H18O6 calcd
342.1103, found 342.1105.
7,8,9-Trimethoxy-5,6-dihydro-4H-benzo[3,4]cyclohepta[1,2-b]thiophen-4-one (138g)

To a solution of 137h (12.6 mg, 0.0414 mmol) in anhydrous dichloromethane (30
mL) was added GaCl3 (1.8 mg, 0.010 mmol, 0.25 equiv.). The mixture was stirred for 48
h at room temperature. Following the addition of water and a conventional extractive
workup (dichloromethane), preparative TLC (1:1 diethyl ether/hexanes) afforded 138g
(8.80 mg, 70 % yield) as a pale yellow oil. IR (neat) max 2931, 1646, 1493, 1452, 1119
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.66 (d, J= 5.5, 1H), 7.33 (d, J= 5.0, 1H), 6.93 (s,
1H), 3.94 (s, 3H), 3.91 (s, 3H), 3.87 (s, 3H), 3.06 (br s, 2H), 2.83 (m, 2H); 13C NMR (125
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MHz, CDCl3) δ 195.4, 151.9, 150.8, 143.6, 142.8, 139.4, 132.7, 129.7, 129.68, 127.1,
108.7, 61.5, 61.0, 56.2, 43.1, 20.0; HRMS m/e for C16H16O4S calcd 304.0769, found
304.0763.
2,3-Dimethoxy-2'H-spiro[cyclohexa[2,5]diene-1,1'-naphthalene]-4,4'(3'H)-dione
(147)

To a solution of 146b (0.0150 g, 0.050 mmol) in anhydrous dichloromethane (15
mL) was added GaCl3 (2.2 mg, 0.0126 mmol). The mixture was stirred for 12 h at room
temperature. Following the addition of water and a conventional extractive workup
(dichloromethane), preparative TLC (1:1 diethyl ether/hexanes) afforded the spiroconjugated compound (147) as a colorless solid (9.63 mg, 67 % yield), mp 135-137 C.
IR (neat) max 3453, 2931, 1685, 1654, 1597, 1491 cm-1; 1H NMR (500 MHz, CDCl3) δ
8.12 (dd, J= 1.0, 8.0, 1H), 7.51 (td, J= 1.5, 7.5, 1H), 7.42 (td, J= 1.5, 7.5, 1H), 7.07 (dd,
J= 0.5, 7.8, 1H), 6.79 (d, J= 10.0, 1H), 6.27 (d, J= 10.0, 1H), 3.94 (s, 3H), 3.81 (s, 3H),
2.95 (m, 1H), 2.83 (m, 1H), 2.70 (m, 1H), 2.24 (m, 1H); 13C NMR (125 MHz, CDCl3) δ
196.1, 184.1, 164.6, 147.0, 141.5, 138.8, 134.1, 132.6, 128.4, 128.1, 127.3, 126.9, 61.2,
60.9, 48.5, 34.3, 32.5; HRMS m/e for C17H16O4 calcd 284.1049, found 284.1051.
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(R)-8,9,10-Trimethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-ol (142a)

A suspension of 3-nitrophenylboronic acid (1.002 g, 6.0 mmol), L-tartaric acid
(0.900 g, 6.0 mmol), and CaH2 (0.500 g, 11.9 mmol) in anhydrous THF (15 mL) was
heated to reflux for 1.5 h. After cooling and allowing the solids to settle completely, the
supernatant solution (ca. 8 mL) was added to ketone 138a (0.1207 g, 0.405 mmol) and
the solution was allowed to stir for 1 h at room temperature. Then, lithium borohydride
(0.2 mL of a 2.0 M solution in THF, 0.405 mmol) was added dropwise over a period of
30 min, and stirring was continued for another one hour at room temperature. The
reaction was then quenched with NaOH (ca. 5 mL of a 10 % aqueous solution) and the
reaction was subjected to a conventional extractive workup using water and diethyl ether.
Column chromatography (2:1 Et2O/hexanes) afforded 142a (0.1199 g, 99 %) as a yellow
viscous oil (99 % ee, Chiralcel OD-H, 10 % i-PrOH/hexanes; flow rate: 0.5 mL/min,
retention time: 20.0 min). [α]22D +80.1 (c 0.625, CH2Cl2). IR (neat) max 3427, 2933,
1404, 1340, 1099, 1041, 1011, 764, 733 cm-1; 1H NMR (500 MHz, DMSO-d6) δ 7.63 (d,
J= 7.5, 1H), 7.37 (m, 3H), 6.79 (s, 1H), 5.21 (d, J= 4.5, 1H), 4.31 (m, 1H), 3.83 (s, 3H),
3.79 (s, 6H), 2.87 (m, 1H), 2.41 (m, 1H), 1.81 (m, 2H); 13C NMR (125 MHz, DMSO-d6)
δ 151.9, 150.7, 143.0, 141.6, 137.7, 135.7, 127.9, 127.7, 127.1, 124.9, 123.9, 108.7, 68.9,
61.9, 60.9, 56.3, 41.9, 21.9; HRMS m/e for C18H20O4 calcd 300.1360, found 300.1360.
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(R)-Methyl 5-hydroxy-8,9,10-trimethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulene-3carboxylate (142b)

Singaram44 protocol: A suspension of 3-nitrophenylboronic acid (1.002 g, 6.0
mmol), L-tartaric acid (0.900 g, 6.0 mmol), and CaH2 (0.500 g, 11.9 mmol) in anhydrous
THF (15 mL) was heated to reflux for 1.5 h. After cooling and allowing the solids to
settle completely, the supernatant solution (ca. 4 mL) was added to ketone 138b (0.024 g,
0.067 mmol) and the solution was allowed to stir for 1 h at room temperature. Then,
lithium borohydride (0.03 mL of a 2.0 M solution in THF, 0.067 mmol) was added
dropwise over a period of 30 min, and stirring was continued for another one hour at
room temperature. The reaction was then quenched with NaOH (ca. 4 mL of a 10 %
aqueous solution) and the reaction was subjected to a conventional extractive workup
using water and diethyl ether. Column chromatography (2:1 Et2O/hexanes) afforded 142b
(0.019 g, 80 %) as a colorless solid (99 % ee, Chiralcel OD-H, 10 % i-PrOH/hexanes;
flow rate: 0.5 mL/min, retention time: 25.5 min), mp 131-133.5 C; [α]22D +128 (c
0.110, CH2Cl2). IR (neat) max 3479, 2934, 1713, 1341, 1290, 1101 cm-1; 1H NMR
(DMSO-d6) δ 8.26 (s, 1H), 7.94 (dd, J= 1.5, 8.0, 1H), 7.52 (d, J= 8.0, 1H), 6.85 (s, 1H),
5.40 (d, J= 5.0, 1H), 4.30-4.34 (m, 1H), 3.89 (s, 3H), 3.84 (s, 3H), 3.80 (s, 3H), 3.79 (s,
3H), 2.88 (dd, J= 6.0, 13.0, 1H), 2.38-2.48 (m, 1H), 1.82-1.88 (m, 1H), 1.72-1.79 (m,
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1H);
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C NMR (75 MHz, DMSO-d6) δ 166.9, 152.1, 150.8, 143.7, 142.6, 142.3, 134.6,

128.8, 128.5, 128.2, 125.2, 108.9, 68.8, 62.0, 61.0, 56.5, 52.7, 41.8, 21.8; HRMS m/e for
C20H22O6 calcd 340.1311 [MH2O]+, found 340.1299.
(S)-7-Azido-2,3,4-trimethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulene (143a)

To a suspension of alcohol 142a (0.0436 g, 0.145 mmol), Zn(N3)2-(pyridine)2
(0.0685 g, 0.217 mmol), and triphenylphosphine (0.1521 g, 0.580 mmol) in toluene (12
mL) was added diisopropyl azodicarboxylate (116µL, 0.580 mmol) in a dropwise fashion.
After stirring for 4 h, the mixture was filtered through a plug of silica gel, and
concentrated under reduced pressure. Column chromatography (5:1 hexanes/Et2O)
afforded compound (143a) as a yellow oil (0.034g, 72 % yield). [α]22D 87 (c 0.55,
CH2Cl2). IR (neat) max 2934, 2097, 1717, 1245,1342, 1110, 766, 747 cm-1; 1H NMR
(500 MHz, DMSO-d6) δ 7.54 (s, 1H), 7.30 (m, 3H), 6.74 (s, 1H), 4.47 (br s, 1H), 3.95 (s,
3H), 3.91 (s, 3H), 3.01 (s, 1H), 2.55 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 152.1, 150.9,
142.0, 138.9, 137.2, 135.5, 128.4, 127.9, 124.5, 108.2, 61.7, 61.1, 56.3, 39.1, 21.6;
HRMS m/e for C18H19N3O3 calcd 325.1426, found 325.1414.
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(S)-Methyl 5-azido-8,9,10-trimethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulene-3carboxylate (143b)

To a suspension of alcohol 142b (0.0844 g, 0.235 mmol), Zn(N3)2-(pyridine)2
(0.111 g, 0.353 mmol), and triphenylphosphine (0.247 g, 0.942 mmol) in toluene (18 mL)
was added diisopropyl azodicarboxylate (188µL, 0.942 mmol) in a dropwise fashion.
After stirring for 4 h, the mixture was filtered through a plug of silica gel, and
concentrated under reduced pressure. Column chromatography (5:1 hexanes/Et2O)
afforded compound (143b) as a yellow oil (0.0676 g, 77 % yield). [α]22D 102 (c 0.490,
CH2Cl2). IR (neat) max 3325, 2980, 2938, 2103, 1721, 1481, 1455, 1435, 1241, 1225,
1108 cm-1; 1H NMR (500 MHz, DMSO-d6) δ 8.07 (s, 1H), 8.01 (d, J= 8.0, 1H), 7.61 (d,
J= 8.0, 1H), 6.91 (s,1H), 4.70 (br s, 1H), 3.89 (s, 3H), 3.86 (s, 3H), 3.81 (s, 6H), 2.80 (br,
1H), 2.54 (m, 1H), 2.02 (m, 1H), 1.21 (m, 1H); 13C NMR (125 MHz, DMSO-d6) δ 166.4,
152.3, 150.9, 142.5, 137.7, 134.1, 129.6, 129.2, 129.1, 124.3, 109.0, 61.9, 60.9, 56.4,
52.7, 38.6, 21.6; HRMS m/e for C20H21N3O5 calcd 383.1481, found 383.1481.
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(S)-N-(8,9,10-Trimethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-yl)acetamide
(144)

Title compound was prepared from azide 143a (0.0333 g, 0.10 mmol) according
to the reductive amination/acylation protocol of Wulff and co-workers.24 Column
chromatography (19:1 CH2Cl2/ MeOH) yielded 144 (0.0248 g, 71% yield) in 98% ee
(Chiralcel OD-H, 10 % i-PrOH/ hexanes; flow rate: 0.5 mL/min, retention time: 22.4
min). A single recrystallization afforded (144), in > 99% ee, as colorless crystals, mp 218220.6 C; [α]22D 35.0 (c 0.355, CHCl3). IR (neat) max 3279, 2933,1635, 1546, 1108,
1054, 770, 749; 1H NMR (500 MHz, DMSO-d6) δ 8.43 (d, J= 8.0, 1H), 7.34-7.37 (m,
4H), 6.84 (s, 1H), 4.52 (m, 1H), 3.86 (s, 3H), 3.80 (s, 3H), 3.79 (s, 3H), 2.92 (m, 1H),
2.18 (m, 1H),1.97 (m, 1H), 1.88 (s, 3H), 1.77 (m, 1H); 13C NMR (75 MHz, DMSO-d6) δ
169.0, 152.2, 150.8, 141.7, 140.3, 138.9, 135.9, 128.5, 128.0, 127.5, 124.4, 123.9, 108.9,
62.0, 61.0, 56.4, 48.9, 23.2, 22.3; HRMS m/e for C20H23NO4 calcd 341.1627, found
341.1616.
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(S)-Methyl 5-acetamido-8,9,10-trimethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulene3-carboxylate (145)

Title compound was prepared from azide 143b (0.0674 g, 0.175 mmol) according
to the reductive amination/acylation protocol of Wulff and co-workers.24 Column
chromatography (19:1 CH2Cl2/ MeOH) yielded 145 (0.033 g, 57% yield) in 99 % ee
(Chiralcel OD-H, 10 % i-PrOH/hexanes; flow rate: 0.5 mL/min, retention time: 29.5
min). A single recrystallization afforded (145), in > 99% ee, as colorless crystals, mp 205207.5 C; [α]22D 136.7 (c 0.1550, CHCl3). IR (neat) max 3266, 2928, 1720, 1643, 1298,
1103, 1012 cm-1; 1H NMR (500 MHz, DMSO-d6) δ 8.61 (d, J= 8.5, 1H), 7.95 (m, 2H),
7.55 (d, J= 7.5, 1H), 6.93 (s, 1H), 4.52 (m, 1H), 3.86 (s, 3H), 3.80 (s, 3H), 3.79 (s, 3H),
2.92 (m, 1H), 2.18 (m, 1H), 1.97 (m, 1H), 1.88 (s, 3H), 1.77 (m, 1H);

13

C NMR (75

MHz, DMSO-d6) δ 169.1, 166.8, 152.3, 150.9, 143.8, 142.4, 141.1, 134.7, 129.1, 129.0,
128.4, 124.8, 124.6, 109.0, 62.1, 61.0, 56.4, 52.8, 48.9, 26.0, 23.2, 22.2; HRMS m/e for
C22H25NO6 calcd 399.1682, found 399.1675.
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